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ABSTRACT 
DEVELOPMENT OF COLLOIDS-BASED FOOD DELIVERY SYSTEMS TO 
ENHANCE THE BENEFICIAL EFFECTS OF NUTRACEUTICALS FOR 
HUMAN HEALTH 
 
MAY 2019 
 
B.A., GANSU AGRICUTURE UNIVERSITY, CHINA 
 
M.A., SOUTHWEST UNIVERSITY, CHINA 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST, USA 
 
Directed by: Professor David Julian McClements 
 
 
Numerous bioactive agents within the food and pharmaceutical industries need to 
be encapsulated in delivery systems to overcome problems associated with poor water-
solubility, chemical instability, and low oral bioavailability. Hydrogel particles are one 
kind of food-grade delivery system that offers considerable scope for tailored 
functionality, which can be used for encapsulation, protection, and controlled release of 
these bioactives. In current studies,  hydrogel particles were formed by polysaccharides 
(i.e., alginate or pectin) and protein (i.e., casein or gelatin) through complex coacervation. 
Our results indicated that the encapsulation of protein or polyunsaturated lipid droplets 
nanoparticles within the hydrogel particles could improve their chemical or physical 
stability during storage. The lipid droplets encapsulated within the hydrogel particles 
could be released under simulated oral conditions, which was triggered by a pH or 
temperature change. The current study further fabricated the hydrogel particles (beads) 
using alginate or carrageenan based on an injection-gelation method. We found 
carrageenan beads had a relatively fragile structure that was easily disrupted in the GIT 
and released the encapsulated lipid droplets and curcumin. Conversely, alginate beads 
 vii 
had a robust structure that remained relatively intact throughout the GIT and retained the 
lipid droplets and curcumin. The incorporation of the β-carotene-loaded lipid droplets 
into hydrogel beads greatly improved its chemical stability during storage and digestion 
process. The current study further fabricated the hydrogel beads with self-regulating 
internal pH microclimates by encapsulating antacid agents (i.e., Mg(OH)2 or CaCO3) 
inside them. A quantitative fluorescence confocal laser scanning microscopy (CLSM) 
method was developed to map the local pH inside the hydrogel beads. Our results showed 
that the pH inside antacid-loaded beads remained close to neutral in the mouth and 
stomach, leading to retention the activity of acid sensitive agents (i.e., lactase, lipase, 
insulin and probiotics) in the small intestine. The current study further studied the effect 
of pH on the encapsulation, retention and release of whey proteins from alginate-based 
hydrogel beads. Our results indicated that the protein encapsulation efficiency and 
retention of the beads increased with decreasing fabrication pH, which was attributed to 
the fact that there was a strong electrostatic attraction between the cationic protein and 
anionic beads matrix (alginate molecules) at low pH conditions. We further found heat-
denaturation of the protein prior to microgel formation led to the highest encapsulation 
efficiency and retention, which was attributed to the formation of a cold-set protein gel 
inside the beads. Simulated GIT studies indicated that protein encapsulation in the 
microgels retarded its digestion in the stomach, but not in the small intestine. Overall, our 
study suggest that hydrogel particles with different structures and compositions can be 
designed for encapsulation, protection, and delivery of hydrophilic or lipophilic bioactive 
agents, which is advantageous for the development of certain functional food products.  
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CHAPTER 1 
INTRODUCTION 
Many pharmaceuticals, nutraceuticals, and vitamins have to be encapsulated 
within delivery systems to overcome physicochemical or physiological challenges that 
normally limit their efficacy, such as poor water solubility, chemical or biochemical 
instability, and low or variable oral bioavailability 1. Numerous types of delivery systems 
have been designed to control the retention, stability, and release of bioactive components 
within the gastrointestinal tract (GIT) 2. In particular, there has been a strong emphasis on 
developing delivery systems that can target or control the release of bioactives at specific 
locations within the GIT (such as mouth, stomach, small intestine, or colon) because this 
may improve their efficacy, as well as reduce any undesirable side effects.  Food grade 
delivery systems are one of the most suitable candidates for encapsulation and delivery of 
bioactives because they are relatively simple and inexpensive to fabricate 3.  
 
Figure 1. 1 A variety of bioactive molecules or particles can be trapped inside filled 
hydrogel particles to alter their physicochemical properties and delivery. 
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Hydrogel particles are one category of food grade delivery system that offers 
considerable scope for tailored functionality (Figure 1.1).  Hydrogel particles contain 
biopolymer networks with a three-dimensional structure that is capable of trapping 
relatively large quantities of water 4.  A filled hydrogel particle contains oil droplets 
trapped within the biopolymer network 5. Typically, bioactives are first dissolved in an 
oil phase, and then an oil-in-water emulsion is formed by homogenizing this oil phase 
with an aqueous phase containing a suitable emulsifier.  The resulting oil droplets are 
then trapped within the hydrogel particles during the preparation procedure. The ability to 
tune the composition, dimensions, shape, and internal structure of hydrogel particles has 
led to widespread interest in their utilization as delivery systems in the food, 
pharmaceutical, and personal care industries.  
In my projects, I was working on the formation and design of food-grade hydrogel 
particles that can encapsulate bioactive agents suitable for use in the food industry, such 
as oil-soluble vitamins and nutraceuticals. In particular, My research focus on the 
application of hydrogel particles for controlled or targeted release of bioactive agents in 
the GIT. 
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CHAPTER 2 
 
LITERATURE REVIEW 
2.1 Hydrogel particle characteristics 
The structural and physicochemical characteristics of hydrogel particles can be 
manipulated to tailor their functional attributes for specific applications.  In this section, 
we therefore highlight some of the most important properties of hydrogel particles that 
can be controlled during the fabrication process, e.g., particle composition, size, pore size, 
and cross-linking. 
2.1.1 Composition 
Hydrogel particles are typically fabricated from natural polymers (such as 
proteins and polysaccharides) due to their good biocompatibility and biodegradability. 
The nature of the biopolymers used to assemble hydrogel particles determines many of 
their functional attributes, such as stability, retention, and release properties. It is 
therefore crucial to have a good understanding of the molecular, physicochemical and 
physiological properties of the biopolymer molecules used to fabricate a hydrogel particle.  
Typically, biopolymers can be distinguished based on their conformations in solutions 
such as globular, random coil, or rod-like (Figure 2.1). 
2.1.2 Polysaccharides 
Polysaccharides are usually isolated from plant or microbial sources and may vary 
considerably in their molecular and physicochemical properties, such as molecular 
weight, branching, flexibility, charge, polarity and digestibility 6. There are a large 
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number of different polysaccharides available to form hydrogels, and we only focus on a 
selected number that have been widely used.  In general, there are three major 
mechanisms that can be used to prepare hydrogels from polysaccharides, i.e. ionotropic, 
cold-set, and heat-set gelation 7. 
 
Figure 2. 1 Biopolymers may adopt different conformations in aqueous solutions, which 
influences their ability to form hydrogel particles with different effective volume 
fractions and volume ratios (Rv). 
2.1.2.1 Pectin 
Pectin can be considered to consist of a linear anionic backbone with neutral side 
chains protruding from certain regions, with an overall molecular weight of around 110 to 
150 kDa 8. The linear backbone is mainly comprised of α(1-4)-d-galacturonic acid 
residues that may be partly esterified with methyl groups.  The degree of methyl 
esterification (DE) is an important factor determining the gel forming properties of  
pectin. Low methoxy (LM) pectin has DE < 50%, and is typically gelled via ionotropic 
gelation by adding divalent ions (e.g. calcium). High methoxy (HM) pectin has a DE > 50% 
and is typically gelled by adding high levels of soluble solids (such as sugar) under acidic 
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conditions 9. Pectin is not digested by gastric or small intestinal enzymes, but is easily 
degraded by pectinases produced by the colonic microflora. LM pectin is more tolerant of 
pH variations and calcium levels, which could make it more suitable for colonic delivery 
systems formation 10. Calcium pectinates have been widely used in different formulations 
for the lipophilic bioactive agents encapsulation and delivery 11-12.The integrity of 
calcium pectinate beads can be reinforced by formation of polyelectrolyte coatings, e.g., 
by electrostatic deposition of cationic biopolymers (such as chitosan) onto the anionic 
beads13. The charge characteristic of pectin can be selected to control lipid digestion and 
bioactive release, e.g., decreasing DE reduced lipid digestion and bioactive 
bioavailability 14-16. 
2.1.2.2 Alginate 
Alginate is a linear anionic biopolymer that is widely used to form hydrogel 
particles to encapsulate lipophilic agents17-19. Alginate is a block copolymer composed of 
1-4-linked residues of β-D-mannuronic acid (M) and α-L-guluronic (G) acid, with an 
overall molecular weight around 60 kDa to 700 kDa 20. Alginate hydrogels are usually 
formed through an electrostatic cross-linking interaction between multivalent cations 
(typically Ca2+) and anionic carboxyl groups (-COO-) on G residues from different 
alginate chains21. The pore size of this type of hydrogel has been reported to be between 
5 and 200 nm depending on alginate and calcium concentration 22. Calcium alginate 
hydrogels shrink at low pH (gastric environment) due to the loss of negative charge on 
the alginate molecules when the carboxyl groups become protonated (-COOH, pKa ≈ 3.5). 
On the other hand, once transferred into higher pH solutions (intestinal phase), the 
alginate molecules become highly charged and the hydrogel network may swell 23. This 
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pH dependent behavior can be exploited to fabricate targeted delivery systems for GIT 
applications. Alginate can be further cross-linked or mixed with other polymers such as 
neutral gums, chitosan or pectin to strengthen the structure and restrict the pore of the gel 
network 22. Studies indicate that the guluronic acid content of the alginate molecules 
influences the release properties of alginate-based hydrogels: the amount of bioactive 
component that diffused out of alginate hydrogels decreased with increasing G-content 24. 
2.1.2.3 Carrageenan 
Carrageenan is another type of linear anionic polysaccharide that is commonly 
used to form hydrogels25.  It consists of galactan monomers linked together by alternating 
(1→3)- and (1→4)-β-D-glycosidic bonds, and has a negative charge due to the presence 
of sulfate groups 26. Carrageenan can form hydrogels through ionotropic gelation coupled 
with a cold-set mechanism. Three types of carrageenan (κ, ι and λ) are commonly used 
that have different molecular and gelation properties: κ- and γ- carrageenan can undergo 
coil-helix conformational transitions and form hydrogels upon cooling in the presence of 
appropriate salts. Gelation of κ-carrageenan is promoted by the presence of potassium 
ions, whereas γ-carrageenan gelation is promoted by the presence of calcium ions. The κ-
type dissolves when heated and forms strong gels that tend to be rigid and brittle, whereas 
the γ-type is either hot or cold soluble and forms soft, elastic and cohesive gels. λ-
carrageenan does not form gels, but it can be used to thicken solutions or as an anionic 
building block for structures held together by electrostatic interactions. These differences 
in functional performance can be attributed to differences in molecular structure, such as 
the linear density of sulfate groups and the preferred molecular conformation (helix 
versus ribbon) 20, 27. After hydrogel formation, it is sometimes possible to modify 
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hydrogel properties and release characteristics by covalent cross-linking, e.g., κ-
carrageenan hydrogel particles have been cross-linked using genipin 28. 
2.1.2.4 Agar 
Agar is a linear neutral polysaccharide that is capable for forming hydrogels under 
appropriate conditions29.  The agar molecule consists of alternating β-1,3-linked-D-
galactose and α-1,4-linked 3,6-anhydro-L-galactose units, and has an overall molecular 
weight above about 100 kDa. The gelling properties of agar depend on its molecular 
weight and chemical characteristics 30. Agar can be dissolved in water after heating, and 
forms a hydrogel when the solution is cooled due to a coil-helix transition and hydrogen 
bonding of helical regions of different molecules. It can therefore be used to form 
hydrogel particles by cooling agar microspheres formed by extrusion or biopolymer 
phase separation 31. Agar hydrogels tend to be transparent, rigid, and brittle. The gelation 
temperature of agar (Tg ≈ 40 °C) tends to be appreciably lower than the melting 
temperature (Tm ≈ 85 °C), which can be useful for forming hydrogel particles that are 
stable over a range of temperatures. The melting and gelling temperatures of agar gels 
have been reported to decrease in the presence of ionic surfactants, whereas nonionic 
surfactants had the opposite effect 32.  Thus, it may be possible to control their thermal 
behavior by incorporating additives that modulate the melting and gelation temperatures. 
2.1.2.5 Starch 
Starch is a water-soluble polysaccharide mainly composed of two types of 
biopolymers: amylose and amylopectin. Amylose is a linear biopolymer consisting of α-
D-glucopyranose units joined by (1 → 4) linkages, whereas amylopectin is a branched 
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biopolymer with a main chain similar to amylose, but with branches formed due to the 
presence of (1 → 6) linkages 33. Certain types of starch (“digestible starch”) are rapidly 
degraded in the mouth and stomach due to hydrolysis by a-amylase, whereas other types 
of starch (“resistant starches”) are not hydrolyzed until they reach the colon. Hydrogel 
particles have been fabricated by thermal gelatinization of digestible starch and used for 
targeted delivery of oil-soluble flavors 34-36. Native starches may be modified by various 
chemical, enzymatic, and physical methods to improve their functional properties, such 
as addition of attachment of hydrophobic, polar, or charge groups, as well as controlled 
hydrolysis or cross-linking 37. Modified starches have been widely used to form different 
kinds of hydrogel particles for bioactive delivery. For example, chemically modified 
starches have been used for targeted delivery of curcumin 38. 
2.1.2.6 Chitosan 
Chitosan is one of the few examples of positively charged polysaccharides 
available to form hydrogels.  It has a linear structure composed of randomly distributed 
β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine units, with an overall average 
molecular weight around 3.8 to 20 kDa 39. The presence of ionizable amino groups (-
NH3+, pKa ≈ 6.3) is the origin of the cationic charge on chitosan and plays an important 
role in its ability to form hydrogels40-41. Chitosan hydrogels can be formed by 
complexation with anionic biopolymers or multivalent ions (such as tripolyphosphate)42. 
The hydrogel particles formed by chitosan tend to swell and dissolve at low pH (gastric 
environment) but be insoluble at higher pH ranges (intestinal phase) due to changes in the 
charge characteristics 43. The mechanism of pH sensitive swelling involves the 
protonation of amine groups of chitosan under low pH conditions. This property means 
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that it is possible to use chitosan to fabricate targeted delivery systems for gastric 
applications. Chitosan-based hydrogel particles may also be a good candidate for delivery 
of lipophilic bioactive agents due to their mucoadhesive properties, which may prolong 
the contact time between the bioactive and absorption sites in the GIT 44. 
2.1.2 Protein 
Proteins are the other commonly used food biopolymer for the fabrication of 
hydrogel particles. Protein-based hydrogels can be formed by various strategies including 
heat-set, cold-set, and ion-set gelation.  Hydrogel particles can be formed using a number 
of top-down and bottom-up fabrication methods (see Section 3).  After particle 
fabrication, a chemical, physical, or enzymatic hardening step can be used to further 
cross-link the proteins and stabilize the particle structures formed 45-48.  It should be noted 
that many proteins have anti-oxidant properties, which makes them particularly suitable 
for encapsulation of lipophilic bioactive agents that are susceptible to oxidation, such as 
carotenoids and w-3 oils. 
2.1.2.1  Gelatin 
Gelatin is usually obtained by acid or alkaline treatment of collagen extracted 
from animal or fish sources. Gelatin can form hydrogels through two different 
mechanisms leading to physical or chemical gels. Physical gels are the result of reversible 
(non-covalent) cross-links formed between different gelatin molecules, which are usually 
induced by cooling below the coil-to-helix transition temperature of gelatin chains 49. 
Conversely, chemical gels are the result of the formation of covalent cross-links between 
different gelatin molecules by chemical or enzyme reactions. Previous studies have 
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shown that once gelatin is cross-linked by chemicals (e.g., gluteraldehyde) or enzymes 
(e.g., transglutaminase), it loses the ability to undergo thermally reversible coil-to-helix 
transitions 50.  Physical gelatin gels can melt slightly below the physiological temperature 
of humans. This “melt-in-the-mouth’’ property can be used to develop gelatin-based 
delivery systems for targeted delivery of bioactive components in the mouth 34. 
2.1.2.2 Whey protein 
Whey proteins are isolated from the supernatant that remains after milk is treated 
to precipitate the casein proteins.  Whey protein actually contains numerous different 
globular protein fractions, with the most abundant being β-lactoglobulin (β-Lg), α-
lactoalbumin (α-La), bovine serum albumin (BSA), and immunoglobulins with molecular 
weights ranging from 14 kDa to 1,000 kDa 51. Whey proteins can form heat-set and cold-
set gels through different processing strategies. Heat-set gels are produced when globular 
proteins are heated above their thermal denaturation temperature under conditions that 
favor protein-protein interactions (i.e., pH near pI and/or high ionic strength).  Cold-set 
gels are formed using a two-step process.  First, the globular proteins are heated above 
their thermal denaturation temperature under conditions that oppose protein-protein 
interactions (i.e., pH far from pI and low ionic strength), which leads to the formation of 
unfolded proteins that assemble into thin filaments.  Second, conditions are altered to 
favor protein-protein interactions (i.e., pH near pI and/or high ionic strength), which 
promotes protein gelation due to aggregation of the filaments.  Cold-set gels are 
particularly suitable for encapsulating lipophilic bioactive agents that are thermally 
unstable52-53.  Whey proteins have an isoelectric point around pH 5, and so are positively 
charged below this value and negatively charged above it. They can therefore be used to 
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assemble structures based on electrostatic attraction, such as coacervates and multilayers.  
In addition, whey proteins are surface-active and can be used to form oil-in-water 
emulsions.  However, whey protein-coated lipid droplets are particularly sensitive to pH, 
ionic strength, and temperature. 
2.1.2.3 Casein 
Caseins are a group of fairly flexible proteins isolated from milk by selective acid 
or enzyme precipitation.  There are four major casein fractions in bovine milk that have 
somewhat different molecular structures and functional properties: aS1 (~ 44%), aS2 (~ 
11%), b (~ 32%) and k (~ 11%) 54. Nevertheless, all types of caseins have relatively 
disordered and flexible structures, with a limited amount of secondary and tertiary 
structure.  Certain caseins have regions along their backbones that are either highly non-
polar or highly charged, which plays an important role in determining their ability to 
associate into hydrogels and other structures.  In their native state, caseins usually exist as 
molecular clusters (“casein micelles”) that are typically between about 50 and 250 nm in 
diameter and are partly held together by mineral ions (such as calcium phosphate). Casein 
micelles may be useful for the development of delivery systems because they can 
encapsulate lipophilic bioactives in their non-polar interiors, such as carotenoids, 
curcumin, and oil-soluble vitamins 55-58.  Caseins are amphiphilic molecules that have 
good surface-activity and can therefore be used as emulsifiers to stabilize lipid droplets.  
They have an isoelectric point around pH 4.6, and are positive at lower pH and negative 
at higher pH.  Casein molecules, casein micelles or casein-coated oil droplets tend to 
aggregate strongly around their isoelectric point due to the reduction in electrostatic 
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repulsion at this pH 59.  Caseins are less sensitive to thermal treatments than globular 
proteins (such as whey protein) due to their disordered flexible structures. 
2.2 Hydrogel particle fabrication methods 
The properties of hydrogel particles can be tailored for specific applications by 
selecting the most appropriate fabrication method and operation conditions.  A wide 
range of different techniques can be utilized to fabricate hydrogel particles, which have 
been reviewed in detail elsewhere 60. Some of the most suitable methods for 
encapsulating lipophilic or hydrophilic bioactives are discussed below. 
2.2.1 Coacervation-based gelation methods 
Coacervation is a well-established technique for encapsulation of bioactive 
components, and it is already widely used in the food industry for fabricating hydrogel 
particles 61-62. The bioactive is trapped within an electrostatic complex formed when two 
oppositely charged biopolymers associate with each other through electrostatic attraction, 
and then the resulting system is gelled to form a hydrogel particle63-64.  The 
swelling/shrinking behavior of hydrogels based on complex coacervation depend on pH 
and ionic strength since these parameters influence the sign, magnitude, and range of 
electrostatic interactions. Changes in pH alter the electrical characteristics of proteins and 
ionic polysaccharides, which influences the formation, stability, and properties of 
coacervate-based hydrogels. For example, a protein and anionic polysaccharide associate 
at pH values around and below the isoelectric point of the protein due to electrostatic 
attraction (one anionic, one cationic), but they may dissociate at higher pH values due to 
electrostatic repulsion (both anionic).  Addition of salt weakens electrostatic attraction, 
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which may also cause dissociation of coacervates.  The type and amount of biopolymers 
used to assemble a coacervate also determines its properties.  The ratio of two 
biopolymers required to form a hydrogel particle using coacervation depends on their 
charge densities 65. The release characteristics of hydrogel particles can be controlled by 
manipulating their composition and fabrication e.g., biopolymer type and concentration, 
order of mixing, stirring conditions, temperature, pH, and ionic strength 66-70.  The pH 
sensitivity of hydrogel particles can be improved by cross-linking the biopolymers 
molecules or by coating them with a layer of polyelectrolytes 71. The main limitations of 
the coacervation method are that it is difficult to tightly control the particle dimensions 
and to avoid particle coalescence and phase separation over time. Previous studies have 
shown that hydrogel particles based on coacervation may vary widely in size, ranging 
from less than 100 nm to greater than 100 µm 34, 72. 
Recently, filled hydrogel particles have been fabricated within our laboratory 
based on complex coacervation using various combinations of biopolymers, e.g. alginate-
chitosan, pectin-casein, gelatin-starch, gelatin-pectin, and alginate-casein 62, 73-75. The 
encapsulation of lipids within coacervate-based hydrogel particles has been shown to 
delay their digestion by pancreatic lipases, which may be useful to controlled delivery 
systems for gastrointestinal applications 76. 
2.2.2 Thermal-denaturation gelation methods 
Studies have shown that protein hydrogels can be formed by heating a solution of 
globular proteins above its thermal denaturation temperature under controlled solution 
conditions, e.g. protein concentration, pH, ionic strength, and holding temperature/time 
77-78.  The proteins expose non-polar groups on their surfaces after they are denatured, 
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which increases the hydrophobic attractive between them. The protein molecules will 
tend to associate with each other and form nanoparticles when the hydrophobic attraction 
is strong enough to overcome any electrostatic repulsion, but not too strong to promote 
extensive aggregation.  The size of the hydrogel particles formed can be controlled by 
altering the initial biopolymer concentration, holding time, holding temperature, pH and 
ionic strength 79. Mixed biopolymer hydrogel particles have been formed by controlled 
thermal treatment of electrostatic complexes containing globular proteins and ionic 
polysaccharides. These particles were formed by heating a solution of globular proteins 
above their thermal denaturation temperature at a specific pH and then complexing with 
an ionic polysaccharide 70, 77, 80-81, or by directly heating a solution of protein–
polysaccharide complexes above the protein's thermal denaturation temperature at a 
specific pH 82. 
2.2.3 Emulsification-based gelation methods 
Emulsification-based methods typically rely on the formation of a water-in-oil 
(W/O) emulsion or microemulsion containing biopolymer molecules dissolved in the 
internal aqueous phase, and then gelling the internal aqueous phase 83.  Typically, an 
aqueous phase containing the biopolymer and an oil phase containing a lipophilic 
surfactant are homogenized together to form a W/O emulsion.  Any bioactive 
components are usually incorporated into the aqueous phase prior to homogenization.  
After the W/O emulsion has been formed the internal aqueous phase is gelled using a 
method that is appropriate for the biopolymer used. For example, a heat-set biopolymer 
could be gelled by heating, a cold-set biopolymer by cooling, or an ion-set biopolymer by 
adding an appropriate organic salt or acid to the oil phase.  Once the internal aqueous 
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phase has gelled, the resulting hydrogel particles have to be isolated from the surrounding 
oil phase, which can be achieved by centrifugation, filtration, and washing with an 
organic solvent.  Finally, the washed hydrogel particles can be dispersed into an aqueous 
solution.  This method can also be used to form filled hydrogel particles by preparing an 
O/W/O emulsion, gelling the aqueous phase, and then isolating the filled hydrogel 
particles from the external oil phase. One of the major advantages of the emulsification-
based methods is that relatively small hydrogel particles with well-defined sizes can be 
produced.  Hydrogel nanoparticles (10 to 1000 nm) can be formed using W/O 
microemulsions as templates, whereas hydrogel microparticles (100 nm to 100 µm) can 
be formed using W/O emulsions. 
2.2.4 Injection-based gelation methods 
Injection or extrusion methods are commonly used to form hydrogel particles 
from food-grade biopolymers 84-86. In this case, a biopolymer solution containing the 
bioactive agent is initially placed into an injection system, such as a syringe (Figure 2.2).  
The biopolymer solution is then injected into another “hardening” solution under 
conditions that promote gelation of the biopolymer molecules.  The hardening solution 
used depends on the gelation mechanism of the biopolymers.  A cold or hot hardening 
solution could be used to promote cold-set or heat-set gelation of biopolymers.  A 
hardening solution containing calcium ions could be used to promote ion-gelation of 
anionic biopolymers, such as alginate, pectin, or carrageenan.  Enzyme or chemical cross-
linking agents could be included to promote hydrogel formation through covalent bonds.  
The size of the hydrogel particles formed can be manipulated by controlling the needle 
diameter, flow rate, and solution viscosity. 
  16 
Calcium alginate beads are commonly formed using the injection method.  For 
example, filled hydrogel particles have been formed by mixing lipid droplets with an 
alginate solution, and then injecting this mixture into a hardening solution containing 
calcium ions. An in vitro digestion study indicated that calcium alginate beads were 
particularly effective at retarding the digestion of the encapsulated lipids, with the extent 
of inhibition increasing with increasing bead size and decreasing pore size 76. The 
functional properties of calcium alginate beads can be further modulated by coating them 
with another polyelectrolyte, such as chitosan 87-88. 
 
Figure 2. 2 Schematic representation of injection method used to produce hydrogel beads. 
A solution containing bioactive and biopolymer is injected into a hardening solution. 
2.2.5 Shearing-based gelation methods 
Fluid gels have been defined as suspensions of hydrogel particles formed by 
application of a flow field to a gelling biopolymer solution. Typically, the bioactive and 
biopolymer are dissolved within an aqueous solution, the system is stirred continuously, 
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  17 
and then gelation is induced using an appropriate method (e.g., altering temperature, 
changing pH, or adding a gelling agent). The dimensions of the particles produced are 
typically around 4 to 100 µm, and depend on the shear rate relative to the gelation rate 89. 
Studies of hydrogel particles formed using this method have shown that their size, shape, 
and strength can be controlled by varying biopolymer type and concentration, gelation 
mechanism, and shearing conditions e.g., rate, duration, and type 90-91. This creates an 
attractive opportunity to fabricate hydrogel particles with specific functional attributes 92. 
For example, fluid gels have been designed to act as pourable viscoelastic fluids suitable 
for the oral delivery of bioactives to individuals with difficulties swallowing 92. 
2.2.6 Spray drying and spray chilling-based methods 
Hydrogel particles can also be formed using spray drying and spray chilling 
methods 20, 93.  In spray drying, an aqueous solution containing the bioactive component 
and the biopolymer is forced through a small nozzle into a hot chamber.  The nozzle 
converts the biopolymer solution into small fluid drops that are rapidly converted into 
solid particles due to water evaporation caused by the hot air.  The solid particles are then 
collected by filtration or centrifugal forces94.  Typically, the solid particles formed have 
dimensions of around 10 to 100 µm, and have to be carefully designed to ensure good 
powder functionality (e.g., flowability, dispersion, and dissolution).  Hydrogel particles 
can be formed by dispersing the powder into an aqueous solution containing a suitable 
gelling agent.  The size of the hydrogel particles formed depends on the relative rates of 
dissolution versus gelation 20.  Spray chilling can often be carried out using a similar 
apparatus as used for spray drying, however the chamber is usually cooled rather than 
heated 93.  In this case, the bioactive and a cold-set biopolymer are dissolved in an 
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aqueous solution held at a temperature above the gelation temperature.  The biopolymer 
solution is then sprayed out of a nozzle into a cooled chamber, which promotes gelation 
of the biopolymers and leads to formation of hydrogel particles that can be collected by 
centrifugal forces or filtration. 
2.2.7 Other methods 
The fabrication methods discussed above are some of those that are most 
commonly used to form food-grade hydrogel particles suitable for encapsulation and 
delivery purposes.  Nevertheless, there are also many other methods that might be 
utilized for specialist applications, such as molding, microfluidic, and electrospraying 
methods. A number of review articles have been published detailing the application of 
these methods for hydrogel particle fabrication 20, 31. 
2.3 Body-particle interactions 
Hydrogel particles can be designed to retain, protect, and deliver bioactive 
components to specific regions within the gastrointestinal tract 95.  For example, they 
might be used to release desirable flavor molecules within the mouth or to retain bitter 
bioactive molecules in the mouth but release them in the stomach.  Alternatively, they 
may be designed to protect labile bioactive components from the harsh conditions in the 
stomach, but release them within the small intestine or colon.  Knowledge of the different 
physicochemical and physiological conditions within the different regions of the GIT is 
required to design effective delivery systems that can retain and release bioactive 
components at specific sites (Figures 2.3 and 2.4). 
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Figure 2. 3 Potential release trigger of bioactive released from hydrogel particles in 
mouth, stomach, small intestinal and colon. 
 
2.3.1 Mouth 
Numerous variables need to be taken into account when designing hydrogel 
particles to retain or release bioactive components in the mouth, including oral 
temperature, saliva composition and flow rate, pH and ionic strength, frictional forces, 
mixing conditions, duration, and enzyme activity 96-97. Typically, fluid foods spend a 
shorter time in the mouth and are not subjected to intense mechanical forces during 
mastication, and are therefore often less susceptible to alterations induced by oral 
processing than solid foods 98. The utilization of hydrogel particles to control the release 
of drugs within the mouth has been investigated by pharmaceutical researchers 99, and 
much of the information obtained from these studies is useful for food applications. Some 
food researchers have also examined the utilization of hydrogel particles to control the 
release of lipophilic bioactive food components in the mouth100-101. 
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Malone and co-workers fabricated a range of different filled hydrogel particles to 
control the release of lipophilic flavors in the mouth through different mechanisms 34. 
Calcium-alginate particles remained intact within the mouth during mastication and 
therefore released the flavors primarily through a diffusion-controlled mechanism. Agar 
particles broke down in the mouth due to fragmentation by mechanical forces and 
therefore released the particles primarily by a degradation-controlled mechanism. Gelatin 
particles and gelatin–gum complexes were susceptible to a combination of melting and 
fragmentation triggers, while starch particles were susceptible to a combination of a-
amylase and fragmentation triggers. Factors such as hydrogel particle size, oil content, 
and partition coefficient affected the rate of flavor release 34. Our laboratory has 
fabricated hydrogel particles based on complex coacervation of casein and alginate that 
dissociated and released encapsulated lipid droplets under simulated oral conditions due 
to a pH change 75. 
 
Figure 2. 4 Delivery systems may be designed to remain intact under one set of 
conditions, but breakdown under another set of conditions.   
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2.3.2 Stomach 
In some cases it is desirable to have a delivery system that remains intact within 
the stomach so that it can protect an encapsulated bioactive component from degradation 
by acids or enzymes, whereas in other cases it is more desirable to release it in the 
stomach to enhance its bioactivity 102. Hydrogel particles encounter a number of harsh 
physicochemical and physiological conditions within the dynamic stomach environment 
103. They are mixed with highly acidic gastric fluids (pH 1 to 3) that have a relatively high 
mineral content (e.g., calcium, potassium, and sodium salts) and contain various types of 
digestive enzyme (e.g., proteases, lipases, and amylases) and surface-active substances 
(e.g., phospholipids and proteins). In addition, they are subjected to dynamic mechanical 
forces and fluid flows due to the motility of the gastric chamber 104-105. 
Alginate gel bead was fabricated with the vegetable oil hold inside the hydrogel 
beads. In vitro digestion results indicated that release rate of drug from these hydrogel 
beads in artificial gastric juice was inversely related to the percentage of oil, which was 
due to the buoyancy characterization of the gel beads at presence of oil inside the gel 
particles 106. Other study suggested that oil-entrapped calcium pectinate gel beads also 
showed a buoyancy characterization in stomach phase, which made them an excellent 
candidate of gastro-retention delivery system for lipophilic agents 107. Calcium alginate 
beads have been shown to remain intact under stomach conditions, and are therefore 
capable of protecting bioactive components in the gastric environment 76.  On the other 
hand, various types of protein-based hydrogel particles have been shown to degrade 
under simulated gastric conditions, and may therefore be suitable for releasing bioactive 
components in the stomach 108-109. 
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2.3.3 Small intestine 
After entering the duodenum, any hydrogel particles remaining in the chyme will 
be mixed with alkaline small intestinal fluids containing bile salts, phospholipids, 
digestive enzymes, and various salts. Pancreatic enzymes (a complex mixture of 
proteases, amylases, and lipases) and other digestive enzymes produced by the small 
intestine act in concert to degrade any digestible macronutrients in the hydrogels: proteins 
are converted to peptides and amino acids by proteases; starches are converted to 
oligosaccharides and glucose by amylases; triacylglycerols are converted to free fatty 
acids (FFA) and monoacylglycerols (MAG) by lipases 104. It is often desirable to have 
bioactive components released from hydrogel particles in the small intestine so as to 
increase their bioavailability. This is particularly important for highly lipophilic 
bioactives (such as oil soluble vitamins, caroteonids, curcuminoids, and long chain fatty 
acids) that normally have low bioavailability because of their limited solubility in 
gastrointestinal fluids.  These components need to be released from the hydrogel particles 
within the small intestine, and then solubilized within mixed micelles formed by bile salts, 
phospholipids, and lipid digestion products. The mixed micelles then transport the 
encapsulated bioactive components to the surfaces of the epithelium cells where they are 
absorbed 110. 
Li and co-workers fabricated filled hydrogel particles by trapping protein-coated 
lipid droplets inside chitosan/calcium alginate hydrogel particles 76. A simulated GIT 
model showed that the hydrogels could control the lipid digestion rate: relatively small 
hydrogel beads (d < 50 µm) caused a moderate delay in lipid digestion, while large 
hydrogel beads (d > 100 µm) delayed appreciably delayed digestion 76. Mun and co-
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workers showed that β-carotene bioaccessibility was increased after being encapsulated 
in starch-based filled hydrogels, which was attributed to the ability of the lipid droplets to 
form mixed micelles and the hydrogels to increase the surface area of lipid exposed to 
digestive enzymes by inhibiting droplet aggregation 111. 
2.3.4 Colon 
 
If they are designed for colonic delivery, then the bioactive components within 
hydrogel particles must pass through the mouth, stomach, and small intestinal without 
being released or absorbed. Most macronutrients (lipids, proteins, and starches) are 
digestible within the upper GIT and therefore they are largely unsuitable for the 
development of hydrogel particles suitable for use as colonic delivery systems. 
Conversely, dietary fibers are not digested within the upper GIT but are digested within 
the lower GIT due to enzymes secreted by colonic bacteria, and are therefore suitable 
building blocks for this type of delivery system 112. Nevertheless, the delivery systems 
must still be carefully designed so that the bioactive agents remain retained and protected 
within the hydrogel particles throughout the upper GIT.  This usually means that they 
should remain intact and impermeable within the mouth, stomach, and small intestine 
fluids.  The ability of bioactive agents to be delivered to the colon by dietary fiber based 
hydrogels is due to the fact that the concentration of microbes present in the colon is 
much higher than that in other regions of the GIT 113. Several dietary fibers had been 
investigated for colon-specific hydrogel particles such as pectin 114, alginate 115, dextran 
116, guar gum 117 and chitosan 118 . 
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2.4 Conclusions 
Structurally-designed hydrogel particles have been developed to encapsulate, 
protect, and release a wide range of bioactive components in the pharmaceutical industry. 
Hydrogel particles are now being explored for similar types of application in the food 
industry.  In this case, food-grade biopolymers, such as proteins and polysaccharides, are 
used to fabricate the hydrogel particles rather than synthetic polymers or chemically-
modified biopolymers. The biopolymers should be selected according to the 
characterization of encapsulated agents and the delivery target of the hydrogel matrix. 
For example, protein should be involved in the ω-3 fatty acids loaded hydrogels design. 
The dietary fiber is a good candidate used in the colon target hydrogel particles 
fabrication. In addition, the hydrogel particles must be fabricated utilizing processing 
operations that are inexpensive, robust, and scalable, which provides additional 
challenges.   Hydrogel particles are being developed to protect bioactive components 
from degradation within foods and specific regions of the gastrointestinal tract, but then 
release them at an appropriate site of action. 
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CHAPTER 3 
 
ENCAPSULATION, PROTECTION, AND RELEASE OF BIOACTIVE LIPIDS 
USING HYDROGEL PARTICLES 
 
3.1 Encapsulation and protection of bioactives using hydrogel particles 
3.1.1 Introduction 
Epidemiological, clinical, and experimental studies indicate that fish oil, which 
contains n-3 polyunsaturated fatty acids (n-3 PUFA) such as eicosapentaenoic acid (EPA, 
20:5 n-3) and docosahexaenoic acid (DHA, 22:6, n-3), can protect against the 
development of chronic diseases such as heart disease, brain disease, arthritis, and certain 
types of cancer (Riediger, Othman, Suh & Moghadasian, 2009, Ruxton, Reed, Simpson, 
Millington & Ruxton, 2007, Yashodhara, Umakanth, Pappachan, Bhat, Kamath & Choo, 
2009). In the USA, where a western-style diet is predominant, the average fish intake is 
currently well below the recommended two to three servings per week 119. There is 
therefore a concerted effort to enrich various food and beverage products with n-3 PUFA 
so as to improve their healthfulness.  However, there are a number of challenges 
associated with incorporating these bioactive lipids into foods.  Firstly, PUFAs are highly 
non-polar molecules with low water-solubility and therefore have to be encapsulated 
within emulsion-based delivery systems if they are going to be introduced into aqueous-
based products 5, 120. Second, PUFAs are highly susceptible to chemical degradation due 
to lipid oxidation, which leads to a reduction in product quality and acceptability, and 
therefore they have to be protected against this form of chemical degradation 121-125.  
Third, it is important that PUFAs are fully absorbed within the upper gastrointestinal (GI) 
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tract after oral ingestion so that they can demonstrate their beneficial health effects 126. 
Consequently, there is a need to develop effective food-grade delivery systems to 
encapsulate, protect, and release PUFAs. 
There is growing interest in the utilization of proteins and peptides (referred to 
collectively as “polypeptides” for convenience) as functional ingredients in foods because 
of their beneficial health effects, such as antioxidant, antimicrobial, and anti-hypertension 
activities 127-130.  Typically, the activity of polypeptides depends on their three-
dimensional structures and specific amino acid sequences 130.  Polypeptide activity may 
therefore be altered in food products during manufacture, storage, or transportation, due 
to changes in solution or environmental conditions that alter protein structure, such as pH, 
ionic strength, ingredient interactions, or temperature 131.  In addition, their activity may 
be altered after they are ingested and pass through the gastrointestinal tract (GIT) because 
they are exposed to digestive enzymes (proteases and peptidases) and environmental 
conditions (pH, ionic strength, and ingredient interactions) that may alter their structure 
132.  Within the GIT, digestive enzymes and highly acidic gastric conditions may 
hydrolyze polypeptide chains at particular bond locations, thereby generating new 
peptides 133.  This process may be undesirable if it leads to loss of the bioactivity of an 
ingested polypeptide, or it may be desirable if it leads to the generation of new peptides 
with improved bioactivity. Consequently, it is often important to design food matrices 
that can control the gastrointestinal fate of polypeptides within foods and within the GIT 
so as to improve their bioactivity profiles 132, 134. 
In the current study, we fabricated filled hydrogel particles containing n-3 PUFA 
droplets embedded within a dietary fiber matrix formed by complex coacervation. We 
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used low-methoxy (LM) amidated pectin as an anionic biopolymer and casein as a 
cationic biopolymer to form hydrogel particles. The casein was enzymatically cross-
linked using transglutaminase to improve the stability of the biopolymer matrix. The 
effect of hydrogel particle encapsulation on the chemical stability of emulsified 
polyunsaturated lipids (fish oil) were investigated. Furthermore,  we investigated the 
possibility of encapsulating protein nanoparticles within polysaccharide-based hydrogel 
particles, and studied the influence of solution and environmental conditions on their 
properties.  Initially, protein nanoparticles were formed from a hydrophobic protein (zein) 
using an antisolvent precipitation method, and utilizing a protein-based emulsifier (whey 
protein) to stabilize them.  These composite protein nanoparticles were then encapsulated 
within microgels formed by acidifying a polysaccharide/protein mixture 
(alginate/caseinate) to induce electrostatic complexation, leading to the formation of a 
hydrogel matrix that trapped the protein nanoparticles inside.  The main focus of this 
study was to examine the influence of solution conditions (pH and ionic strength) on the 
stability and properties of the protein nanoparticle-loaded microgels.  This information is 
useful for establishing their potential application in food products, and their potential 
behavior within the gastrointestinal tract 
3.1.2 Materials and methods 
3.1.2.1 Materials  
Powdered sodium caseinate was obtained from the American Casein Company 
(MP Biomedicals LLC) and was used without further purification. As stated by the 
manufacturer, the protein and moisture content of the powder were 91.4% and 5.0%, 
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respectively. Zein (Lot# SLBD5665V) and sodium alginate (Lot 50K0180) were 
purchased from Sigma–Aldrich (St. Louis, MO, USA). Whey protein isolate (WPI) 
powder was obtained from Davisco Foods International Inc. (Le Sueur, MN, 
USA).  Alginic acid (sodium salt) (Lot# 180947) was purchased from the Sigma 
Chemical Company (St. Louis, MO). Low methoxyl amidated pectin (Genu Pectin 
(Citrus), LM-104 AS-Z) was donated by CP Keloco (Lille Skensved, Denmark) and was 
used without further purification. The degree of esterification (DE) was approximately 27% 
as provided by the manufacturer. The protein cross-linking enzyme transglutaminase 
(Activa TI) was donated by Ajinomoto Food Ingredients (Chicago, Illinois). According to 
the manufacturer, the activity of this enzyme was 100 units per gram of powdered 
preparation. Fish oil was obtained from DSM Nutritional Products Ltd. (Basel, 
Switzerland). This oil contained 101 mg of EPA/g of oil, 148 mg of DHA/g oil, and a 
total w-3 PUFA content of 312 mg/g of oil. 
All chemicals used, including technical grade Nile red dye (CAS #7385-67-3) and 
fluorescein isothiocyanate isomer I, were purchased from Sigma-Aldrich (St. Louis, MO).  
Double distilled water was used to prepare all solutions and emulsions. 
3.1.2.2 Conventional emulsion preparation  
A 10% (w/w) oil-in-water (O/W) emulsion stabilized by sodium caseinate (NaC) 
was prepared as a stock emulsion. An emulsifier solution was prepared by dispersing 1% 
(w/w) NaC powder in 10 mM phosphate buffer (pH 7) with continuous stirring at 700 
rpm for 2 hours (40 oC). A coarse emulsion was then prepared by blending fish oil (10% 
w/w) and emulsifier solution (90% w/w) using a high speed blender for 2 min (Tissue 
Tearor Model 985370-395, Biospec Products Inc., Bartles- ville, OK). The droplet size in 
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this coarse emulsion was further reduced by passing it three times through a high-
pressure homogenizer (Microfluidics Microfluidizer M-110P, Newton, MA USA) at 
12,000 psi. 
3.1.2.3 Protein nanoparticles preparation 
Protein nanoparticles were fabricated from zein using an antisolvent precipitation 
method. Initially, zein (26.4 mg/mL) was dissolved in ethanol solution (80% v/v). Then, 
25 mL of aqueous ethanol solution was rapidly injected into 75 ml of whey protein 
solution (0.25% WPI, PBS, pH 6.5) that was continuously stirred at 1200 rpm using a 
magnetic stirrer (IKA R05, Werke, GmbH). The resulting colloidal dispersion was then 
stirred for another 30 min at the same speed. The ethanol remaining in the final colloidal 
dispersions was evaporated using a rotary evaporator (Rotavapor R110, Büchi Corp., 
Switzerland), and the same volume of pH 6.5 PBS was added to compensate for the lost 
ethanol. 
3.1.2.4 Unfilled hydrogel particle preparation 
The method used to form the hydrogel microspheres was adapted from Chung et 
al (2012) with some slight modifications. This method involves inducing thermodynamic 
incompatibility at a pH where the biopolymers have similar charges (e.g., pH 7), and then 
adjusting the pH to a value where the biopolymers have opposite charges (e.g., pH 4.5) to 
induce coacervation.  This procedure promotes the formation of casein-rich microspheres 
surrounded by a pectin shell.  Initially, 3% (w/w) NaC and 3% (w/w) pectin solutions 
were prepared by dissolving weighed amounts of biopolymers into phosphate buffer (pH 
7).  2 M sodium hydroxide was used to adjust the biopolymer solution to pH 7. Equal 
  30 
weights of the two stock solutions were then mixed together using stirring. The pH of this 
mixture was adjusted to 7 (if necessary) using 2 M sodium hydroxide. This mixture was 
then acidified to pH 4.5 using 1 M citric acid at a rate of 1 drop/10 s with continuous 
stirring at 500 rpm. The hydrogel particles were then cross-linked by adding a solution of 
transglutaminase (0.1 g/ml 10 mM PBS, pH 4.5) at a level of 10 units of enzyme 
activity/per gram of protein.  The solution was then incubated at 40 oC for 2 hours with 
constant stirring at 500 rpm. At the end of the incubation period, the reaction was stopped 
by heating the samples in an 85 oC water bath for 5 minutes. Control (not cross-linked) 
particles were exposed to the same incubation and inactivation conditions as enzyme 
treated particles. 
For the protein nanoparticles encapsulation, another hydrogel particles were 
prepared using caseinate and alginate. Firstly, 2 M sodium hydroxide was used to adjust 
caseinate (2%) and alginate (2%) solutions to pH 7. Then these two stock solutions and 
phosphate buffer were mixed together at different volume ratios under continuous stirring 
to form final compositions of 0.33% sodium caseinate/1.33% alginate (mass ratio 1:4). 
The mixtures were then acidified to pH 5 using 1 M citric acid at a rate of 1 drop/10 s 
with continuous stirring at 500 rpm to promote complex formation. 
3.1.2.5 Filled hydrogel microsphere preparation 
Stock solutions of 6% casein and 3% pectin were prepared separately in 10 mM 
phosphate buffer at pH 7 and stirred until fully dissolved. 2 M sodium hydroxide was 
used to adjust the dissolved biopolymer solution to pH 7. After pH adjustment, 10% (w/w) 
oil-in-water emulsion, 6% casein, and 10 mM phosphate buffer were mixed together to 
obtain a system containing 3% casein and 2% fat. Then equal volumes of droplet-
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biopolymer mixture and pectin were mixed (500 rpm) and the solution was adjusted to 
pH 7.0 (if necessary). The obtained mixture was finally acidified to pH 4.5 using 1 M 
citric acid at a rate of 1drop/10 s with continuous string at 500 rpm to promote complex 
coacervation. The same procedure was also used as described in 2.2.1 to form cross-liked 
filled hydrogel microspheres. 
2 M sodium hydroxide was used to adjust caseinate solutions, alginate solutions, 
and protein nanoparticle dispersions to pH 7. After pH adjustment, 6.6 mg/mL protein 
nanoparticle dispersion and 2% sodium caseinate solution were mixed together at a 1:1 
volume ratio. Then, this system was mixed (500 rpm) with 2% alginate solution at a 
volume ratio of 1:2.  Finally, the resulting mixture was acidified to pH 5 using 1 M citric 
acid with continuous stirring at 500 rpm to promote complex formation. The final 
composition of the resulting system was 1.1 mg/mL protein nanoparticles, 0.33% sodium 
caseinate, and 1.33% alginate. 
3.1.2.6 Microstructure analysis 
The microstructure of all systems was examined using optical and confocal 
scanning laser microscopy with a 60 × objective lens and 10 × eyepiece (Nikon D-
Eclipse C1 80i, Nikon, Melville, NY, U.S.). A small aliquot of sample was placed on a 
microscope slide and covered with a cover slip prior to analysis. For the confocal 
microscopy, samples were dyed prior to particle formation. The oil phase in the filled 
hydrogel particles was dyed with Nile red solution (1 mg/mL ethanol) by adding 0.1 mL 
of Nile red solution to 2 mL of oil, covering, and stirring overnight. The dyed oil was 
then used to form an emulsion as described in Section 2.2.1. The NaC phase was dyed 
with fluorescein thiocyanate isomer I (FITC) solution (1 mg/mL dimethyl sulfoxide) 
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prior to measurements by adding 0.1 mL of FITC dye solution to 2 mL of sample. The 
excitation and emission spectrum for Nile red were 543 nm and 605 nm, respectively 
while for FITC they were 488 nm and 515 nm, respectively. The microstructure images 
for confocal microscopy were taken and analyzed using image analysis software (NIS-
Elements, Nikon, Melville, NY). 
3.1.2.7 Determination of lipid oxidation 
The chemical stability of the filled hydrogel particles and non-encapsulated lipid 
droplets was evaluated by monitoring the formation of hydroperoxides over the course of 
7 days storage. The hydroperoxides of different systems were extracted using 
chloroform/methanol solution: 1 ml of emulsion or filled hydrogel microsphere 
suspension was vigorously vortexed three times with 7.5 ml of chloroform: methanol (2:1 
vol/vol) followed by centrifugation for 5 min at 1300g. Then 0.2 ml of the 
chloroform/methanol extract (lower layer) was carefully removed and mixed with 2.8 ml 
of methanol/1-butanol (2:1 vol/vol). Depending on the concentration of hydroperoxides, 
the chloroform/methanol extract was diluted with solvent such that the final absorbance 
of the reacted sample remained below 1.0 cm-1. This mixture (3.0 ml) was then reacted 
with 15 µL of 3.94 M ammonium thiocyanate and 15 µL of ferrous iron solution 
(prepared by reacting 0.132 M barium chloride and 0.144 M ferrous sulphate). The 
mixture was vortexed and allowed to react for 20 min at room temperature in the dark 
before the absorbance of the sample was measured at 510 nm using a spectrophotometer. 
The concentration of hydroperoxides was determined based on a standard curve of 
cumene hydroperoxide (0–20 µM). 
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3.1.2.8 Stability of environmental conditions 
The particle size and microstructure of the colloidal dispersions were determined 
after they were exposed to various environmental conditions. 
Effect of pH: Freshly prepared colloidal dispersions were mixed with equal 
volumes of 10 mM phosphate buffer with pH values ranging from 3.0 to 7.0. The samples 
were then adjusted to the desired pH values with 1 mol/L NaOH or HCl. 
Effect of salt:  Protein nanoparticles were mixed with equal volumes of phosphate 
buffer at pH 6.5 containing sodium chloride (50–400 mM NaCl). While, nanoparticle-
loaded microgels were mixed with equal volumes of phosphate buffer at pH 5.0 
containing sodium chloride (0.5–2 M NaCl). If necessary, the samples were then adjusted 
to pH 6.5 or pH 5.0 with 1 mol/L NaOH or HCl. 
3.1.2.9 Statistical analysis 
All experiments were carried out on two or three freshly prepared samples. The 
results are expressed as means ± standard deviations (SD). Data were subjected to 
statistical analysis using SPSS software (version 18.0). Means were subject to Duncan's 
test and a P-value of <0.05 was considered statistically significant. 
3.1.3 Results and discussion 
3.1.3.1 Microstructure 
The microstructure of the particles in the different delivery systems was measured 
using confocal scanning laser microscopy. The lipid droplets were dyed using Nile red 
(stained red) and the casein was dyed using FITC (stained green). The confocal images 
show that small lipid droplets were distributed throughout the casein-rich phase. In the 
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emulsion, the casein was distributed throughout the aqueous phase, indicating that it was 
not all adsorbed to the lipid droplet surfaces (Figure 3.1 a). In the unfilled hydrogel 
particles, casein-rich microspheres were distributed throughout a black background, 
indicating that most of the casein was present within the hydrogel particles. The location 
of pectin within the hydrogel particle suspensions could not be determined since it was 
not specifically dyed by a fluorochrome. However, based on the negative particle charge, 
we expect that some pectin molecules formed a coating around the casein-rich 
microspheres. In the presence of lipid droplets, the confocal images indicate that almost 
all of the lipid droplets (red) were embedded inside the casein-rich hydrogel microspheres 
(Figure 3.1c). Samples containing larger microspheres were prepared using moderate 
stirring conditions during fabrication of the filled hydrogel particles so as to better 
observe their internal structure. The images of these larger particles clearly indicate that 
lipid droplets (red) were encapsulated within casein-rich microspheres (green) (Figure 
3.1d). This result is in agreement with the static light scatting data mentioned above. 
Both the filled and non-filled hydrogel microspheres had a uniform small diameter 
(around 3 to 5 µm). These filled hydrogel particles are smaller than those typically 
produced using conventional coacervation methods, which may an advantage for some 
commercial applications within the food industry. 
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(a)                                                                        (b) 
   
                            (c)                                                                          (d) 
 
Figure 3. 1 Confocal micrographs (60× magnifications) of (a) 1% oil-in-water emulsion, 
(b) hydrogel particles fabricated without fat, (c) filled hydrogel particles and (d) filled 
hydrogel particles fabricated with moderate stirring. The oil phase (red) was stained with 
Nile red while the protein phase (green) was stained with FITC. 
3.1.3.2 Lipid oxidation in filled hydrogel particles and emulsions  
One of the major challenges associated with the fortification of foods with omega-
3 fatty acids is their high susceptibility to lipid oxidation during storage 105, 122-123. The 
rate and extent of lipid oxidation of emulsified lipids can often be overcome using well-
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designed colloidal delivery systems.  We therefore compared the oxidative stability of the 
lipid (fish oil) droplets in filled hydrogel microspheres and conventional emulsions 
(Figure 3.2). We measured the concentration of primary reaction products 
(hydroperoxides) in conventional emulsions and filled hydrogel microspheres during 7 
days storage. The hydroperoxide concentration in the conventional emulsions increased 
sharply after 4 days storage and then remained high during further storage. On the other 
hand, the hydroperoxide concentration remained relatively low from 0 to 7 days storage 
for the lipid droplets encapsulated within filled hydrogel microspheres. These results 
were somewhat different from a previous study, which reported that filled casein-rich 
microspheres and casein-stabilized emulsions had fairly similar oxidation rates, but filled 
hydrogel microspheres had much better stability than Tween-stabilized emulsions 73. 
These differences may be due to the different fabrication methods and materials used to 
form the filled hydrogel microspheres in both studies. Casein is known to have 
antioxidant properties due to its ability to scavenge free radicals and chelate pro-oxidant 
transition metals, such as iron or copper 135. The confocal fluorescence images discussed 
earlier indicated that casein was concentrated within the hydrogel microspheres, and 
therefore there would be a high local concentration of this antioxidant protein in the 
vicinity of the lipid droplets. This casein-rich matrix may have been able to scavenge free 
radicals and bind transition metals thereby inhibiting their interaction with the lipid 
droplets inside the hydrogel microspheres. Overall, these results suggest that 
encapsulating fish oil droplets within a hydrogel matrix containing high concentrations of 
antioxidant proteins may be a more effective means of inhibiting lipid oxidation than 
simply having a thin layer of casein molecules around each lipid droplet. 
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3.1.3.3 Influence of pH on stability 
Colloidal delivery systems utilized within foods and beverages may experience 
appreciably different pH environments depending on the nature of the product.  In 
addition, they may be exposed to considerable variations in pH as they pass through the 
human gastrointestinal tract after ingestion.  Consequently, it is useful to understand the 
influence of pH on the properties of any colloidal delivery system intended for use in 
commercial food and beverage products. 
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Figure 3. 2 Concentration of hydroperoxides formed from fish oil during 7 days storage 
in simple oil-in-water emulsions and in filled hydrogel particles 
3.1.3.3 Influence of pH on stability 
Colloidal delivery systems utilized within foods and beverages may experience 
appreciably different pH environments depending on the nature of the product.  In 
addition, they may be exposed to considerable variations in pH as they pass through the 
human gastrointestinal tract after ingestion.  Consequently, it is useful to understand the 
influence of pH on the properties of any colloidal delivery system intended for use in 
commercial food and beverage products. 
3.1.3.3.1 Protein-nanoparticles 
The tendency for aggregation to occur is highlighted in measurements of the 
influence of pH on the particle size and microstructure of the protein nanoparticle 
suspensions (Figures 3.3 to 3.5).  At high pH values (6.5 to 7), the particles were 
relatively small (d32 < 1 µm), had a monomodal distribution, and were evenly distributed 
throughout the sample.  At intermediate pH values (pH 5.5. to 4), the particle size was 
relatively big (d32 > 10 µm) and large irregular shaped aggregates were observed in the 
microscopy images. At low pH values (3 to 3.5), there was an appreciable increase in 
particle size detected by light scattering, and also evidence of some large aggregates in 
the microscopy images (Figures 3.3 to 3.5).  It is possible that these aggregates formed 
as the suspensions were moved from high pH to low pH, and were not fully broken down 
under acidic conditions. The reason for the difference in appearance of the protein 
nanoparticle suspensions at low and high pH values also indicated that the nature of the 
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particles present had changed due to an alteration in the strength of the electrostatic 
interactions in the system. 
 
Figure 3. 3 Effect of pH on mean particle diameters (d32) of protein nanoparticles and 
filled hydrogel particles. Different letters mean significant differences (p < 0.05) of the 
particle diameter at different pH values. 
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Figure 3. 4 The pH-dependence of the particle size distribution of (a) protein 
nanoparticles and (b) protein nanoparticle-filled hydrogel particles.  
 
   
(a)                                                                (b) 
Figure 3. 5 Confocal fluorescence micrographs of (a) protein nanoparticles and (b) 
protein nanoparticle-filled hydrogel particles after incubation at different pH values. 
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3.1.3.3.2 Filled microgels 
We then examined the influence of pH on the properties of the protein-
nanoparticle filled microgels. The light scattering measurements indicated that the 
dimensions of the microgels remained relatively constant from pH 3 to 6, with a 
monomodal particle size distribution (Figures 3.3 and 3.4b).  However, the particle size 
distribution became bimodal at pH 6.5 and 7, with a population of particles around 180 
nm and another population around 4 µm. We hypothesize that the microgels dissociated 
at these higher pH values because the alginate and caseinate molecules both had strong 
negative charges and so there was a strong electrostatic repulsion between them.  
Consequently, the microgels may have released the protein nanoparticles, which would 
account for the population of small particles observed in the particle size distributions at 
these pH values (Figure 3.4b).  This observation was supported by the confocal 
microscopy images of the influence of pH on the microstructure of the system (Figure 
3.5b).  At pH 3 to 5, the microgels remained as discrete intact particles, i.e., the images 
showed discrete regions of high fluorescence intensity (protein-rich particles) surrounded 
by a black (protein-free) background.  At pH 5.5, there was evidence that some of the 
protein had leaked out of the microgels, i.e., the images showed discrete regions of high 
fluorescence intensity (protein-rich particles) surrounded by a green (protein-rich) 
background. At pH 7, it appeared that the microgels had almost completely disintegrated 
and the protein was evenly distributed throughout the system.  In these systems, we 
hypothesize that the protein nanoparticles had been released from the microgels and 
formed a stable colloidal dispersion.  This hypothesis is based on the fact that a 
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population of small particles was observed in the light scattering data (Figure 3.4b), , and 
the protein was evenly spread throughout the samples. 
3.1.4 Conclusion 
This study has shown that protein nanoparticles and polyunsaturated lipid droplets 
can be successfully incorporated into biopolymer microgels formed from electrostatic 
complexation of casein and alginate.  Incorporating polyunsaturated lipid droplets within 
the hydrogel microspheres effectively inhibited lipid oxidation, which may be important 
for stabilizing these healthy lipids in food and beverage products. In addition, we found 
The protein nanoparticles were retained within the microgels at low pH values (3 to 5.5) 
with no aggregation formed. Overall, our results suggest that encapsulation of protein or 
polyunsaturated lipid droplets nanoparticles within microgels may be a viable method of 
improving their chemical or physical stability, which have important implications for the 
development of food-grade delivery systems to fortify foods and beverages with 
bioactive protein and lipids. 
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3.2 Release of bioactives using hydrogel particles: pH-triggered release 
3.2.1 Introduction 
Various types of lipophilic active agents need to be incorporated into aqueous-
based products, protected during storage, and then released in the mouth after ingestion, 
e.g., certain oil-soluble drugs 136-137, antimicrobials for oral health 138-139, and food flavors 
140. Lipophilic actives usually have to be solubilized within an emulsified oil phase before 
they can be successfully incorporated into aqueous-based products. It is often important 
to be able to control the release profile of lipophilic components within the mouth after 
ingestion, e.g., for controlled flavor release in the food industry 34, 101, 141. In some 
situations, a rapid or burst release profile is required, but in other cases a prolonged or 
delayed release is preferred 142. It is therefore important to develop delivery systems that 
can encapsulate lipophilic active agents, protect them within products, but then release 
them within the mouth. A number of studies have encapsulated lipophilic actives within 
solid particles produced by drying oil-in-water emulsions 143-146. The resulting delivery 
systems are in a powdered form that is particularly suitable for application within low-
moisture products. However, there is also a need for delivery systems that can be 
incorporated into high-moisture products (such as beverages, dressings, sauces, and 
desserts). For these applications it is possible to encapsulate lipophilic actives within 
hydrogel particles formed from food-grade biopolymers 34, 101. These hydrogel particles 
may be specifically designed to control the release profile of lipophilic actives within the 
mouth. 
Hydrogel particles can be formed using various fabrication methods, including 
extrusion, templating, molding, thermodynamic incompatibility, and coacervation, with 
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each method having certain advantages and disadvantages for particular applications 20, 79. 
Complex coacervation is a relatively simple method that relies on the formation of 
electrostatic complexes between polymers that have opposite charges 147-148. 
Coacervation refers to the phase separation of a liquid phase into a polymer-rich phase 
(coacervate) and a polymer-poor phase 149-152. Coacervation is already widely used in the 
food and pharmaceutical industries to encapsulate active ingredients 145, 153-154. Filled 
hydrogel microspheres based on complex coacervation can be used as aqueous-based 
delivery systems, and can be considered to be examples of O/W1/W2 type structured 
emulsions 79. Lipid droplets are trapped within hydrogel microspheres (W1), which 
themselves are suspended within a continuous aqueous phase (W2). In recent studies, we 
have successfully fabricated fish oil loaded hydrogel particles based on complex 
coacervation of caseinate and LM-pectin 155. Encapsulation of fish oil within filled 
hydrogel particles improved their stability to lipid oxidation compared to conventional 
emulsions. 
The design of delivery systems that can control the release of encapsulated actives 
within the mouth relies on an understanding of their oral processing 156-158. Aqueous-
based delivery systems containing relatively small particles do not require chewing 
before swallowing. Nevertheless, they are still exposed to changes in environmental 
conditions within the mouth that may alter their release properties, such as changes in 
temperature, enzyme activity, dilution, pH, ionic strength, flow profiles, and interactions 
159-161. A number of these factors may be used as potential triggers to release encapsulated 
active components within the mouth. 
  45 
In this work, we fabricated filled hydrogel particles by trapping emulsified lipids 
within complex coacervates formed from two food-grade biopolymers: alginate and 
casein. Casein is a milk protein with a flexible structure known to have strong antioxidant 
properties 155, and may therefore be used to stabilize encapsulated polyunsaturated lipids 
from oxidation during storage 155. Alginate is an anionic linear polysaccharide that is 
commonly used as a building block in the formation of hydrogel particles 6. The ability of 
hydrogel particles to control the release of encapsulated lipid droplets within the mouth 
was evaluated using simulated oral conditions. We hypothesized that lipid droplets could 
be retained within hydrogel particles during storage, but released under simulated oral 
conditions using pH as a trigger. The results of this study provide valuable information 
for the rational design and fabrication of delivery systems for lipophilic agents that need 
to be released in the mouth. 
3.2.2 Materials and methods 
3.2.2.1 Materials  
Powdered sodium caseinate was obtained from the American Casein Company 
(MP Biomedicals LLC) and was used without further purification. As stated by the 
manufacturer, the protein and moisture content of the powder were 91.4% and 5.0%, 
respectively. Corn oil was purchased from a local supermarket and used without further 
purification. Alginic acid (sodium salt) (Lot# 180947, viscosity of 1% alginic acid in 
water is 15–20 cp) was purchased from Sigma–Aldrich (St. Louis, MO). All chemicals 
used were analytical grade and purchased from Sigma-Aldrich (St. Louis, MO). Double 
distilled water was used to make all solutions. 
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3.2.2.2 Conventional emulsion preparation  
A 10% (w/w) oil-in-water (O/W) emulsion stabilized by sodium caseinate (NaC) 
was prepared as a stock emulsion. An emulsifier solution was prepared by dispersing 1% 
(w/w) NaC powder into 10 mM phosphate buffer (pH 7) with continuous stirring at 700 
rpm for 2 hours (40 oC). A coarse emulsion was then prepared by blending corn oil (10% 
w/w) and emulsifier solution (90% w/w) together using a high-speed blender for 2 min 
(Tissue Tearor Model 985370-395, Biospec Products Inc., Bartles- ville, OK). The 
droplet size in this coarse emulsion was further reduced by passing it 3 times through a 
high-pressure homogenizer (Microfluidics Microfluidizer M-110P, Newton, MA USA) at 
12,000 psi. 
3.2.2.3 ζ-potential measurements  
The electrical charge (ζ-potential) of caseinate and alginate at different pH values 
(2 to 7) was measured using a particle electrophoresis instrument (Zetasizer Nano ZA 
series, Malvern Instruments Ltd. Worcestershire, UK). Samples were diluted using 10 
mM phosphate buffer (at the same pH as the sample) prior to analysis to keep the 
instrument attenuation value between 5 and 10. All measurements were made on at least 
two freshly prepared samples and each sample was measured in duplicate. 
3.2.2.4 Turbidity measurements  
The turbidities of dispersions containing caseinate and alginate were determined 
using a UV–visible spectrophotometer at 600 nm (Ultrospec 3000 pro, Biochrom Ltd., 
Cambridge, UK). The samples were contained within 1 cm path length optical cells, and 
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phosphate buffer was used as a control. Turbidity measurements were carried out on at 
least two freshly prepared samples. 
3.2.2.4 Unfilled and filled hydrogel microsphere preparation  
Initially, 1% (w/w) NaC and 2% (w/w) alginate solutions were prepared by 
dissolving weighed amounts of biopolymers into phosphate buffer (pH 7). 2 M sodium 
hydroxide was used to adjust the dissolved biopolymer solution to pH 7. Then these two 
stock solutions and phosphate buffer were mixed together at different volume ratios 
under continuous stirring to form final compositions of 0.33% casein/1.33% alginate 
(mass ratio 14) and 0.75% casein/0.25% alginate (mass ratio 3:1). The pH of the 
biopolymer mixtures was adjusted to 7.0 (if necessary) using 2 M sodium hydroxide. The 
mixtures were then acidified to pH 5 using 1 M citric acid at a rate of 1 drop/10 s with 
continuous stirring at 500 rpm. The influence of pH on the characteristics of the hydrogel 
particles formed was studied by adding different amounts of 1 M citric acid or sodium 
hydroxide. 
Stock solutions of 2% casein and 2% alginate were prepared separately in 10 mM 
phosphate buffer at pH 7 and stirred until fully dissolved. 2 M sodium hydroxide was 
used to adjust the dissolved biopolymer solution to pH 7. After pH adjustment, 6% (w/w) 
oil-in-water emulsion and 2% casein were mixed together to obtain a system containing 1% 
casein and 3% fat. Then this droplet-biopolymer mixture was mixed (500 rpm) with 2% 
alginate solution at a volume ratio of 1:2. The obtained mixture was finally acidified to 
pH 5 using 1 M citric acid with continuous string at 500 rpm to promote complex 
coacervation. The final composition of the resulting system was 1% fat, 0.33% casein, 
and 1.33% alginate. 
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3.2.2.5 Particle size measurements  
The particle size of hydrogel particles at different pH (2-7) was determined using 
static light scattering (Mastersizer 2000, Malvern Instruments, Worcestershire, United 
Kingdom). This instrument infers the size of the particles from measurements of their 
angular scattering pattern. All measurements were made on at least two freshly prepared 
samples. Samples were diluted in 10 mM phosphate buffer (pH 2-7) by adding small 
aliquots into a measurement chamber. A refractive index of 1.33 was used for the 
aqueous phase, 1.472 for the oil phase and hydrogel particle phase. Particle size 
measurements are reported as surface-weighted mean diameter (d32). 
3.2.2.5 Simulated Oral Conditions 
Simulated saliva fluid (SSF), containing mucin and various salts, was prepared 
according to a previous study 162. A 5 mL-aliquot of the filled hydrogel particle solution 
was mixed with 5 mL of SSF, so that the final mixture contained 0.5% (w/w) oil. The pH 
of the mixture was adjusted to 6.8 and it was incubated at 37 °C for 10 min with 
continuous agitation at 100 rpm. The particles size distribution and microstructure were 
measured immediately after incubation. 
3.2.2.6 Microstructure analysis 
The microstructure of all systems were examined using confocal scanning laser 
microscopy with a 60 × objective lens and 10 × eyepiece (Nikon D-Eclipse C1 80i, 
Nikon, Melville, NY, U.S.). A small aliquot of sample was placed on a microscope slide 
and covered with a cover slip prior to analysis. For the confocal microscopy, samples 
were dyed prior to particle formation. The oil phase in the filled hydrogel particles was 
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dyed with Nile red solution (1 mg/mL ethanol) by adding 0.1 mL of Nile red solution to 2 
mL of oil, covering, and stirring overnight. The dyed oil was then used to form an 
emulsion as described in Section 2.2.1. The sodium caseinate phase was dyed with 
fluorescein thiocyanate isomer I (FITC) solution (1 mg/mL dimethyl sulfoxide) prior to 
measurements by adding 0.1 mL of FITC dye solution to 2 mL of sample. The excitation 
and emission spectrum for Nile red were 543 nm and 605 nm, respectively while for 
FITC they were 488 nm and 515 nm, respectively. The microstructure images for 
confocal microscopy were taken and analyzed using image analysis software (NIS-
Elements, Nikon, Melville, NY). 
3.2.2.7 Statistical analysis 
All experiments were carried out in triplicate using freshly prepared samples. The 
mean and standard deviations were calculated from these values using SPASS. 
3.2.3 Results and discussion 
3.2.3.1 Electrical characteristics of biopolymer molecules 
The formation of hydrogel particles by complex coacervation is an 
electrostatically driven process, and so it is important to measure the electrical 
characteristics of the biopolymers used. The pH dependence of the ζ-potential of the two 
biopolymers was therefore determined using an electrophoresis method i.e., by measuring 
the direction and velocity of molecular movement in a well-defined electrical field. The 
charge on the caseinate molecules went from negative at pH 7.0 (≈ -27 mV) to positive at 
pH 2.0 (≈ +18 mV), with a point of zero charge around pH 4.6 (Fig. 3.6). The point of 
zero charge is in good agreement with the reported isoelectric point (pI) of caseinate 
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molecules 163. The ζ-potential of alginate changed from strongly negative (≈ -68 mV) at 
pH 7 to slightly negative (≈ -9 mV) at pH 2 (Fig. 3.6). Thus, the magnitude of the 
negative charge on the alginate molecules was appreciably lower under acidic conditions 
than neutral conditions, which can be attributed to the fact that the anionic carboxylic (–
COO-) groups on the mannuronic and guluronic acid groups became partially protonated 
(–COOH) in this pH range (pK ≈ 3.5). Fig. 3.6 also shows the ζ-potential obtained for the 
mixed caseinate-alginate system at different pH values. The charge on the mixed system 
was between those of the individual caseinate and alginate values, which suggested that 
alginate was electrostatically bound to caseinate molecules over the pH range studied.  
Nevertheless, in mixed systems it is difficult to precisely determine whether the measured 
charge is from a complex or from individual molecules. 
 
Figure 3. 6 Dependence of pH on the ζ-potential for 0.1 wt% caseinate and 0.1 wt% 
sodium alginate in 10 mM phosphate buffer. 
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In this study, hydrogel particles were assembled/dissembled by modulating 
solution conditions so as to induce complex coacervation of the two biopolymers. Based 
on the electrical characteristics of the two biopolymers we would expect them to 
associate with each other at low-to-intermediate pH values because they have opposite 
charges, but to dissociate at high pH values because they have similar charges (Fig. 3.6). 
Thus, we would anticipate that hydrogel particles could be assembled by complex 
coacervation in the pH regime where both biopolymers had opposite charge. Nevertheless, 
the characteristics of hydrogel particles formed under conditions where electrostatic 
attraction occurs is known to be highly dependent on interaction strength and 
stoichiometry 147. We therefore used turbidity, light scattering, and microscopy 
measurements to obtain information about the influence of pH and biopolymer 
composition on the nature of the electrostatic complexes formed. 
3.2.3.2 Aggregation characteristics of mixed biopolymer systems 
  Initially, the formation of protein-polysaccharide complexes was studied by 
measuring the change in turbidity as a function of pH at two different biopolymer mass 
ratios. Initially, we characterized the behavior of a biopolymer mixture where the protein 
was in excess, i.e., caseinate-to-alginate mass ratio in the final mixture was 3:1 (Fig. 
3.7a). At pH 7, the turbidity of the mixed biopolymer solution was relatively low (≈0.016 
cm-1), which can be attributed to a relatively strong electrostatic repulsion between the 
anionic alginate and anionic caseinate under neutral pH conditions (Fig. 3.7). When the 
pH was decreased, there was initially a gradual increase in turbidity around pH 5.6, and 
then a much steeper increase around pH 3.7. The turbidity exhibited a maximum value at 
pH 3.1, and then decreased appreciably when the pH was adjusted to lower values. 
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(a)                                                                     (b) 
Figure 3. 7 Turbidity at 600 nm as a function of pH for the system of caseinate/alginate 
at different biopolymers volume mixing ratios: (a) 0.1% sodium caseinate (NaC) and 0.1% 
sodium alginate (NaA), 3:1, (b) 0.1% casein and 0.2% alginate, 1:2. 
 
Critical pH values corresponding to the formation of different structures for the 
caseinate-alginate mixtures are also given in Fig. 3.7a. In general, complex coacervation 
involves two main pH-induced structuring events associated with the formation of 
soluble and insoluble complexes 164. The formation of soluble complexes (“coacervates”) 
occurs at a pH (denoted “pHC”) corresponding to the first experimentally detectable 
increase in turbidity during a pH titration from a region where the biopolymers have 
similar charges and do not form complexes. This is followed by a second structure-
forming event (denoted “pHΦ1”), associated with the formation of insoluble complexes 
(“precipitates”) and a large rise in turbidity. In our study, complex coacervation began 
around pH 5.6 (pHC), and insoluble complex formation began around pH 3.65 (pHΦ1) 
(Fig.3.7a).  These results indicate that complex coacervation began under conditions (pH 
5.6) where both the caseinate and alginate molecules had net negative charges (Fig. 3.7). 
Previous studies have also shown that coacervates can be formed under conditions where 
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a protein and anionic polysaccharide have similar net negative charges, due to 
electrostatic attraction between anionic groups on the polysaccharides and cationic 
patches on the protein surfaces 147, 165-166. 
We also studied the aggregation behavior of a biopolymer mixture in which the 
polysaccharide was dominant, i.e., a caseinate-to-alginate mass ratio of 1:4 (Fig. 3.7b).  
Qualitatively, the behavior of this biopolymer mixture was similar to that where protein 
was dominant: as the pH was reduced, the turbidity initially remained low, then increased 
slightly, then increased steeply to a maximum value, and then fell.   The two different 
casein-to-alginate mixing ratios used (3:1 and 1:4) gave similar pHC values (pH ≈ 5.6), 
but the pHΦ1 values shifted to lower pH values with decreasing mixing ratio (Fig. 3.7b). 
These results are in agreement with other studies that showed that the protein-to-
polysaccharide mixing ratio had little effect on pHC 167-168. The turbidity measurements 
indicate that the protein and polysaccharide used in this study may form either soluble or 
insoluble complexes depending on the pH. In the following section, we examined the 
influence of biopolymer ratio on the microstructure of the complexes formed. 
3.2.3.3 Microstructural characteristics of hydrogel particles 
To identify suitable conditions for forming hydrogel particles, we measured the 
particle size distribution of biopolymer mixtures containing different ratios of casein and 
alginate (Fig. 3.8). These samples were prepared by adjusting the mixed biopolymer 
solutions from pH 7 to 5 to induce electrostatic complex formation. This final pH was 
selected based on the turbidity versus pH profiles of the biopolymer mixtures (Fig. 3.7), 
which showed that coacervates could be formed under these conditions, i.e., pHI < pH < 
pHC.  At a casein-to-alginate ratio of 3:1 very large hydrogel particles were detected by 
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static light scattering (d ≈ 700 µm). Presumably, hydrogel particles formed under these 
conditions were highly prone to coalescence, and were therefore unsuitable for use as 
delivery systems. On the other hand, at a casein-to-alginate ratio of 1:4 small uniform 
hydrogel particles were detected (d ≈ 4 µm). Caseinate solutions are highly prone to 
aggregation near their isoelectric point (pI ≈ 4.6), and therefore there may have been 
insufficient alginate present to prevent some protein aggregation from occurring in the 
mixed systems containing high protein levels (3:1).  Conversely, in the mixed system 
containing high alginate levels (1:4) there may have been sufficient anionic 
polysaccharide molecules present to inhibit aggregation between protein molecules 
thereby forming more stable complexes. Another possible explanation is that the protein 
molecules were on the outside of the electrostatic complexes for the 3:1 system thereby 
promoting aggregation, but the alginate molecules were at the exterior for the 1:4 system 
thereby inhibiting aggregation. For this reason, we only used the 1:4 mass ratio of 
caseinate-to-alginate in the following experiments. 
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Figure 3. 8 Particle size distribution of hydrogel particles formed at pH 5 by different 
mixing ratios: 1% casein and 1% alginate at volume ratio of 3:1(concentration ratio: 3:1) 
and 1% casein and 2% alginate at volume ratio of 1:2 (concentration ratio: 1:4). 
3.2.3.4 Influence of pH on hydrogel particle integrity 
Hydrogel particles may be exposed to various pH conditions in food products and 
after ingestion when they pass through the various stages of the gastrointestinal tract 169-
170. Knowledge of the influence of pH on the properties of hydrogel particles is therefore 
important for their commercial application, and for creating delivery systems designed to 
release encapsulated lipids in response to a particular pH trigger (such as the oral 
environment). We therefore used confocal scanning laser microscopy and static light 
scattering to study the influence of pH on the microstructure and dimensions of the 
hydrogel particles. 
Initially, hydrogel particles were formed by adjusting a 1:4 caseinate-to-alginate 
mixture from pH 7 to 5 to induce complex coacervation. The change in particle size and 
microstructure was then measured when this system was adjusted to lower or higher pH 
values. The observed changes can be divided into three distinct pH regions according to 
the structures formed. At pH 4 to 5, stable hydrogel particles were formed which had 
fairly uniform dimensions with diameters around 2 to 4 µm. Most of the particles had a 
spherical shape, which can be attributed to the presence of sufficient alginate to stabilize 
the casein molecules 171. These hydrogel particles may be suitable for incorporation into 
commercial products that have aqueous phases in this intermediate pH range (such as 
yogurts). When the system was increased into the range pH 6 to 7 the hydrogel particles 
completely dissociated, as indicated by the confocal images, which showed that the 
continuous phase became a uniform green color suggesting that the caseinate molecules 
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were evenly distributed throughout the system rather than located within hydrogel 
particles (Fig. 3.9). The origin of this effect can be attributed to the change in the 
electrical characteristics of the two biopolymers.  At high pH values, both the caseinate 
and alginate molecules have relatively high negative charges and therefore there will be a 
strong electrostatic repulsion between them.  The increase in particle size measured by 
light scattering at high pH values suggests that there may have been some biopolymer 
aggregation, even though hydrogel particles were not formed. For example, there may 
have been some bridging of caseinate and alginate molecules through electrostatic 
attraction of cationic patches on the protein and anionic groups on the polysaccharide. 
When the pH of the mixed biopolymer system was reduced from pH 5 to 3 there 
was a large increase in mean particle diameter determined by light scattering, and 
extensive protein aggregation observed by confocal microscopy (Fig. 3.9). This 
phenomenon can also be attributed to changes in the electrical characteristics of the two 
biopolymers. When the pH is reduced below the isoelectric point of the caseinate, the two 
biopolymers have opposite charges, which leads to a strong electrostatic attraction 
between them. Consequently, the biopolymers become more closely packed and larger 
aggregates are formed. Extensive protein aggregation also occurred at pH 2, but the size 
of the aggregates was smaller than those formed at pH 3 (Fig. 3.9), which probably 
occurred because the anionic groups on the alginate molecules became partially 
protonated causing a reduction in their negative charge and therefore weaker electrostatic 
attraction 172. Insolubilization and/or precipitation of alginate would also be induced at 
pH value lower than the pKa of carboxyl groups. An understanding of the influence of 
pH on the properties of the hydrogel particles is useful for developing delivery systems 
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for oral applications. Our results indicate that the caseinate-alginate hydrogel particles 
should be stable at pH 4 to 5, but should dissociate at pH 7 thereby releasing any 
encapsulated components. 
 
Figure 3. 9 Influence of pH (2-7) on the particle size (d32) of hydrogel particles. 
(Confocal micrographs show the hydrogel particles at pH 3, 5, 7 respectively in the up 
right, protein phase in green was stained with FITC). 
3.2.3.5 Influence of simulated oral conditions on lipid droplet release 
For certain applications it is desirable to have filled hydrogel particles that remain 
intact within food products, but then release encapsulated lipid droplets within the mouth 
after ingestion. We therefore prepared hydrogel particles at pH 5 containing encapsulated 
lipid droplets, and then exposed them to simulated oral conditions (SSF, pH 6.8, 37 ºC). 
The particle size distribution and microstructure of the filled hydrogel particles before 
and after being exposure to oral conditions was determined by static light scattering and 
confocal microscopy (Figs. 3.10 and 3.11). In addition, the particle size distribution and 
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microstructure of the lipid droplets in the initial emulsion were also measured (Figs. 
3.10and 3.11) 
 
Figure 3. 10 Particle size distribution of filled hydrogel particles before and after mouth 
digestion. 
 
The particle size distribution of the lipid droplets in the initial emulsion had a 
single broad peak at a particle diameter of about 0.2 µm (Fig. 3.10), and the droplets were 
evenly distributed throughout the system (Fig. 3.11). Thus, the initial protein-coated lipid 
droplets were relatively small and stable to aggregation. It should be noted that the 
aqueous phase surrounding the lipid droplets had a relatively strong green color, which 
suggests that there was an appreciable amount of non-adsorbed casein in the initial 
emulsions. Prior to exposure to oral conditions (pH 14), the particle size distribution of 
the filled hydrogel particles showed a single peak around 3 µm (Fig. 3.10), which was 
fairly similar to that observed in the absence of lipid droplets (Fig. 3.9). This suggests 
that incorporation of lipid droplets into the hydrogel particles did not cause a major 
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change in their overall dimensions.  The confocal microscopy images indicated that all of 
the lipid droplets and casein molecules were initially trapped inside the hydrogel particles, 
i.e., the red (lipid) and green (protein) fluorescence dyes were located together in 
spheroid shapes surrounded by black (Fig. 3.11). This finding is also supported by the 
light scattering data which indicated that there was no small peak corresponding to free 
lipid droplets in the particle size distribution of the filled hydrogel particles at pH 5 (Fig. 
3.10). After exposure to the oral phase, the particle size distribution of the filled hydrogel 
particles and lipid droplets were fairly similar (Fig. 3.10), which suggested that the 
hydrogel particles had dissociated and released the lipid droplets. As mentioned earlier, 
the origin of this effect is likely to be the dissociation of the complex coacervates at 
neutral pH because of the strong electrostatic repulsion between the negatively charged 
protein and polysaccharide molecules 173. 
  
                                          (a)                                                                 (b) 
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                                  (c) 
Figure 3. 11 Confocal micrographs of (a) oil emulsion, (b) filled hydrogel particles 
before digestion and (c) after mouth digestion. The oil phase (red) was stained with Nile 
red while the protein phase (green) was stained with FITC.  
3.2.3 Conclusions 
In this study, hydrogel particles containing encapsulated lipid droplets were 
fabricated based on complex coacervation of caseinate and alginate.  Relatively small and 
stable hydrogel particles could be formed at pH values around the isoelectric point of the 
protein (pH 4 to 5), even under conditions where both biopolymers had net negative 
charges.  This effect can be attributed to electrostatic attraction between anionic groups 
on the alginate and cationic groups on the caseinate molecules. The biopolymer mixing 
ratio was also an important factor in forming stable hydrogel particles. At a relatively 
high protein-to-polysaccharide ratio very large unstable aggregates were formed that 
were unsuitable as delivery systems, but at a high polysaccharide-to-protein ratio small 
stable hydrogel particles were formed.  These hydrogel particles remained stable from pH 
4 to 5, but aggregated at lower pH due to increased electrostatic attraction or 
insolubilization and/or precipitation of alginate, and dissociated at higher pH due to 
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increased electrostatic repulsion. Using simulated oral conditions, we showed that filled 
hydrogel particles could be made to release encapsulated lipid droplets within the mouth. 
These results have important implications for the development of food-grade delivery 
systems that may protect encapsulated lipophilic active agents in products, but release 
them in the mouth. One limitation of the delivery systems developed in this study, is that 
the hydrogel particles are only stable over a narrow range of pH conditions (pH 4 to 5), 
which would limit the number of food or beverage products they could be incorporated 
into. This problem could be overcome by using different combinations of biopolymers or 
different cross-linking approaches. 
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3.3 Release of bioactives using hydrogel particles: temperature-triggered release 
3.3.1 Introduction 
There is increasing interest within the food and biomedical industries to 
incorporate lipophilic bioactive agents into functional food and medical food products, 
e.g., vitamins, nutraceuticals, pharmaceuticals, antimicrobials, flavors, and colors 174-177. 
However, the poor water-solubility and chemical stability of many lipophilic bioactive 
agents makes them difficult to incorporate into food matrices.  The low solubility of these 
bioactive agents in aqueous environments means they tend to phase separate, whereas 
their chemical instability means they may degrade within the product prior to 
consumption, thereby reducing their efficacy.  It is therefore necessary to design food-
grade delivery systems to improve the dispersibility and chemical stability of lipophilic 
bioactive agents in food matrices 178. 
Flavor perception (taste and aroma) throughout the eating process is a key factor 
in determining the desirable sensory attributes of many food products 140, 179-180. It is often 
important to control the release profile of lipophilic flavors within the mouth to provide 
the desired overall sensory experience 181. Other types of lipophilic bioactive agents may 
also need to be released within the mouth after consumption of medical or functional 
foods. e.g., some oil-soluble drugs 182-183, and antimicrobials for oral health 138-139. It is 
therefore important to food-grade effective delivery systems that can: encapsulate 
efficacious levels of lipophilic bioactive agents; easily be incorporated into food or 
beverage matrices; protect the bioactive agents from chemical degradation during storage; 
release them within the mouth after ingestion (often at a controlled rate). 
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For many applications, delivery systems are needed that can be incorporated into 
high-moisture food matrices, such as those in beverages, yogurts, dressings, sauces, 
creams, soups, dips, and desserts.  A variety of different emulsion-based delivery systems 
have been developed to encapsulate lipophilic bioactive agents, including emulsions, 
nanoemulsions, multiple emulsions, multilayer emulsions, filled hydrogel particles, and 
solid lipid nanoparticles 105, 184-189. Each of these delivery systems has their own 
advantages and disadvantages in terms of cost, ease of preparation, in-product stability, 
product compatibility, ingredient utilization, and functional performance. 
In this study, we focus on the utilization of filled hydrogel particles, which consist 
of lipid droplets trapped within hydrogel microspheres. Initially, the lipophilic bioactive 
agents are dissolved in an oil phase, and then an oil-in-water emulsion or nanoemulsion is 
formed using an appropriate homogenization method 190.  The hydrogel microspheres can 
be formed using a number of different fabrication methods depending on the final 
characteristics of the particles required, including extrusion, templating, molding, 
thermodynamic incompatibility, and complexation 79. Electrostatic complexation is a 
relatively straightforward method that can easily be implemented commercially, since it 
simply relies on the formation of complexes between polymers in solution that have 
opposite charges 148, 191.  Filled hydrogel particles can be designed to control the 
protection and release of lipophilic bioactive agents by controlling the composition and 
structure of the hydrogel matrices.  The properties of hydrogel particles formed using 
electrostatic complexation can be modulated by selecting biopolymers with different 
molecular characteristics (such as electrical properties, molecular weight, and structure) 
and by modulating preparation conditions (such as pH, salt, and stirring).   
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The design of delivery systems that can control the release of encapsulated 
bioactive agents within the mouth depends on an understanding of oral processing 156-158. 
Numerous factors can potentially influence the behavior of delivery systems within the 
oral cavity, including: warming or cooling in the mouth; saliva composition, volume and 
flow rate; mixing, disruption and frictional forces; and pH changes. In a recent study, we 
fabricated hydrogel particles by trapping lipid droplets within electrostatic complexes 
formed by sodium caseinate and alginate at pH 5 192.  We showed that these lipid droplets 
could be retained within hydrogel particles during storage, but released from the hydrogel 
matrix under conditions simulating oral processing.  In that system, the main driving 
force for hydrogel disruption and droplet release was the pH change in the mouth. Under 
storage conditions (pH 5), the electrostatic complexes were stable due to electrostatic 
attraction between anionic pectin and cationic patches on the caseinate molecules. 
However, under oral conditions (pH 7), the complexes dissociated due to electrostatic 
repulsion between the anionic pectin and anionic caseinate molecules.  These results 
suggested that filled hydrogel particles based on electrostatic complexation of two 
oppositely charged biopolymers might be useful for oral delivery of lipophilic bioactive 
agents. 
The purpose of the current study was to develop filled hydrogel particles that 
would release encapsulated lipid droplets primarily through a temperature trigger.  These 
hydrogel particles were prepared by incorporating lipid droplets into electrostatic 
complexes formed from two food-grade proteins: gelatin and sodium casein. The filled 
hydrogel particles formed can be considered to be an oil-in-water-in-water (O/W1/W2) 
emulsion that contains oil droplets (O) trapped within hydrogel microspheres (W1), which 
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are themselves suspended within a continuous aqueous phase (W2). A potential advantage 
of using caseinate to form the hydrogel particles is that it can stabilize encapsulated 
polyunsaturated lipids against oxidation, which has been attributed to its antioxidant 
capacity 193. On the other hand, a potential advantage of using gelatin for fabricating oral 
delivery systems, is that it can form gels that melt in the mouth, i.e., undergo a gel-to-sol 
transition around body temperature. The information obtained from this study could be 
useful for the rational design of emulsion-based delivery systems that release 
encapsulated lipophilic bioactive agents within the mouth. 
3.3.2 Materials and methods 
3.3.2.1 Materials  
Corn oil was purchased from a local supermarket and used without further 
purification. Sodium caseinate powder was obtained from the American Casein Company 
(MP Biomedicals LLC). As stated by the manufacturer, this ingredient had a protein 
content of 91.4% and moisture content of 5.0%. Type A gelatin (100 bloom, extracted 
from pork skin) was kindly donated by GELITA American Company (Sergeant Bluff, 
IA). Double distilled water was used to prepare all solutions. 
3.3.2.2 Methods  
3.3.2.2.1 Emulsion preparation  
An oil-in-water (O/W) emulsion stabilized by sodium caseinate (NaC) was 
prepared as a stock emulsion. Initially, an aqueous emulsifier solution was prepared by 
dispersing 1% (w/w) NaC powder into 10 mM phosphate buffer solution (pH 7) with 
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continuous stirring at 700 rpm for 2 hours (40 oC).  A coarse emulsion was then prepared 
by blending corn oil (10% w/w) and emulsifier solution (90% w/w) together using a high-
shear mixer for 2 min (Model 985370-395, Tissue Tearor, Biospec Products Inc., 
Bartlesville, OK). The size of the droplets in the resulting coarse emulsion was further 
reduced by passing it three times through a high-pressure homogenizer (Microfluidics 
Microfluidizer M-110P, Newton, MA USA) at 12,000 psi. The final emulsion was then 
diluted to 6% (w/w) for the further experiments. 
3.3.2.2.2 ζ-potential measurements  
The electrical characteristics (ζ-potential) of solutions of caseinate, gelatin, and 
their mixture were measured at different pH values (pH 5 to 10) using a particle 
electrophoresis instrument (Zetasizer Nano ZA series, Malvern Instruments Ltd. 
Worcestershire, UK). Samples were diluted using 10 mM phosphate buffer (at the same 
pH as the sample) prior to analysis so that the instrument attenuation value was within the 
optimum range (5 to 10).  All measurements were made on at least two freshly prepared 
samples and each sample was measured in duplicate. 
3.3.2.2.3 Turbidity measurements  
The turbidities of dispersions containing caseinate and gelatin were determined 
using a UV–visible spectrophotometer at 600 nm (Ultrospec 3000 pro, Biochrom Ltd., 
Cambridge, UK). The samples were contained within 1 cm path length optical cells, and 
phosphate buffer was used as a control. Turbidity measurements were carried out on at 
least two freshly prepared samples. The turbidity of biopolymer solutions (pH 5.8) with 
increasing temperature was analyzed using an UV/visible spectrophotometer at 600 nm 
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(Ultraspec 3000 pro, Biochrom Ltd., Cambridge, UK). Temperature scanning was carried 
out from 20 to 60 °C at a heating rate of 1 °C per minute. 
3.3.2.2.4 Unfilled and filled hydrogel microsphere preparation  
Stock solutions of 2% sodium casein and 1% gelatin were prepared separately in 
10 mM phosphate buffer at pH 7 and stirred until fully dissolved. 2 M sodium hydroxide 
was used to adjust the dissolved biopolymer solutions to pH 10. After pH adjustment, 6% 
(w/w) caseinate-stabilized oil-in-water emulsion (prepared in the section 2.2.1) and 2% 
caseinate solution were mixed together (1:1 volume ratio) with continuous stirring at 200 
rpm to obtain a system containing 1% sodium casein and 3% oil. The resulting mixture of 
caseinate-coated lipid droplets and sodium casein was then mixed with a 1% gelatin 
solution (1:2 volume ratio) to form filled hydrogel particles. The final mixture was then 
acidified to pH 5.8 using 1 M citric acid with continuous string at 500 rpm to promote 
electrostatic complexation. The final composition of the resulting system was 1% fat, 
0.33% sodium casein, and 0.67% gelatin. 
3.3.2.2.5 Particle size measurements  
The particle size of the various samples was determined using static light 
scattering (Mastersizer 2000, Malvern Instruments, Worcestershire, United Kingdom). 
This instrument infers the particle size distribution from measurements of the angular 
scattering pattern. Samples were diluted in 10 mM phosphate buffer by adding small 
aliquots into a measurement chamber. A refractive index of 1.33 was used for the 
continuous phase (water) and 1.472 for the disperse phase (oil or hydrogel). Particle size 
measurements are reported as the surface-weighted mean diameter (d32). 
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3.3.2.2.6 Rheological measurements 
A higher total biopolymer concentration was required to produce samples that 
were viscous enough to make reliable rheology measurements.  Consequently, 3% (w/w) 
NaC and 3% (w/w) gelatin solutions were used to fabricate hydrogel particles using a 
similar approach to that described in Section 2.2.4. The rheology of the hydrogel particle 
suspensions was characterized using a dynamic shear rheometer with a cup-and-bob 
measurement cell (Kinexus, Malvern, Worcestershire, UK). The effect of thermal 
treatment on the apparent shear viscosity was determined by temperature scanning from 
25 to 60 and then to 25 °C at a scan rate of 1 °C/min-1.  A constant shearing rate (10 s-1) 
and test time (1 min) was used for all measurements. 
3.3.2.2.7 Simulated Oral Conditions 
Simulated saliva fluid (SSF), containing mucin and various salts, was prepared as 
described in an earlier study 162.  A 5 mL-aliquot of the filled hydrogel particle solution 
was mixed with 5 mL of SSF, so that the final mixture contained 0.5% (w/w) oil. The 
resulting mixture was then adjusted to pH 6.8 and incubated at 37 °C for 10 min with 
continuous agitation (100 rpm). This time is longer than the time a food would typically 
spend in the mouth, but was used to ensure consistent measurements between samples.  
The particle size distribution and microstructure were then measured immediately after 
incubation under these conditions. 
3.3.2.2.8 Microstructure analysis 
The microstructure of the samples was examined using confocal scanning 
fluorescent laser microscopy with a 60 × objective lens and 10 × eyepiece (Nikon D-
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Eclipse C1 80i, Nikon, Melville, NY, U.S.).  A small aliquot of sample was placed on a 
microscope slide and covered with a glass cover slip prior to analysis. Samples were 
stained with a fluorescent dye prior to particle formation. The oil phase in the filled 
hydrogel particles was dyed with Nile red by adding 0.1 mL of Nile red solution (1 
mg/mL ethanol) to 2 mL of oil, covering, and stirring overnight. The dyed oil was then 
used to form an emulsion as described in Section 2.2.1. The sodium caseinate phase was 
dyed with fast green (0.4% w/v in deionised water) after one night cold storage at 5 °C. 
The excitation and emission spectrum for Nile red were 543 nm and 605 nm, respectively 
while for fast green they were 488 nm and 515 nm, respectively. The microstructure 
images were acquired and then analyzed using image analysis software (NIS-Elements, 
Nikon, Melville, NY). 
3.3.2.2.9 Statistical analysis 
All experiments were carried out in triplicate using freshly prepared samples. 
Means and standard deviations were calculated from a minimum of three measurements 
using SPSS (IBM, USA). Means were subjected to Duncan's test and a P-value of <0.05 
was considered statistically significant. 
3.3.3 Results and discussion 
3.3.3.1 Electrical characteristics of single and mixed biopolymer solutions 
The hydrogel particles used in this study were assembled by electrostatic 
complexation of gelatin and caseinate. Knowledge of the electrical characteristics of 
these biopolymers is therefore useful for the rational design and fabrication of the filled 
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hydrogel particles. For this reason we measured the pH dependence of the ζ-potential of 
the two biopolymers and their mixture using electrophoresis (Figure 3.12). 
The charge on the solution containing individual gelatin molecules went from 
negative at pH 10.0 (≈ -5 mV) to positive at pH 5.0 (≈ +4 mV), with a point of zero 
charge around pH 6. This value was appreciably different from the isoelectric point of 
gelatin reported by the manufacturer (around pI ≈ 8-9), which we attributed to some 
binding of ions in the buffer solution to charged groups on the gelatin molecules. We 
therefore measured the pH dependence of the ζ-potential for gelatin dissolved in distilled 
water. The results indicated that the zero point charge of gelatin in water was indeed 
around pH 8 (data not shown). One possible explanation for this difference is that 
phosphate anions (PO4-) from the buffer solution adsorbed to cationic groups on the 
gelatin molecule, thereby altering its net charge characteristics. For the solution 
containing only caseinate, the charge was negative (-22 to -36 mV) over the entire pH 
range (pH 5 to 10), which can be attributed to the fact that the caseinate molecules were 
always above their isoelectric point (pI = 4.6). We also measured the ζ-potential of a 
biopolymer mixture (1:2 w/w caseinate:gelatin), since this biopolymer ratio was used to 
prepare the hydrogel particles (discussed later). The charge on the mixed system was 
between those of the individual caseinate and gelatin values, which suggested that the 
two biopolymers formed a complex over the entire pH range studied. It is likely that 
cationic groups on the gelatin molecules bound to anionic groups on the caseinate 
molecules (and vice versa). 
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Figure 3. 12 The pH-dependence of the ζ-potential of 0.1 wt% caseinate, 0.1 wt% gelatin, 
0.1% mixed biopolymers (0.033 wt% caseinate + 0.067 wt% gelatin) in 10 mM 
phosphate buffer and 0.1 wt% gelatin in water. 
 
Though the net charge point of the mixture was shown around pH 5.4. In mixed 
biopolymer systems, it is difficult to precisely determine the electrical characteristics of 
the complexes themselves as the net particle charge determined by the electrophoresis 
instrument may be a result of the signal from individual biopolymer molecules as well as 
from the complexes. Turbidity measurements were therefore used to provide further 
information about the influence of pH on electrostatic complex formation. 
3.3.3.2 Influence of pH on complex formation 
The turbidity of a solution depends on the size and concentration of the 
complexes it contains 194. Turbidity measurements therefore present a simple but 
powerful tool for monitoring the electrostatic complexation of biopolymers. Typically, 
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soluble complexes are formed when the electrostatic interactions are fairly weak and the 
net charge is relatively high, whereas coacervates are formed when the electrostatic 
interactions are stronger and the net charge is low 191, 195-196. Turbidimetric titrations were 
therefore performed to obtain qualitative information about the interaction of the sodium 
casein and gelatin. 
Transparent and homogeneous mixtures were obtained when the two biopolymers 
were mixed above pH 8, which suggests that no electrostatic complexes large enough to 
scatter light were formed (Figure 3.13).  The electrophoresis measurements indicated 
that both biopolymers had negative charges in this pH range (Figure 3.12), which would 
have inhibited the formation of large hydrogel particles due to electrostatic repulsion. The 
first small increase in turbidity in the biopolymer mixtures was considered to be the 
critical pH (pHc) where primary soluble complexes were formed, which was around pH 9 
(Figure 3.13).  This pH value is slightly above the reported isoelectric point of this type 
of gelatin.  Consequently, the electrostatic complexes may have formed due to the 
binding of negative groups on the caseinate molecules to positive patches on the gelatin 
surfaces.  A sharp rise in turbidity was detected when the pH was decreased below about 
6, which is often designated as the critical coacervation pH i.e., pHϕ 197.  There was a 
maximum in the turbidity around pH 4.8, after which the turbidity decreased steeply with 
further acidification. This decrease in turbidity is probably a result of dissociation of the 
electrostatic complexes.  Below the isoelectric point of caseinate (pI ≈ 4.6), both proteins 
will have a net positive charge, and therefore there will be an electrostatic repulsion 
between them. 
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Based on these results, we used a pH of 5.8 to prepare the particles, since this led 
to the formation of electrostatic complexes that still had an appreciable negative charge 
(Figure 3.12), and were therefore more stable to aggregation and phase separation. 
 
 
Figure 3. 13 The pH-dependence of the turbidity (600 nm) of mixed biopolymer 
solutions containing 0.333 % caseinate and 0.667% gelatin (biopolymer ratio = 1:2). 
3.3.3.3 Influence of temperature on complex properties 
Gelatin solutions undergo a sol-to-gel transition during heating due to changes in 
the molecular conformation of the gelatin molecules, i.e., a helix-to-coil transition 198.  
Hydrogel particles based on electrostatic complexation were fabricated by mixing a 1% 
sodium casein solution and a 1% gelatin solution at a volume ratio of 1:2 at pH 5.8 (final 
composition = 0.33% sodium casein and 0.67% gelatin). A range of different 
biopolymers ratios were tested in preliminary studies, and this ratio gave the most stable 
complex particles and was therefore used to prepare the hydrogel particles.  The effect of 
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temperature scanning on the stability of the hydrogel complexes was determined by 
measuring their turbidity during heating from 25 to 60 °C, and then cooling back to 25 ºC 
(Figure 3.14). The initial turbidities of the caseinate-gelatin complex solutions at pH 5.8 
and ambient temperature were high (around 0.82 cm-1), which meant that hydrogel 
particles were relatively stable under these conditions. The turbidity of the hydrogel 
particles remained relatively constant from 25 to 31 °C, decreased steeply from 31 to 
38 °C, and then reached a fairly constant value at higher temperatures. These results 
suggested that the structure of caseinate-gelatin complexes were appreciably altered by 
heating, which may be important for the development of temperature-triggered delivery 
systems.  The dissolution of the caseinate-gelatin complexes appeared to be closely 
associated with the melting characteristics of the gelatin molecules. Indeed, previous 
researchers have reported that the gel-melting temperature of gelatin is just below body 
temperature, i.e., < 35 °C 198. 
 
Figure 3. 14 Influence of temperature on turbidity of hydrogel particles (0.333% casein 
and 0.667% gelatin) during heating and cooling. 
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Heating-cooling scans were carried out to determine whether the complexes 
dissociation behavior was thermally reversible or irreversible. In these experiments the 
change in turbidity with temperature was recorded when the heated hydrogel particles 
were cooled back to 25 °C.  The turbidity of the biopolymer mixture remained relatively 
low when the samples were cooled back to their initial temperature (25 °C), which may 
have occurred because of thermal hysteresis i.e., the gelation temperature is appreciably 
lower than the melting temperature 198. Whether the gelatin molecules remained attached 
to the caseinate molecules after cooling is currently unknown, and would be an 
interesting area for future studies. 
3.3.3.4 Influence of temperature on rheology of hydrogel suspensions 
The shear rheology of hydrogel particle suspensions was measured as a function 
of temperature, i.e. heating from 25 to 60 °C and then cooled to 25 °C (Figure 3.15). 
There was a slight decrease in the apparent shear viscosity of the samples after being 
heated from 25 to 33 °C, followed by a step decrease from 34 °C to the end of the 
measurements. These results suggested that heating the gelatin-hydrogel particles above a 
critical temperature led to network breakdown. This critical temperature was close to the 
hydrogel particle dissociation temperature determined using the turbidity measurements 
(Figure 3.14), and this phenomenon may again be due to melting of the gelatin around 
these temperatures. These results are in agreement with a previous study that reported 
that the viscosity of suspensions of chondroitin 6-sulfate and gelatin decreased with 
increasing temperature 199. 
Heating-cooling scans showed that the viscosity of hydrogel particle suspensions 
increased slightly with decreasing temperature and did not return back to the initial value 
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after cooling back down to 25 °C. These results might again be attributed to the thermal 
hysteresis effect of gelatin mentioned earlier. 
 
 
Figure 3. 15 Influence of temperature on the viscosity of hydrogel particles fabricated by 
mixing 3% casein and 3% gelatin solutions. 
 
Taken together, the turbidity and viscosity results indicated that the caseinate-
gelatin hydrogel particles were stable at room temperature, but dissociated above a 
particular temperature (close to body temperature). These hydrogel particles may 
therefore be suitable for developing food-grade delivery system for lipophilic bioactive 
agents that respond to a temperature-trigger in the oral cavity. 
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3.3.3.5 Influence of simulated oral conditions on lipid droplet release 
For many applications it is desirable to have delivery systems that will remain 
intact within food products, but then release the encapsulated active agents in the mouth 
after ingestion. The melt-in-the-mouth behavior of gelatin hydrogels make them 
particularly suitable for this type of application 34. We therefore fabricated gelatin-based 
hydrogel particles containing encapsulated lipid droplets, and then exposed them to 
simulated oral conditions (SSF, pH 6.8, 37 ºC). The particle size distribution and 
microstructure of the filled hydrogel particles before and after being exposure to 
simulated oral conditions was determined by static light scattering and confocal 
microscopy (Figures 3.16 and 3.17). In particular, fast green was used to stain caseinate 
so that they appeared green in the confocal images, while the gelatin remained black. In 
addition, the particle size distribution and microstructure of the lipid droplets in the initial 
emulsion were also measured as a control (Figures 3.16 and 3.17). 
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Figure 3. 16 Particle size distribution of filled hydrogel particles before and after mouth 
processing. 
 
After the filled hydrogel particles were passed through the simulated mouth phase 
the particle size distribution became fairly similar to that of the initial emulsion, which 
suggests that the lipid droplets had been released from the dissociated hydrogel particles, 
but the emulsion remained stabilized by sodium caseinate. Control experiments were 
carried out keeping all conditions the same, except that room temperature was used rather 
than 37 ºC.  The particle size distribution and microstructure results indicated that the 
lipid droplets remained within the hydrogel particles after exposing to the oral conditions 
at this lower temperature. These results suggested that the temperature change in the 
mouth was the major factor promoting hydrogel dissociation and the release of the lipid 
droplets. 
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                                   (a) 
 
   
                                 (b)                                                               (c) 
Figure 3. 17 Confocal micrographs of (a) filled hydrogel particles before digestion and (b) 
after mouth processing and (c) oil emulsion. The oil phase (red) was stained with Nile red 
while the protein phase (green) was stained with fast green.  
3.3.4 Conclusions 
The objective of this study was to develop delivery systems for lipophilic 
bioactive agents based on electrostatic complexation of biopolymers that would release 
the bioactive agents due to a temperature-trigger under oral conditions. Gelatin and 
caseinate were used to fabricate the hydrogel particles. Relatively stable filled hydrogel 
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particles were formed at pH 5.8 with the majority of the lipid droplets being trapped 
inside the hydrogel phase. Optical and rheological measurements indicated that the 
structure of the hydrogel particles was disrupted when they were heated above a critical 
temperature (around body temperature), which was attributed to the melting properties of 
gelatin.  After simulated oral processing, the lipid droplets were shown to be released 
from the hydrogel particles and dispersed into the surrounding continuous phase. The 
temperature change in the mouth was identified as the main trigger mechanism for 
hydrogel dissolution. These results have important implications for the development of 
food-grade delivery systems that may protect encapsulated lipophilic active agents in 
food products, but release them in the mouth. 
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CHAPTER 4 
 
ENCAPSULATION, PROTECTION, AND RELEASE OF BIOACTIVE AGENTS 
USING HYDROGEL BEADS 
4.1 Encapsulation of curcumin in polysaccharide-based hydrogel beads: Impact of 
bead type on lipid digestion and curcumin bioaccessibility 
4.1.1 Introduction 
Turmeric is a commonly used pigment, spice, and nutraceutical in foods due to its 
intense yellowish color, unique flavor profile, and biological activities 200-201. Curcumin is 
the major bioactive agent in turmeric, and it consists of three closely related lipophilic 
molecules that have a number of phenolic groups and conjugated double bonds 201-202. 
The potential pharmaceutical activity of curcumin has been established for numerous 
diseases, including multiple myeloma, rheumatoid arthritis, cystic fibrosis, inflammatory 
bowel disease, and colon cancer 201-203.  Previous research suggests that the health 
benefits of curcumin are associated with a number of biological activities, including anti-
oxidative, anti-inflammatory, anti-microbial, anti-parasitic, anti-mutagenic, and anti-
tumor activities 203-205. Another benefit of curcumin is that it has a low toxicity even when 
ingested at relatively high doses. Consumer demand for health-promoting foods 
containing fewer synthetic additives has made curcumin of particular interest as a natural 
nutraceutical ingredient 206. 
However, there are a number of physicochemical characteristics of curcumin that 
currently limit its incorporation into many functional food products, such as its intense 
color, strong flavor, low water-solubility, and chemical instability 207. Moreover, 
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curcumin is rapidly metabolized within the gastrointestinal tract (GIT), which limits its 
potential beneficial biological effects 206, 208. Some of these limitations can be overcome 
by appropriate food product selection, e.g., appearance and flavor problems can be 
overcome by incorporating curcumin into highly colored and spicy products. Other 
limitations can be overcome by encapsulating curcumin within food-grade colloidal 
delivery systems or by mixing it with colloidal excipient systems 209-215.  A colloidal 
delivery system consists of small particles (typically comprised of lipids, phospholipids, 
surfactants, and/or biopolymers) that contain the curcumin 134.  On the other hand, a 
colloidal excipient system consists of small particles that are mixed with another food 
containing curcumin 216.  These small particles are specifically designed to boost the 
bioavailability of curcumin.  Colloidal delivery systems can be designed to facilitate the 
incorporation of curcumin into commercial food products, while both colloidal delivery 
and excipient systems can be designed to improve curcumin’s chemical/biochemical 
stability and to control its fate within the GIT. 
Previous studies have demonstrated the potential of improving the bioavailability 
of curcumin using colloidal delivery systems 217-222 or colloidal excipient systems 215-216, 
223. Emulsion-based systems are particularly useful for this purpose because their 
composition and structures can be designed to alter the bioaccessibility, absorption, and 
transformation of lipophilic bioactives 177. In particular, the lipid phase in emulsions can 
be designed to rapidly digest within the small intestine and form mixed micelles capable 
of solubilizing and transporting lipophilic bioactives 224-225.  In addition, emulsions are 
already integral parts of many commercial food and beverage products 226, and so 
emulsion-based delivery or excipient systems can easily be incorporated into a wide 
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range of foods and beverages. One of the main limitations of conventional oil-in-water 
emulsions for this purpose is that they only have limited scope for controlling the stability 
and release of any encapsulated bioactive agents because the lipid droplets are only 
coated by a thin layer of emulsifier molecules.  This limitation can be overcome by 
trapping the lipid droplets inside hydrogel beads (“microgels”). 
Hydrogel beads suitable for utilization in the food industry are usually fabricated 
from food-grade biopolymers, such as proteins and/or polysaccharides 227-229. These 
beads can be fabricated using numerous approaches, including injection, coacervation, 
thermodynamic incompatibility, antisolvent precipitation, templating, and molding 
methods 79. The injection-gelation method is one of the simplest and most widely used 
approaches for the encapsulation, protection, and delivery of food-grade bioactive 
components such as nutrients, nutraceuticals, and vitamins. In this method, a biopolymer 
solution containing the bioactive component is injected into another ‘‘hardening’’ 
solution under conditions that promote the gelation of the injected biopolymer. This 
procedure results in the formation of a hydrogel bead with the bioactive components 
trapped inside.  The nature of the hydrogel matrix surrounding the bioactive can be 
designed to improve its physical and chemical stability, as well as to control its GIT fate. 
In the present study, curcumin was initially solubilized within the lipid phase of 
an oil-in-water nanoemulsion.  The curcumin-loaded lipid droplets were then used as 
delivery systems themselves, or they were incorporated into hydrogel beads fabricated 
from either carrageenan or alginate.  The filled hydrogel beads were formed by mixing 
the lipid droplets with a polysaccharide solution (alginate or k-carrageenan), and then 
injecting the resulting mixture into a solution of positively charged ions (Ca2+ or K+, 
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respectively). The cations act as salt bridges to promote gelation of the anionic 
polysaccharides molecules.  Carrageenan and alginate were used to form the hydrogel 
beads because they are already widely utilized as food-grade ingredients.  Furthermore, 
these two polysaccharides were used because they are expected to form hydrogel beads 
with different functional attributes. Alginate is a block copolymer composed of 1–4-
linked residues of β-d-mannuronic acid (M) and α-l-guluronic (G) acid. Carrageenan 
consists of galactan monomers linked together by alternating (1 → 3)- and (1 → 4)-β-d-
glycosidic bonds with a negative charge due to the presence of sulfate groups within the 
molecules. The hydrogel beads formed by the polysaccharides with these different 
structures may show different gastrointestinal fate of the encapsulated curcumin during 
digestion. The potential gastrointestinal fate of the different curcumin delivery systems 
was studied using a simulated GIT (mouth, stomach, and small intestine). In particular, 
the influence of the different hydrogel beads on the bioaccessibility of encapsulated 
curcumin was compared. The information obtained in this study may facilitate the 
rational design of hydrogel beads to modulate the bioavailability of encapsulated 
lipophilic nutraceuticals. 
4.1.2 Materials and methods 
4.1.2.1 Materials  
Corn oil was purchased from a local supermarket and used without further 
purification. The following chemicals were purchased from the Sigma Chemical 
Company (St. Louis, MO): alginic acid (sodium salt) (Lot# 180947, viscosity of 1% 
alginic acid in water is 15–20 cp); curcumin (C1386-10G, purity ≥ 65%); mucin from 
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porcine stomach (M2378-100G); pepsin from porcine gastric mucosa (P7000-25G); 
lipase from porcine pancreas pancreatin (L3126-100G); porcine bile extract (B8631-
100G); Tween 80 (P1754-1L); and Nile Red (N3013-100MG). Carrageenan was kindly 
donated by FMC Biopolymer (Viscarin SD 389, Philadelphia, PA). All chemicals used 
were analytical grade. Double distilled water was used to make all solutions. 
4.1.2.2 Preparation of oil-in-water emulsions  
Initially, an aqueous phase was prepared by mixing 1% (w/w) Tween 80 with a 
buffer solution (5 mM phosphate buffer saline (PBS), pH 6.5) and stirring for at least 2 h. 
The emulsifier solution were then stored overnighted at 4 °C to ensure complete 
dissolution. Excipient emulsions stabilized by Tween 80 were prepared by homogenizing 
10% (w/w) corn oil with 90% (w/w) aqueous emulsifier solution using a high-speed 
blender for 2 min (M133/1281-0, Biospec Products, Inc., ESGC, Switzer- land). The 
droplet size in this coarse emulsion was reduced by passing it through a high-pressure 
homogenizer (Microfluidizer, M110Y, Microfluidics, Newton, MA) with a 75 µm 
interaction chamber (F20Y) at an operational pressure of 12,000 psi for 3 passes. The 
resulting excipient emulsions were stored in a refrigerator at 4 °C before use. 
4.1.2.3 Preparation of curcumin-loaded emulsion  
The curcumin was solubilized within the lipid phase of the emulsions using a 
method described previously 223. Curcumin (9 mg) was weighed into a beaker and then 
excipient emulsion (10% oil, 30 mL) was added, and then held at 100 °C for 10 min. This 
amount of emulsion was utilized because it has the ability to completely dissolve the 
curcumin based on the measured equilibrium solubility of curcumin reported in corn oil 
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at ambient temperature ≈ 3.2 ± 0.1 mg/mL 217. The resulting curcumin-loaded emulsion 
was stored in the refrigerator (4°C) prior to hydrogel bead fabrication. 
4.1.2.4 Preparation of curcumin-loaded emulsion  
Aqueous k-carrageenan and alginate (2.5% w/w) solutions were prepared by 
dissolving powdered polysaccharide ingredients in distilled water and then stirring 
continuously at 60 °C for an hour, and then reducing the temperature to 35 °C.  
Polysaccharide solutions and curcumin-loaded emulsions were then mixed together (1:4, 
mass ratio) for 2 h with continuous stirring to form a solution that contained 8% emulsion 
(w/w) and 0.5 % polysaccharide (w/w). Curcumin-loaded carrageenan hydrogel beads 
were prepared using a syringe to drip curcumin-loaded emulsion/k-carrageenan mixtures 
into 10 mL 5% potassium chloride solution with continuous stirring.  Similarly, 
curcumin-loaded alginate hydrogel beads were formed by dripping curcumin-loaded 
emulsion/alginate mixtures into 5% calcium chloride solution. The hydrogel beads 
formed were incubated with the cations (K+ or Ca2+) for a 1 h at ambient temperature to 
promote cross-linking. The beads were then collected by filtration and subsequently 
washed with distilled water and phosphate buffer to remove any excess ions from their 
surfaces. 
4.1.2.5 Gastrointestinal tract model  
Curcumin delivery systems with the same total lipid concentration (5%) and total 
volume (15 mL) were prepared by diluting the original systems with buffer solution (5 
mM PBS, pH 6.5). The samples were then passed through a static GIT model that 
simulated the mouth, stomach, and small intestine phases.  This method has been 
described in detail in our previous study 230, and so is only briefly summarized below. 
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Initial System: 15 mL of the initial systems were placed into a glass beaker in an 
incubator shaker at a rotation speed of 100 rpm for 15 min at 37 °C for preheating 
(Innova Incubator Shaker, Model 4080, New Brunswick Scientific, Edison, NJ). Three 
different initial curcumin-loaded delivery systems were tested: (i) lipid droplets, (ii) filled 
alginate beads, and, (iii) carrageenan beads.  
    Mouth phase: 15 mL of simulated saliva fluid (SSF) containing 0.03 g/mL mucin was 
preheated to 37 °C and then mixed with the initial samples. After being adjusted to 
pH 6.8, the mixture was incubated in an incubator shaker for 10 min at 37 °C to mimic 
agitation in the mouth. 
    Stomach phase: 30 mL of the “bolus” sample resulting from the mouth phase was 
mixed with 30 mL of simulated gastric fluid containing 0.0032 g/mL pepsin preheated to 
37 °C and then the pH was adjusted to 2.5. This mixture was incubated in the incubator 
shaker for 2 h at 37 °C to mimic stomach conditions. 
Small intestine phase: 60 mL of “chyme” sample from the stomach phase was 
placed into a 150 mL glass beaker that was placed into a water bath at 37 °C and then 
adjusted to pH 7.00. 3 mL of simulated intestinal fluid was added to the reaction vessel, 
followed by 7 mL of bile salt solution with constant stirring. The pH of the reaction 
system was adjusted back to 7.00. 5 mL of lipase solution was then added to the sample 
and an automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and 
maintain it at pH 7.0 by titrating 0.25 mM NaOH solution into the reaction vessel for 2 h 
at 37 °C. The amount of free fatty acids released was calculated from the titration curves 
as described previously 231.  
4.1.2.6 Determination of particle characterization  
The particle size distribution of the samples was measured using a static light 
scattering device (Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, 
UK). Initial, mouth, and small intestine samples were diluted with phosphate buffer 
(5 mM, pH 7.0) and stomach samples were diluted with acidified water (pH 2.5) to avoid 
multiple scattering effects. The refractive index of the oil phase used in the calculations 
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was 1.472. The average particle sizes are reported as the surface-weighted mean diameter 
(d32). The hydrogel beads could not be analyzed by static light scattering because they 
were too large and rapidly sedimented or creamed inside the measurement chamber. We 
therefore used image analysis software (Image J, version 1.49) to characterize the particle 
size distribution of the hydrogel beads based on images of the samples. The images of the 
beads after each digestion stage were obtained using a regular camera at the fixed height, 
and at least 20 samples were selected to determine the particle size characterization of the 
hydrogel beads. 
4.1.2.7 Microstructure analysis 
The microstructure of samples after passing each digestion process was studied in 
this section. The microstructure of the all the samples were examined using confocal 
scanning laser microscopy with a 60 × objective lens (Nikon D-Eclipse C1 80i, Nikon, 
Melville, NY, U.S.). For the confocal microscopy, each sample was dyed prior to 
confocal microscopy observation. The corn oil was dyed with Nile red solution (1 mg/mL 
ethanol) by adding 0.1 mL of Nile red dye solution to 2 mL of sample and storage at 5 °C 
overnight. The excitation and emission spectrum for Nile red were 543 nm and 605 nm, 
respectively. The microstructure images for confocal microscopy were taken and 
analyzed using image analysis software (NIS-Elements, Nikon, Melville, NY). 
4.1.2.8 Determination of curcumin concentration, bioaccessibility, and 
transformation 
After the samples had passed through the simulated GIT, 25 g of digesta from the 
small intestine phase was collected and centrifuged (18,000 rpm, Thermo Scientific, 
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Waltham, MA) at 25 °C for 30 min. The clear supernatant was collected and assumed to 
be the “micelle fraction” in which the curcumin was solubilized. Aliquots of 3 mL of 
micelle fraction were mixed with 3 mL of chloroform, vortexed, and centrifuged at 1,750 
rpm for 10 min at ambient temperature. The bottom layer containing the solubilized 
curcumin was collected, while the top layer was mixed with an additional 3 mL of 
chloroform and the same procedure was repeated. The two collected chloroform layers 
were mixed together and then diluted to an appreciate concentration to be analyzed by a 
UV-visible spectrophotometer at 419 nm. The concentration of curcumin was calculated 
from the absorbance using a standard curve. 
The bioaccessibility of curcumin (i.e., the fraction in the small intestine that was 
solubilized in the mixed micelle phase) was calculated from this data: B* = 100 × 
CMicelle/CDigesta, where CMicelle and CDigesta are the curcumin concentrations in the micelle 
faction and in the total digesta collected after the small intestine phase, respectively.  The 
transformation of curcumin (i.e., the fraction remaining in a non-transformed state in the 
small intestine) was calculated: T* = 100 × CDigesta/CInitial, where CInitial is the curcumin 
concentration in the small intestine phase calculated based on the initial amount added, 
which was calculated based on the curcumin concentration in initial sample before 
digestion and the theoretical dilution process during the digestion. The effective 
bioavailability (i.e., the fraction of ingested curcumin present in the mixed micelle phase) 
was also calculated: BA = 100 × CMicelle/CInitial.   The bioaccessibility and transformation 
of curcumin in the filled hydrogel beads could not be calculated because it was not 
possible to extract all of the curcumin from the hydrogel beads, so CDigesta could not be 
measured.   
4.1.2.9 Statistical analysis 
All experiments were performed on at least two freshly prepared samples. The 
results are reported as averages and standard deviations, and the differences among 
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treatments were calculated based on an analysis of variance (ANOVA) and a post-hoc 
Duncan test with a confidence level of 95 %. These analyses were carried out using 
statistical analysis software (SPSS, IBM Corporation, Armonk, NY, USA). 
4.1.3 Results and discussion 
4.1.3.1 Preparation of the curcumin-loaded emulsions and filled hydrogel beads 
In this study, three different curcumin delivery systems were prepared: lipid droplets; 
filled alginate beads; and filled carrageenan beads (Fig. 4.1).  The filled hydrogel beads 
were formed by injection of a mixture of the lipid droplets and anionic biopolymer into a 
crosslinking cationic mineral solution.  In general, several parameters may influence the 
physicochemical and structural properties (e.g., size, shape, porosity, and hardness) of 
hydrogel beads fabricated by the injection method, including biopolymer concentration, 
cation concentration, needle diameter, injection flow rate, and hardening time.  After 
some preliminary experiments to optimize the preparation conditions, we fabricated the 
hydrogel beads by injecting a 0.5 % polysaccharide solution (alginate or carrageenan) 
into a 5% cationic mineral solution (Ca2+ or K+) using a syringe with a needle diameter of 
0.5 mm at a rate of one drop per 2 s.  After injection, the hydrogel beads were incubated 
in the cationic mineral solutions for an hour at ambient temperature to promote 
polysaccharide cross-linking.  The alginate beads fabricated using this method had a 
spherical shape with a smooth surface, and had diameters ranging from about 2 to 3 mm 
(Fig. 4.1 and Table 4.1).  Conversely, the carrageenan beads formed using the same 
method had an irregular shape and had rough surfaces with a larger mean particle 
diameter (around 3 to 4 mm).  The difference in the properties of the hydrogel beads can 
be attributed to differences in the gelation mechanisms of the two different 
polysaccharides. The hydrogel matrix within the alginate beads is formed by calcium ion 
crosslinking of guluronic acid blocks within the alginate chains 232, whereas that in the 
carrageenan beads is formed by potassium ion crosslinking of sulfate groups along the 
carrageenan chains 233. The fact that the alginate beads had a more spherical and 
smoother structure suggests that the crosslinking of the alginate molecules by calcium 
ions occurred more rapidly than the crosslinking of the carrageenan molecules by 
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potassium ions.  Thus, the initial spherical shape of the polysaccharide solution injected 
into the cation solution was maintained more readily for the fast-gelling alginate system.  
This may have been because the multivalent calcium ions were more efficient at 
crosslinking that the monovalent potassium ions.  We hypothesized that the difference in 
initial structure and properties of the hydrogel beads formed by the two different 
polysaccharides would alter their behavior within the simulated GIT, e.g., their 
susceptibility to enzyme penetration, and their stability to mechanical forces or pH 
changes.  
 
 
Figure 4. 1 Appearance of different curcumin-delivery systems prepared in buffer 
solution (5 mM PBS, pH 6.5), from left to right: lipid droplets; Filled alginate beads, and 
Filled carrageenan beads.  Unfilled alginate beads (far right) are shown as a reference.  
 
It is interesting to note that unfilled alginate and carrageenan beads sedimented to 
the bottom of the test tubes, whereas the filled beads creamed to the top (Fig. 4.1). This 
difference in behavior can be attributed to the influence of lipid droplets on the effective 
density of the hydrogel beads 173: unfilled beads are denser than water, whereas filled 
beads are less dense than water.  This effect occurs because lipids have a lower density 
than water, whereas biopolymers have a higher density.  The buoyancy characteristics of 
filled hydrogel beads makes them good candidates for stomach targeting delivery systems 
as they may spend a longer time within the gastric cavity 106. 
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4.1.3.2  Influence of GIT conditions on particle size and microstructure 
The particle size distribution (Fig. 4.2), general appearance (Fig.4.3), and 
microstructure (Fig. 4.4) of the curcumin-loaded lipid droplets and filled hydrogel beads 
were measured during passing through the simulated GIT.  
Table 4. 1 The mean particle diameters of three curcumin delivery systems after each 
digestion stage in a simulated GIT: Lipid droplets; Filled alginate beads; and, Filled 
carrageenan beads.   
 
 
Curcumin-loaded lipid droplets. The mean particle diameters (d32) of the curcumin-
loaded lipid droplets were fairly similar for the initial samples (0.13 µm) and the samples 
that had been exposed to the mouth (0.14 µm) and stomach (0.15 µm) phases (Table 4.1).  
In addition, the particle size distributions of the initial, mouth, and stomach samples were 
also fairly similar (Fig. 4.2).  These results suggest that the lipid droplets were stable to 
coalescence in the simulated saliva and gastric fluids, which can be attributed to the fact 
that they were coated with a non-ionic surfactant (Tween 80) that inhibits droplet 
coalescence through steric repulsion.  Other studies have also reported the good 
coalescence stability of lipid droplets coated by non-ionic surfactants under simulated 
mouth and stomach conditions 234-235.  Despite the fact little droplet coalescence was 
observed by light scattering, the confocal microscopy images indicated that there was 
some aggregation of the lipid droplets within the mouth and stomach phases (Fig. 4.4), 
 Mean Particle Diameter (µm) 
Sample Initial Mouth Stomach Intestine 
Lipid Droplets 0.13 ± 0.01 0.14 ± 0.01 0.15 ± 0.01 0.22 ± 0.01 
Filled alginate 
beads 2604 ± 75 2857 ± 166 2555 ± 204 1796 ± 58 
Filled carrageenan 
beads 3107 ± 159 824 ± 640 372 ± 344 848 ± 184 
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which may have been due to depletion flocculation caused by the presence of non-
adsorbed mucin molecules in the simulated saliva 236.  These non-adsorbed mucin 
molecules generate an osmotic attraction between the lipid droplets that forces them 
together.  These large particles were not seen in the particle size distributions because the 
samples had to be diluted for the light scattering measurements, which would have 
caused dissociation of any flocs held together by depletion forces.  After passing through 
the small intestine phase, the particle size distribution of the samples initially containing 
curcumin-loaded lipid droplets became bimodal (Fig. 4.2a). This suggests that there was 
a wide range of different-sized colloidal particles present in the digesta after exposure to 
small intestinal fluids containing lipase and bile salts. These colloidal particles may have 
been mixed micelles (micelles and vesicles), undigested lipid droplets, and/or insoluble 
calcium salts.  
 
 
(a) 
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(c) 
Figure 4. 2 Particle size distribution of different samples: (a) Lipid droplets, (b) Filled 
carrageenan beads, and (c) Filled alginate beads after each digestion stage. 
 
Filled hydrogel beads.  The particle size and microstructure of the filled hydrogel 
beads in the different regions of the GIT depended on the type of polysaccharide used 
(Figs. 4.2 to 4.4). For the alginate beads, the general shape of the particle size distribution 
remained fairly similar from initial-to-mouth-to-stomach, exhibiting a major population 
of large particles with diameters around 2,500 µm (Table 4.1, Fig. 4.2c).  In addition, 
observation of the general appearance of the alginate beads indicated that they remained 
intact after exposure to the different GIT phases (Fig. 4.3).  There was an appreciable 
decrease in the mean particle diameter of the alginate beads when they were moved from 
the simulated stomach to small intestine (Table 4.1).  Previous studies have also reported 
that calcium alginate beads shrink under highly acidic gastric conditions 76, 237, which can 
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be attributed to a reduction in the electrostatic repulsion between the alginate molecules 
below the pKa value of the carboxyl groups.  The closer packing of the biopolymer 
molecules within the hydrogel beads under stomach conditions may be useful for 
protecting encapsulated components from the harsh gastric environment.  Interestingly, 
there appeared to be an increase in the turbidity of the aqueous solution surrounding the 
hydrogel beads in the small intestine (Fig. 4.3b), which suggests that there were colloidal 
particles present large enough to scatter light.  These particles may have been undigested 
lipid droplets or mixed micelles released from the hydrogel beads.  Indeed, confocal 
microscopy images of the aqueous phase collected from outside of the hydrogel beads 
indicated that they contained some lipid-rich particles (data not shown).     
4.1.3.3  Influence of delivery system type on lipid digestion 
An automatic titration (pH stat) method was used to evaluate the effect of delivery 
system type on the rate and extent of lipid digestion. The fraction of free fatty acids 
(FFAs) released from the samples during the small intestine phase was calculated from 
measurements of the volume of NaOH that had to be titrated into the reaction chamber to 
maintain a constant pH (7.0).  The nature of the delivery system clearly had a pronounced 
impact on the rate and extent of lipid digestion (Fig. 4.5).  The free lipid droplets were 
rapidly digested during the first 10 minutes with over 60% of the FFAs being released, 
followed by a more gradual digestion for the remainder of the incubation time.  
Conversely, the rate of FFAs released was much slower for the filled hydrogel beads, and 
depended on polysaccharide type.  For the filled alginate beads, no lipid digestion 
occurred during the first 30 minutes, then there was a relatively slow rate of lipid 
digestion at longer times, with only 33% of the FFAs being released by the end of the 2 
hour digestion period.  For the filled carrageenan beads, lipid digestion started 
immediately and occurred throughout the incubation period, but it was relatively slow 
compared to the free lipid droplets, with only 46% of FFAs released by the end of the 
small intestine phase.  These results indicate that encapsulation of the lipid droplets 
within the hydrogel beads retarded lipid digestion, with the degree of lipase inhibition 
depending on hydrogel type.  Similar results have been reported in earlier studies of lipid 
digestion in hydrogel beads 76. 
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(b) 
 
Figure 4. 3 Images of different curcumin-loaded beads after each digestion stage: (a) 
Filled alginate beads, and (b) Filled carrageenan beads. 
 
There are a number of reasons that encapsulation may have inhibited lipid digestion. 
Firstly, lipid digestion can only occur if pancreatic lipase is able to adsorb to the surfaces 
of the lipid droplets and come into close proximity with its substrate, i.e., triacylglycerol 
and diacylglycerol molecules 238.  For the free lipid droplets, the pancreatic lipase is able 
to rapidly move from the aqueous phase to the lipid droplet surfaces and initiate lipolysis. 
For the filled hydrogel beads, lipase and the other GIT components required for digestion 
(such as co-lipase and calcium) have to penetrate into the beads and diffuse through the 
hydrogel matrix before they can reach the lipid droplet surfaces.  In particular, these 
components must diffuse through the network of cross-linked biopolymer molecules that 
 
Initial Mouth 
Stomach Intestine 
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makes up the interior of the hydrogel beads 76.  The time taken for lipase molecules to 
reach the lipid droplets within the interior of the beads increases as the pore size of the 
hydrogel matrix decreases, the diameter of the beads increases, or the surface area of the 
beads decreases 76, 239.  The lag time observed before any lipid digestion occurred for the 
alginate beads may have been because the hydrogel matrix shrank under gastric 
conditions thereby decreasing the bead pore size and inhibiting penetration of lipase.  
However, the pore size expanded once the beads were placed into the small intestinal 
fluids, thereby allowing the lipase molecules to penetrate.  This hypothesis is supported 
by the fact that the mean diameter of the alginate beads was smaller in the gastric fluids 
than in the intestinal fluids (Table 4.1).  After the lag phase, the relatively slow rate of 
lipid digestion observed in the alginate beads, may have been because they were larger 
than the carrageenan beads.  As mentioned earlier, the alginate beads maintained their 
general structure throughout the GIT, whereas the carrageenan beads were largely 
disrupted by the small intestine phase.  The slow rate of digestion for the alginate beads 
may also have been because they had a smaller pore size than the carrageenan beads, 
which would inhibit lipase diffusion.   A second potential reason for retarded lipid 
digestion in the filled hydrogel beads is that the long chain FFAs generated at the 
surfaces of the lipid droplets have to be removed otherwise the lipolysis reaction will be 
retarded 240-241. Typically, FFAs are removed from the droplet surfaces by being 
incorporated into mixed micelles with bile salts and phospholipids, or by forming 
insoluble salts with calcium ions 242.  The removal of FFAs away from the lipid droplet 
surfaces may therefore be limited because bile salts, phospholipids, and calcium cannot 
easily penetrate through the cross-linked biopolymer network inside the hydrogel beads. 
In addition, the diffusion of the FFAs themselves out of the hydrogel beads may also be 
inhibited by the presence of the biopolymer network. These results clearly show that 
encapsulating lipid droplets in hydrogel beads can modulate the rate and extent of their 
digestion. 
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Figure 4. 4 Microstructures of three samples including free emulsion, emulsion in 
alginate beads and emulsion in carrageenan beads exposed to different regions of a 
simulated GIT. Scale bar is 20 µm. 
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Figure 4. 5 Amount of fatty acids released from three samples including free emulsion, 
emulsion in alginate beads and emulsion in carrageenan beads measured in a pH-stat 
in vitro digestion model. 
4.1.3.4 Influence of delivery system type on curcumin release 
The amount of curcumin released into the mixed micelle phase clearly depended on 
the nature of the delivery system used to encapsulate it: free droplets > filled carrageenan 
beads > filled alginate beads (Fig. 4.6).  For the free oil droplets, it was possible to 
calculate the bioaccessibility (73%), transformation (78%), and effective bioavailability 
(57%) from the initial, digesta, and micelle curcumin concentrations (Section 2.7). The 
effective bioavailability of the curcumin in the filled alginate beads (12%) and 
carrageenan beads (15%) was also determined. Pure curcumin typically has a very low 
bioavailability because of its poor chemical stability and low solubility in gastrointestinal 
fluids 202, 206. Our results suggest that encapsulation of curcumin within free lipid droplets 
led to a relatively high effective bioaccessibility.  This enhanced bioavailability can be 
attributed to two main physicochemical factors.  First, when curcumin is present within 
the interior of the lipid droplets it is protected from chemical degradation induced by 
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aqueous phase components, which leads to a relatively high amount remaining in an 
active form in the small intestine (high T*). Second, the digestion of the lipid droplets 
leads to the formation of mixed micelles that can solubilize the hydrophobic curcumin 
molecules (high B*).  Previous studies in our laboratory have also reported that 
nanoemulsions can increase curcumin bioaccessibility and transformation through these 
mechanisms when used as either delivery systems 217 or excipient systems 216, 223.  
 
Figure 4. 6 Bioaccessibility (%) of curcumin in three samples including lipid droplets, 
filled alginate beads, and filled carrageenan beads after in vitro digestion.  
 
The relatively low effective bioavailability of the curcumin in the filled hydrogel 
beads can largely be attributed to the fact that not all of the lipid phase was digested for 
these systems.  Consequently, some of the curcumin remained within the undigested lipid 
droplets trapped inside the hydrogel beads and was therefore not released.  In addition, 
there will have been less mixed micelles available in the aqueous phase to solubilize any 
curcumin molecules released: (i) because of the relatively low extent of lipid digestion; 
and, (ii) because the diffusion of any FFAs and monoacylglycerols formed within the 
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beads may have been hindered by the hydrogel matrix.  There appeared to be a good 
correlation between the extent of lipid digestion at the end of the small intestine phase 
and curcumin release, i.e., they followed the same trend: free droplets > filled 
carrageenan beads > filled alginate beads.   
Overall, these results have a number of important practical implications.  First, it is 
important to ensure that any hydrogel beads used to encapsulate and protect curcumin 
within food products do not inhibit its release within the GIT.  Otherwise, any potential 
health benefits associated with consuming curcumin may not be fully realized.  Second, it 
may be possible to control the release of curcumin in different regions of the GIT by 
encapsulating it within hydrogel beads.  For example, if it was important to release 
curcumin in the colon then it could be encapsulated within hydrogel beads that retained it 
in the mouth, stomach, and small intestine, but released it in the colon.  Alternatively, if 
one wanted to mask the taste of curcumin, but still ensure that it was absorbed in the 
upper intestine, it could be incorporated into hydrogel beads that retained it in the mouth, 
but released it in the stomach or small intestine. 
4.1.4  Conclusions 
In the present study a simulated GIT was used to study the influence of different 
types of delivery systems on lipid digestion and curcumin release: free lipid droplets; 
filled carrageenan beads; and, filled alginate beads.  In all systems, the crystal form of 
curcumin was first dissolved in a digestible lipid phase, which was then converted into an 
oil-in-water nanoemulsion.  In the case of the filled hydrogel beads, the curcumin-loaded 
lipid droplets were then trapped within a hydrogel matrix using an injection-gelation 
method.  The alginate beads had a uniform spherical shape with diameters ranging from 2 
to 3 mm, whereas the carrageenan beads had irregular shapes and diameters around 3 to 4 
mm. Differences in hydrogel bead morphology were attributed to differences in the initial 
rate of biopolymer gelation during the injection process.  Simulated GIT studies indicated 
that free lipid droplets were digested more rapidly and fully than those encapsulated 
within hydrogel beads.  In addition, they showed that the rate and extent of lipid digestion 
in filled hydrogel beads depended on polysaccharide type, which was partly attributed to 
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differences in their integrity within the GIT.  Alginate beads remained relatively intact 
throughout the GIT, while the carrageenan beads partly disintegrated. The extent of 
curcumin release into the mixed micelle phase in different samples followed the 
following order: free droplets > filled carrageenan beads > filled alginate beads. Our 
results have important implications for designing hydrogel beads to increase the oral 
bioavailability of lipophilic bioactives. 
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4.2 The physicochemical stability and in vitro bioaccessibilityof β-carotene in 
alginate-based hydrogel beads 
4.2.1 Introduction 
Carotenoids are naturally occurring groups of pigments widely present in various 
fruits and vegetables to play essential roles in photosynthesis and photo-protection 
reactions. β-Carotene, one of the major carotenoids, is regarded as a natural carotenoid 
precursor of vitamin A. Because of its antioxidant and non-antioxidant activities, β-
carotene have showed biological activities to reduce the risk of certain chronic diseases 
including cardiovascular disease, cataracts, age-related macular degeneration and cancers 
when ingestion of sufficient levels. Growing concern on healthy diet has encouraged 
many food companies to fortify their products with this bioactive ingredient. However, 
the pure hydrogen-carbon skeleton structure and high unsaturation degree of β-carotene 
greatly restrict its incorporation into many commercial foods and beverages. β-carotene 
has been reported to have low water-solubility, high melting point, and poor chemical 
instability 243-244. Moreover, β-Carotene can be rapidly metabolized like most of 
lipophilic bioactive agents within the gastrointestinal tract (GIT), which limits its 
potential beneficial biological effects. 
Colloidal delivery systems are one of the most convenient methods for incorporating 
lipophilic bioactive ingredients into food products. They usually consist of small particles 
(typically comprised of lipids, phospholipids, surfactants, and/or biopolymers) that 
contain the lipophilic bioactive agents. These small particles can be designed to facilitate 
the incorporation of bioactive agents into commercial food products, improve 
chemical/biochemical stability and control their fate within the GIT. A typical bioactive-
loaded colloidal system can be simply prepared by solubilizing the lipophilic bioactive 
components within an oil phase and then homogenising it with an aqueous phase 
containing an emulsifier to form the oil-in-water emulsions. Previous studies have 
reported that emulsion-based systems were particularly suitable for encapsulation and 
delivery of carotenoids such as lutein 245, lycopene 246 and β-Carotene 247-248. The 
bioavailability of carotenoids was greatly increased after encapsulation in emulsion-based 
systems 249. One of the major limitations of conventional oil-in-water emulsions is that 
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they have limited scope for controlling the stability of lipophilic bioactives because the 
bioactives-loaded lipid droplets are coated only with a thin layer of emulsifier molecules, 
which hardly guarantee the encapsulated bioactives suffer from the harsh environment 
conditions. In particular, carotenoids have a conjugated polyunsaturated hydrocarbon 
chain, which makes them highly prone to degradation due to autoxidation promoted by 
light, heat, singlet oxygen, transition metals, free radicals and highly acidic condition 247. 
This limitation can be overcome by trapping the lipid droplets inside hydrogel beads 
(“microgels”). Carotenoids may have a more stable environment after encapsulation in a 
polymer matrix, which creating a single compartment and thus protecting them from 
degradation. 
Hydrogel beads are usually fabricated from food-grade biopolymers such as proteins 
and/or polysaccharides. These beads can be fabricated from numerous approaches such as 
injection, coacervation, thermodynamic incompatibility, antisolvent precipitation, 
templating, and molding methods 79. The injection-gelation method is one of the simplest 
and most widely used approaches for the encapsulation, protection, and delivery of food-
grade bioactive components. In this method, a biopolymer solution containing the 
bioactive component is injected into another ‘‘hardening’’ solution under conditions that 
promote the gelation of the injected biopolymer. This procedure results in the formation 
of a hydrogel bead with the bioactive components trapped inside. The nature of the 
hydrogel matrix surrounding the bioactive can be designed to improve its physical and 
chemical stability, as well as to control its GIT fate. In general, hydrogel beads with a 
particle size greater than 1.0 mm in diameter are prepared using a syringe with a needle 
or a pipette. Smaller size beads (less than 1 mm in diameter) could be fabricated using an 
extrusion device (Encapsulator). The beads with relatively small size may have several 
advantages over the traditional large ones on appearance, rheology and mouthfeel. The 
sizes of these beads can be further adjusted by several factors including the polymers and 
ion concentration, instrument parameters and hardening time. 
 In the present study, a high-pressure homogenisation method was used to prepare 
nanoemulsions containing β-carotene. The β-carotene-loaded lipid droplets were then 
used as delivery systems themselves, or they were incorporated into hydrogel beads 
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fabricated from alginate. The filled hydrogel beads were fabricated by mixing the lipid 
droplets with an alginate solution, and then injecting the resulting mixture into an ion 
solution (Ca2+) with the extrusion device (Encapsulator). Two different alginate 
concentrations (0.5% and 1%) were used because they are expected to form hydrogel 
beads with different physical and functional attributes. The stability of β-carotene 
encapsulated within oil-in-water nanoemulsions and filled hydrogel beads was studied 
during the storage. In particular, the influence of the different delivery systems 
(nanoemulsion and filled hydrogel beads) encapsulation on the bioaccessibility of 
encapsulated β-carotene was compared using a gastrointestinal (GI) model that simulates 
the mouth, stomach and small intestine. The information obtained from this study should 
be useful for the development of bead-based functional food products fortified with 
lipophilic bioactive ingredients that may improve human health and wellness. 
4.2.2 Materials and methods 
4.2.2.1 Materials  
Whey protein isolate (WPI) was kindly provided by Davisco Foods International Inc. 
(Le Sueur MN). The WPI was reported to contain 97.9 wt.% protein, 0.2 wt.% fat. Corn 
oil was purchased from a local supermarket and used without further purification. The 
following chemicals were purchased from the Sigma Chemical Company (St. Louis, MO): 
β-carotene; alginic acid (sodium salt); mucin from porcine stomach; pepsin from porcine 
gastric mucosa; lipase from porcine pancreas pancreatin; porcine bile extract; and Nile 
Red. All chemicals used were analytical grade. Double distilled water was used to make 
all solutions. 
4.2.2.2 Preparation of β-carotene-loaded emulsions 
Initially, an aqueous phase was prepared by mixing 1% (w/w) WPI with a buffer 
solution (5 mM phosphate buffer saline (PBS), pH 7) and stirring for at least 2 h. The 
emulsifier solution was stored overnighted at 4 °C and filtered before use to ensure the 
complete dissolution of any large particles. The β-carotene-loaded lipid droplets were 
prepared by dispersing β-carotene (0.1%, w/w) in corn oil by heating (55°C, 10 min) and 
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then ultrasonic processing (2min). This procedure was repeated several times to ensure 
the complete dissolution of β-carotene in the oil phase. The coarse emulsion was prepared 
by homogenizing 10% (w/w) corn oil with 90% (w/w) aqueous emulsifier solution using 
a high-speed blender for 2 min (M133/1281-0, Biospec Products, Inc., ESGC, Switzer- 
land). The droplet size in this coarse emulsion was further reduced by passing it through a 
high-pressure homogenizer (Microfluidizer, M110Y, Microfluidics, Newton, MA) with a 
75 µm interaction chamber (F20Y) at an operational pressure of 12,000 psi for 3 passes. 
The resulting β-carotene-loaded emulsions were stored in a refrigerator at 4 °C before use. 
4.2.2.3 Encapsulation of β-carotene in alginate beads 
Different concentration of aqueous alginate solutions were prepared by dissolving 
powdered alginic acid (1% and 2%, w/w) in distilled water and stirring continuously at 
60 °C for an hour, and then reducing the temperature to 35 °C. Alginate solutions and β-
carotene-loaded emulsions were then mixed together (1:1, mass ratio) for 2 h with 
continuous stirring to form a solution that contained 5% emulsion (w/w) and 
polysaccharide (0.5% and 1%). The β-carotene-loaded hydrogel beads were prepared 
using a commercial encapsulation unit (Encapsulator B-390, BUCHI, Switzerland) with a 
120µm nozzle to inject the β-carotene/alginate solution into 10% calcium chloride 
solution. The formed hydrogel beads were incubated with the Ca2+ for 1 h at ambient 
temperature to promote cross-linking. The beads were then collected by filtration and 
subsequently washed with distilled water and phosphate buffer to remove any excess ions 
from their surfaces. The formed beads were then storage in refrigerator to dehydration 
and then the total weight was determined to facilitate the further measurements.  
4.2.2.4 Measurement of β-carotene stability 
The physicochemical stability of β-carotene encapsulated in the free emulsion and 
filled hydrogel particles were tested: 4 ml 5% emulsion samples and filled hydrogel 
beads (5% oil) were transferred into glass tubes and stored in the dark at 55°C for 12 days 
(pH 7). The β-carotene was isolated from a nanoemulsion and hydrogel beads using 
solvent extraction methods: each sample was extracted by the chloroform and alcohol 
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(volume fraction 1:1) solution at least two times. For the filled hydrogel beads, saturated 
ethylene diamine tetraacetic acid (EDTA) solution was used to dissolve the beads and 
release the encapsulated β-carotene. The transparent lower organic phase containing the 
β-carotene was collected and transferred to a cuvette, and then its absorbance was 
measured at 450 nm using a UV–visible spectrometer. A pure chloroform and alcohol 
solution was used as a blank. A corn oil nanoemulsion containing no added β-carotene 
was also analyzed as a control. The β-carotene content was determined using a standard 
curve created from solutions with varying amounts of known β-carotene. All 
measurements were repeated three times. 
4.2.2.5 Gastrointestinal tract model 
β-carotene delivery systems (free emulsion and filled hydrogel beads) with the same 
total lipid concentration (2%) and total volume (7.5 mL) were prepared by diluting the 
original systems with buffer solution (5 mM PBS, pH 7). The samples were then passed 
through a static GIT model that simulated the mouth, stomach, and small intestine phases.  
This method has been described in detail in our previous study 230, and so is only briefly 
summarized below. 
Initial System: 7.5 mL of the initial systems were placed into a glass beaker in an 
incubator shaker at a rotation speed of 100 rpm for 15 min at 37 °C for preheating 
(Innova Incubator Shaker, Model 4080, New Brunswick Scientific, Edison, NJ). Three 
different initial β-carotene-loaded delivery systems were tested: (i) lipid droplets, (ii) 
filled alginate beads (0.5 % alginate) (iii) filled alginate beads (1 % alginate).  
    Mouth phase: 7.5 mL of simulated saliva fluid (SSF) containing 0.03 g/mL mucin was 
preheated to 37 °C and then mixed with the initial samples. After being adjusted to 
pH 6.8, the mixture was incubated in an incubator shaker for 10 min at 37 °C to mimic 
agitation in the mouth. 
    Stomach phase: 15 mL of the “bolus” sample resulting from the mouth phase was 
mixed with 15 mL of simulated gastric fluid containing 0.0032 g/mL pepsin preheated to 
37 °C and then the pH was adjusted to 2.5. This mixture was incubated in the incubator 
shaker for 2 h at 37 °C to mimic stomach conditions. 
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Small intestine phase: 30 mL of “chyme” sample from the stomach phase was 
placed into a 150 mL glass beaker that was placed into a water bath at 37 °C and then 
adjusted to pH 7.00. 1.5 mL of simulated intestinal fluid was added to the reaction vessel, 
followed by 3.5 mL of bile salt solution with constant stirring. The pH of the reaction 
system was adjusted back to 7.00. 2.5 mL of lipase solution was then added to the sample 
and an automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and 
maintain it at pH 7.0 by titrating 0.25 mM NaOH solution into the reaction vessel for 2 h 
at 37 °C. The amount of free fatty acids released was calculated from the titration curves 
as described previously 231.  
4.2.2.6 Determination of particle characterization 
The particle size distribution of the samples after passing each digestion process was 
measured using a static light scattering device (Mastersizer 2000, Malvern Instruments 
Ltd., Malvern, Worcestershire, UK). Initial, mouth, and small intestine samples were 
diluted with phosphate buffer (5 mM, pH 7.0) and stomach samples were diluted with 
acidified water (pH 2.5) to avoid multiple scattering effects. The refractive index of the 
oil phase used in the calculations was 1.472. The average particle sizes are reported as the 
surface-weighted mean diameter (d32) for emulsion samples and volume-weighted mean 
diameter (d43) for beads.  
4.2.2.7 ζ-potential measurements 
The electrical charge (ζ-potential) of the samples after passing each digestion 
process was measured using a particle electrophoresis instrument (Zetasizer Nano ZA 
series, Malvern Instruments Ltd. Worcestershire, UK). Initial, mouth, and small intestine 
samples were diluted with phosphate buffer (5 mM, pH 7.0) and stomach samples were 
diluted with acidified water (pH 2.5) prior to analysis to keep the instrument attenuation 
value between 5 and 10. All measurements were made on at least two freshly prepared 
samples and each sample was measured in duplicate. 
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4.2.2.8 Microstructure analysis 
The microstructure of samples after passing each digestion process was studied in 
this section. The microstructure of the all the samples were examined using confocal 
scanning laser microscopy with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon, 
Melville, NY, U.S.). For the confocal microscopy, each sample was dyed prior to 
confocal microscopy observation. The corn oil was dyed with Nile red solution (1 mg/mL 
ethanol) by adding 0.1 mL of Nile red dye solution to 2 mL of sample and storage at 5 °C 
overnight. The excitation and emission spectrum for Nile red were 543 nm and 605 nm, 
respectively. The microstructure images for confocal microscopy were taken and 
analyzed using image analysis software (NIS-Elements, Nikon, Melville, NY).  
4.2.2.9 Determination of β-carotene concentration, bioaccessibility, and 
transformation  
After the samples had passed through the simulated GIT, 20 g of digesta from the 
small intestine phase was collected and centrifuged (18,000 rpm, Thermo Scientific, 
Waltham, MA) at 4 °C for 30 min. The β-carotene in digesta and micelle phase was 
extracted based on the methods described in section 2.4. The EDTA solution was used to 
dissolve the hydrogel beads and release the encapsulated β-carotene. The clear 
supernatant after extraction was collected and assumed to be the “micelle fraction” in 
which the β-carotene was solubilized. Aliquots of 2 mL of micelle fraction were mixed 
with 2 mL of chloroform and 2 mL of alcohol, vortexed several times, and centrifuged at 
3500 rpm for 5 min at ambient temperature. The collected chloroform layers were diluted 
to an appreciate concentration to be analyzed by a UV-visible spectrophotometer at 450 
nm. The concentration of β-carotene was calculated from the absorbance using a standard 
curve.  
The bioaccessibility of β-carotene (i.e., the fraction in the small intestine that was 
solubilized in the mixed micelle phase) was calculated from this data: B* = 100 × 
CMicelle/CDigesta, where CMicelle and CDigesta are the β-carotene concentrations in the micelle 
faction and in the total digesta collected after the small intestine phase, respectively.  The 
transformation of β-carotene (i.e., the fraction remaining in a non-transformed state in the 
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small intestine) was calculated: T* = 100 × CDigesta/CInitial, where CInitial is the β-carotene 
concentration in the small intestine phase calculated based on the initial amount added. 
The effective bioavailability (i.e., the fraction of ingested β-carotene present in the mixed 
micelle phase) was also calculated: BA = 100 × CMicelle/CInitial.    
4.2.2.10 Statistical analysis 
All experiments were performed on at least two freshly prepared samples. The 
results are reported as averages and standard deviations, and the differences among 
treatments were calculated based on an analysis of variance (ANOVA) and a post-hoc 
Duncan test with a confidence level of 95 %. These analyses were carried out using 
statistical analysis software (SPSS, IBM Corporation, Armonk, NY, USA). 
4.2.3 Results and discussion 
4.2.3.1 filled hydrogel beads formation and β-carotene stability 
In current study, β-carotene was loaded into two delivery systems including 
nanoemulsion and filled alginate beads. The filled hydrogel beads were formed by 
injection of mixture of the emulsion and alginate solution into Ca2+ solution using an 
extrusion device (Encapsulator). Base on preliminary experiments, the size of these beads 
could be determined by several parameters including the biopolymer and cation 
concentration, infusing gas pressure, vibrational frequency, electrode voltage, nozzle size 
and the distance between the nozzle and the surface of the crosslinking solution. Two 
different alginate concentrations (0.5% and 1%) were chosen to fabricate the hydrogel 
beads using the same operating conditions (frequency 800 Hz, electrode 800 V, pressure 
450 mbar). As shown in Fig. 4.7 and Table 4.2, the beads formed with different alginate 
concentration showed significant different size and appearance characterization: the 0.5% 
alginate-based beads with diameters around 285 µm creamed to the top of the test tube, 
whereas the 1% alginate-based beads with diameters around 660 µm sedimented to the 
bottom. These beads formed with different concentration of alginate may have different 
physical structure and properties. It can be expected that the difference in initial structure 
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and properties of the beads would alter the stability and in vitro digestion fate of 
encapsulated β-carotene. 
 
 
Figure 4. 7 The appearance of the β-carotene loaded emulsion in different alginate-based 
beads. Left to right: 1% alginate based beads and 0.5% beads 
 
Table 4. 2 The mean particle diameter of three samples including free emulsion, 
emulsion in 0.5% alginate beads and emulsion in 1% alginate beads after each digestion 
stage. 
 
Mean particle 
Diameter (µm) Initial Mouth Stomach Intestine 
Free emulsion 0.15±0.01 0.29±0.02 33.3±3.2 6.6±1.1 
0.5% bead 284.8±5.2 469.7±27.5 364.1±18.1 405±8.6 
1% bead 660.6±26.4 879.7±33.5 718.4±22.8 837.3±31.5 
 
β-carotene was widely reported to be sensitive to thermal and oxidative degradation 
during storage because of its highly unsaturated structure 250-251. The effect of filled 
hydrogel beads encapsulation on the stability of β-carotene was thus examined in this 
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section. Fig.4.8 shows the relative β-carotene content in the different delivery systems 
including nanoemulsion, hydrogel beads formed by 0.5% alginate (0.5% beads) and 
hydrogel beads formed by 1% alginate (1% beads) during storage. The relative β-
carotene content fell from an initial value of 100% after preparation to 0.2%, 37.6% and 
55% for nanoemulsion, 1% beads and 0.5% beads respectively, after storage at 55 °C for 
12 days. These results indicated that the β-carotene in nanoemulsions was highly unstable 
to chemical degradation stored at elevated temperatures, and hydrogel beads 
encapsulation could significantly improve its stability. There may be two reasons 
attributed to the hydrogel beads protection effect: firstly, the assembled size of the 
emulsion droplets was larger in hydrogel beads than those in the free emulsions, which 
meant a smaller surface area for chemical reaction of β-carotene degradation. The other 
reason is that beads encapsulation provides a physical barrier of wall polymers for the β-
carotene, which limits the diffusion of oxygen, pro-oxidant or free radicals into the 
particle core to interact with β-carotene. It is interesting to note that the retention rate of 
β-carotene in 0.5% beads was higher than that in 1% beads. This is presumably due that 
these beads fabricated by 0.5% alginate have relatively smaller particle and also pore size, 
which provide the encapsulated β-carotene more protection by inhibiting less diffusion of 
oxygen, pro-oxidant and free radicals. The visual appearance of different samples before 
and after storage was also measured and shown in Fig. 4.9. It can be observed that β-
carotene normally had an intense orange-yellow colour, but this colour completely faded 
to white when it underwent chemical degradation in nanoemulsion. The alginate-based 
beads encapsulation showed a good retention of the yellow colour of β-carotene after 
storage. These results suggested that alginate-based hydrogel beads encapsulation could 
improve the stability of β-carotene.  
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Figure 4. 8 Degradation rates of β-carotene loaded in different delivery systems 
(nanoemulsion and hydrogel beads) during storage at 55 °C. 
4.2.3.2 Influence of GIT conditions on particle charge 
In this section, changes in the charge characteristics of the samples were determined 
as they passed through the different stages of the GIT model to provide information about 
alterations in interfacial properties. 
The ζ-potential of the initial samples of free emulsion, 0.5% beads and 1% beads 
were -47.6, -9 and -9.5, respectively (Fig. 4.10). The strong negative charge on the free 
emulsion can be due to the presence of the whey protein isolate (WPI) molecules at the 
droplet surfaces. WPI is above its isoelectric point (pI = 5.1) at the initial solution 
conditions (pH 7), and therefore shows a negative charge. The beads were negatively 
charged for both alginate concentrations, which attributed to the anionic carboxylic (–
COO−) groups on the mannuronic and guluronic acid groups of alginate molecules. The 
concentration of alginate showed little influence on the magnitudes of the electric charges. 
These results were also in accordance with the previous study 252.  
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Figure 4. 9 The appearance of the β-carotene loaded in different delivery systems 
(nanoemulsion and hydrogel beads) before and after stability measurements. Left to right: 
the β-Carotene-loaded samples before and after storage. 
 
After subjecting to simulated mouth conditions, there was a gently decrease in the 
magnitude of the negative charge on free emulsion (-40.9), while a slightly increase on 
these alginate-based beads (-11.2 for 0.5% beads, -15.6 for 1% beads). These changes 
were presumably due to electrostatic screening by mineral ions present within the 
simulated saliva, or it may have been due to interactions of the mucin molecules with the 
samples surfaces (WPI and alginate). There was an appreciable decrease in the magnitude 
of the electrical charge when all the samples were passing through stomach phase. It 
might be attributed to the low pH and high ionic strength in stomach phase, which 
resulted in the electrostatic screening effect on the electrical charge of the samples. It 
could be observed that free emulsion droplets were slightly negatively under gastric 
conditions, suggesting that they were not only coated by emulsifier whey proteins. 
Presumably some of the proteins was digested and displaced, and that some of the mucin 
molecules from the simulated saliva could also adsorb to the emulsion droplet surfaces 253. 
The relative small magnitude of negative charge of alginate beads could be attributed to a 
loss of negative charge on the carboxyl groups at pH values around their pKa value (≈3.5). 
The anionic carboxylic (–COO−) groups of alginate molecules became partially 
protonated (–COOH) in the stomach phase (pH around 2.5). After small intestine 
digestion, all the samples showed relatively high negative charges (around -23). Previous 
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study has attributed that to the presence of various types of anionic particles in the 
digestion mixture phase such as micelles, vesicles, calcium salts and undigested lipids 
and proteins 253. These anionic species may have come from the original emulsions (e.g., 
peptides, free fatty acids, or phospholipids) or from the gastrointestinal fluids (e.g., bile 
salts and phospholipids).  
 
Figure 4. 10 The charge characterization of different samples including free emulsion, 
emulsion in 0.5% alginate beads, and emulsion in 1% alginate beads after each digestion 
stage. 
4.2.3.3 Influence of GIT conditions on particle size and microstructure 
β-carotene-loaded emulsion droplets. The particle size distribution of the lipid 
droplets in the initial emulsion had a single broad peak with a diameter around 0.15µm 
(Table 4.2, Fig. 4.11), and the droplets were evenly distributed throughout the system as 
shown from the confocal microscope images (Fig. 4.12). It can be deduced that the WPI-
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coated lipid droplets were relatively small and stable to aggregation in the initial 
condition. After passing through the mouth phase, the particle size distributions of these 
emulsions became bimodal, with a slight increase in mean particle diameter (d32≈ 
0.29µm). The confocal microscopy images indicated that extensive droplet aggregation 
occurred in mouth phase. It could be attributed either bridging or depletion flocculation 
induced by the presence of mucin in the simulated saliva, which is also in agreement with 
our previous study 254. Bridging flocculation occurs because of the binding of mucin 
molecules to the surfaces of oil droplets, whereas depletion flocculation occurs due to the 
increase in the osmotic attractive forces between the droplets generated by non-adsorbed 
mucin molecules 253. After exposure to the stomach phase, these emulsions showed an 
appreciable increase in mean particle diameter (d32≈ 33.31µm), and a further droplet 
aggregation could be observed from the confocal microscopy measurements (Fig.4.12). It 
has been reported that protein-stabilized emulsions was prone to aggregation under 
gastric conditions because of hydrolysis of adsorbed proteins, weakening of electrostatic 
repulsion, and depletion or bridging flocculation induced by mucin 230. After passing 
through the small intestinal stage, the emulsions still contained relatively large size 
droplets (d32≈ 6.58µm) as detected by both light scattering and confocal microscopy 
methods. Presumably, there were many colloidal particles present in the digesta including 
undigested lipid droplets, undigested protein aggregates, micelles, vesicles, and insoluble 
calcium salts. 
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(c) 
 
Figure 4. 11 Particle size distribution of different samples (a) Free emulsion, (b) 
Emulsion in 0.5% alginate beads, and (c) Emulsion in 1% alginate beads after each 
digestion stage. 
 
Filled hydrogel beads. The particle size and microstructure of the filled hydrogel 
beads depended on the alginate concentration used for the beads formation. Initially, 
these beads fabricated with higher concentration of alginate showed larger size, which 
has been mentioned in the previous section. The reason could be attributed to the alginate 
property and the beads formation mechanism used by the instrument (Encapsulator). The 
alginate solution could form polymer flows when being pumped through the nozzle of the 
Encapsulator. After obtaining the electrical charge from the equipment, the polymer 
flows could be separated with each other due to the electrical repulsion, and then form 
small size droplets injected into cross-link agent solution (Ca2+). High concentration of 
alginate tends to form high viscous polymer solution, which is hardly separated by 
electrical repulsion force and form small size droplets. High concentration polymers 
therefore can potentially form larger size beads using the Encapsulator methods.   
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Figure 4. 12 Microstructures of different samples including free emulsion, emulsion in 
0.5% alginate beads, and emulsion in 1% alginate beads after exposing to different 
regions of a simulated GIT model (Scale bar is 20 µm). 
 
For both concentrations of the alginate beads, the general shape of the particle size 
distribution remained relatively similar during the whole digestion process. In addition, 
the confocal microscope images showed the similar structure (e.g., shape) of the beads 
after each digestion steps, indicating that they remained intact after exposure to the 
different GIT phases. There was an appreciable increase and then decrease in the mean 
particle diameter of the alginate beads when they were moved from the initial to mouth, 
and then from mouth to stomach phase. Presumably, it could be attributed to increase in 
the electrostatic repulsion between the alginate molecules in the mouth phase, and a 
reduction in the electrostatic repulsion below the pKa value of the carboxyl groups in the 
stomach phase. Previous studies have also reported that calcium alginate beads tend to 
swell when placed in higher pH solutions, while shrink under highly acidic gastric 
conditions 255-256. We can expect that the closer packing of the β-carotene within the 
alginate-based beads under stomach conditions may be useful for protecting encapsulated 
β-carotene from the harsh gastric environment. After intestinal digestion, the inner red 
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fluorescence dye of hydrogel beads faded to black, and there were aggregated particles 
surrounding the hydrogel beads observed from the confocal microscope images 
(Fig.4.12). These results suggested that lipids digestion occurred in intestine phase and 
colloidal particles were released from the beads after digestion. These particles may have 
been undigested lipid droplets or mixed micelles. It is therefore interesting to study the 
dynamic digestion process (e.g., the diffusion of lipase and digestion products) of filled 
hydrogel beads in the future studies.  
4.2.3.4 Influence of delivery system type on lipid digestion 
The effect of different delivery system encapsulation on the rate and extent of lipid 
digestion was evaluated using an automatic titration (pH stat) method. The fraction of 
free fatty acids (FFAs) released from the samples during the digestion process was 
calculated from measurements of the volume of NaOH that had to be titrated into the 
reaction chamber to maintain a constant pH (7.0) as shown in Fig. 4.13. The free 
emulsion was rapidly digested during the first 5 minutes with over 76% of the FFAs 
being released, followed by a more gradual digestion until a relatively constant final 
value (95.8%) was attained for the remainder of the incubation time. Conversely, the 
FFAs release rate was much slower for the filled hydrogel beads, which also depended on 
the alginate concentration. Around 22.2% and 36.7% FFA were released within first 5 
min of digestion, and around 56.2% and 82.5% FFA had been release after 120min 
digestion for the 1% and 0.5% beads respectively. These results indicate that 
encapsulation of the lipid droplets within the hydrogel beads was highly effective at 
retarding lipid digestion. There are a number of physicochemical phenomena might 
account for the decreased digestion rate for the encapsulated oil droplets. Firstly, lipid 
digestion only occurs when pancreatic lipase can adsorb to the surfaces of the lipid 
droplets and come into proximity with its substrate such as triacylglycerol and 
diacylglycerol molecules 238. For the free emulsion, the pancreatic lipase is able to 
rapidly move from the aqueous phase to the lipid droplets surfaces and thus initiate 
lipolysis. Whereas for the filled hydrogel beads, lipase (and the other GIT components) 
has to penetrate into the beads and diffuse through the hydrogel network before they can 
reach the lipid droplet surfaces. The diffusion rate to the interior of the beads increases as 
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the pore size of the hydrogel matrix decreases and also the diameter of the beads 
increases. The 0.5% beads with a smaller beads diameter therefore showed a higher 
digestion rate and extent compared with 1% beads. A second possible reason is that long 
chain FFAs generated in the digestion process must be removed otherwise the lipolysis 
reaction will be retarded 76. These FFAs can be typically removed by being incorporated 
into mixed micelles with bile salts and phospholipids, or by forming insoluble salts with 
calcium ions 242. For these hydrogel beads, the removal of FFAs away from the lipid 
droplet surfaces may be limited because bile salts, phospholipids, and calcium have to 
penetrate into the biopolymer matrix of the hydrogel beads. Furthermore, the diffusion of 
the FFAs themselves out of the beads may also be inhibited by the presence of the 
biopolymer network. Our results indicated that the in vitro digestion fate of lipid droplets 
could be modulated by encapsulating them in different hydrogel beads.  
 
Figure 4. 13 Amount of fatty acids released from different samples including free 
emulsion, emulsion in 0.5% alginate beads, and emulsion in 1% alginate beads measured 
in a pH-stat in vitro digestion model. 
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4.2.3.5 Influence of delivery system type on β-carotene release 
It has been mentioned earlier that pure β-carotene typically has a very low 
bioavailability because of its poor chemical stability and low solubility in gastrointestinal 
fluids. The concentration of β-carotene in the mixed micelle phase, total digesta and 
initial phase were thus determined to provide a measure of the amount of β-carotene that 
was solubilized and the amount that was not chemically degraded. The bioaccessibility, 
transformation, and effective bioavailability of β-carotene were also calculated from the 
equations described in section 2.9. It is indicated from the Fig.4.13 that free emulsion 
samples had higher bioaccessibility (B*) and effective bioavailability (BA) of 
encapsulated β-carotene compared with the hydrogel beads. It can be expected that the 
digestion of the lipid droplets lead to the formation of mixed micelles that can solubilize 
the high amount of β-carotene molecules (high B* and BA). Previous studies in our 
laboratory had also reported that emulsion systems (e.g., emulsion-based delivery 
systems and emulsion-based excipient systems) could increase lipophilic bioactive 
ingredients bioaccessibility through these mechanisms 257-259. The relatively low B* and 
BA of the β-carotene in the filled hydrogel beads in current study can be attributed to 
several reasons. Firstly, some of the β-carotene remained within the undigested lipid 
droplets inside the hydrogel beads and was not released and solubilized in micelle. The 
second reason is that there was less mixed micelles available in the aqueous phase to 
solubilize any β-carotene molecules released from the hydrogel beads (Fig. 4.13). Both of 
these reasons could be attributed to the low β-carotene concentration in micelle. The 
transformation (T*) of β-carotene was also calculated to determine the extent of any 
chemical changes during digestion (Fig. 4.15). It was indicated that β-carotene 
encapsulated in free emulsion samples showed slightly lower transformation 
(CDigesta/CInitial) than hydrogel beads. We can expect that alginate-based hydrogel beads 
encapsulation can protect the β-carotene from degradation during digestion. Based on our 
preliminary experiments, the slight degradation of β-carotene majorly occurred after 
stomach digestion phase, and the reason could be attributed to the protonization of the 
methine carbon of β-carotene in high acid stomach phase. There appeared to be a good 
correlation between the β-carotene transformation and extent of β-carotene degradation 
during evaluated temperature storage, i.e., they followed the completely opposite trend: 
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0.5% beads > 1% beads > Free emulsions. These results suggest that β-carotene showed 
higher stability after encapsulation in hydrogel beads. 
 
Figure 4. 14 Bioaccessibility (B*) and effective bioavailability (BA) of β-carotene in 
different delivery systems including free emulsion, emulsion in 0.5% alginate beads, and 
emulsion in 1% alginate beads measured in a pH-stat in vitro digestion model. 
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Figure 4. 15 Transformation (%) of β-carotene in in different delivery systems including 
free emulsion, emulsion in 0.5% alginate beads, and emulsion in 1% alginate beads after 
full digestion (mouth, stomach and intestine) process. 
4.2.4 Conclusions 
The influence of types of delivery systems encapsulation on physicochemical 
stability and in vitro bioaccessibilityof β-carotene was studied in this present study. 
Three different delivery systems were prepared including free emulsion, filled hydrogel 
beads formed by 0.5% alginate and filled hydrogel beads formed by 1% alginate. The 
hydrogel beads formed with different concentration of alginate showed different physical 
structure and properties: the 0.5% beads (creamed to the top of the buffer phase) had 
much smaller diameter than 1% beads (sedimented to the bottom). The stability studies 
indicated that hydrogel beads encapsulation could protect the β-carotene from 
degradation. The retention rate of β-carotene in 0.5% beads was higher than that in 1% 
beads. In vitro digestion studies indicated that free lipid droplets were digested more 
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rapidly and fully than those encapsulated within hydrogel beads. The rate and extent of 
lipid digestion in filled hydrogel beads depended on alginate concentration: the 0.5% 
beads showed a higher digestion rate and extent compared with 1% beads. Free emulsion 
samples showed higher bioaccessibility and effective bioavailability of encapsulated β-
carotene than that in the hydrogel beads. While the β-carotene transformation in different 
delivery systems followed the following order: 0.5% beads > 1% beads > Free emulsions. 
Our results may have important implications for designing hydrogel beads to increase the 
stability and oral bioavailability of β-carotene 
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CHAPTER 5 
 
ENCAPSULATION, PROTECTION, AND RELEASE OF BIOACTIVE AGENTS 
USING HYDROGEL BEADS WITH SELF-REGULATING MICROCLIMATE 
PH PROPERTIES 
5.1 Confocal fluorescence mapping of pH profile inside hydrogel beads (microgels) 
with controllable internal pH values 
5.1.1 Introduction 
There is growing interest in the design and fabrication of particle-based delivery 
systems to load, protect and release bioactive agents in the food, supplement, and 
pharmaceutical industries (Badruddoza, Godfrin, Myerson, Trout, & Doyle, 2016; Janes, 
Calvo, & Alonso, 2001). A diverse range of bioactive agents with differing molecular, 
physicochemical and biological properties need to be encapsulated, including proteins, 
peptides, probiotics, prebiotics, vitamins, minerals, nutraceuticals, triacylglycerol oils, 
flavors, colors, antimicrobials, and preservatives (Cook, Tzortzis, Charalampopoulos, & 
Khutoryanskiy, 2012; Zhu, Mallery, & Schwendeman, 2000). For example, many 
bioactive proteins and peptides need to be encapsulated because of their propensity to 
cause bitterness or astringency in the mouth, or their susceptibility to denaturation or 
degradation in the stomach and small intestine (Liu & Schwendeman, 2012). Similarly, 
probiotic bacteria often need to be encapsulated to maintain their viability when exposed 
to highly acidic gastric conditions, but then released in the colon where they exhibit their 
beneficial actions on colonic microflora (Li, et al., 2017). Many hydrophobic bioactive 
agents (such as carotenoids, curcumin and polyphenols) need to be encapsulated to 
prevent their chemical degradation within foods and the gastrointestinal tract (GIT) 
(Altunbas, Lee, Rajasekaran, Schneider, & Pochan, 2011; Zhang, Zhang, & McClements, 
2016).  
Numerous studies have shown that particle-based delivery systems can be designed 
to improve the handling, dispersibility, stability, and bioavailability of certain bioactive 
agents (Keen, Slater, & Routh, 2012; McClements, 2016). However, to be effective these 
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delivery systems must be carefully designed based on the molecular and physicochemical 
properties of the bioactives, the processing and storage conditions they are exposed to 
(such as pH, ionic strength, and temperature), and the desired quality attributes of the 
final products (such as optical, rheological, organoleptic, and stability properties).  For 
certain applications, hydrogel beads are particularly suitable for encapsulation and 
delivery of bioactive agents (McClements, 2016). These hydrogel beads are typically 
spherical particles whose interiors are comprised of a porous network of cross-linked 
hydrophilic polymers.  Hydrogel beads are often formed from natural polymers (such as 
polysaccharides and proteins) using relatively mild preparation conditions, and so they 
usually have little adverse affects on the properties of the encapsulated bioactives (Kim, 
Bae, & Okano, 1992; Zhang, Zhang, Zou, & McClements, 2016).   
Many bioactive agents are highly susceptible to physical, chemical, or biological 
degradation over a certain pH range, but stable at other pH values.  For example, some 
natural colors fade rapidly under highly acidic pH conditions, but slowly under neutral 
conditions (Castañeda-Ovando, Pacheco-Hernández, Páez-Hernández, Rodríguez, & 
Galán-Vidal, 2009).  Similarly, many probiotics are rapidly inactivated under highly 
acidic conditions, but viable under neutral conditions (Anselmo, McHugh, Webster, 
Langer, & Jaklenec, 2016; Li, et al., 2016).  A major drawback associated with the 
utilization of conventional hydrogel beads for encapsulation of pH-labile bioactives is 
that they are highly porous (Zhang, Zhang, Chen, Tong, & McClements, 2015), and so 
small acidic or basic ions (such as H+ or OH-) can easily diffuse in or out of them, 
thereby causing the internal pH to be fairly similar to the external pH.  Consequently, pH-
labile substances may be rapidly degraded when they are encapsulated in hydrogel beads 
that are exposed to destabilizing pH conditions.  The pH sensitivity of conventional 
hydrogel beads therefore limits their utilization for certain applications in the food, 
supplement, and pharmaceutical industries. Attempts have been made to improve the pH-
stability of bioactive agents in hydrogel beads by delaying the diffusion of acidic or basic 
ions into them, e.g., by reducing the pore size of the internal core or the outer shell (Mei, 
et al., 2014). Nevertheless, these approaches have had limited success because the pH-
determining ions involved are so small (< 1 nm) that they can rapidly diffuse through 
even small pores.   
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In the current study, hydrogel beads were fabricated with self-regulating internal pH 
microclimates.  This was achieved by trapping a basic buffer (magnesium hydroxide) that 
was insoluble under neutral conditions but soluble under acidic conditions inside the 
beads.  Initially, the hydrogel beads are formed under neutral conditions so that the buffer 
remains in an insoluble form.  However, when the beads are submerged in an acidic 
environment some of the magnesium hydroxide dissolves, which releases OH- ions that 
can neutralize the H+ ions, thereby maintaining a neutral internal pH (until all the buffer 
has dissolved).  A quantitative fluorescent method was developed to map the local pH 
inside the hydrogel beads when they were exposed to different pH conditions. This 
method involved encapsulating a pH-sensitive fluorescent probe inside of the hydrogel 
beads.  The probe used has two functional groups, one that is pH sensitive and one that is 
pH insensitive, so that the pH can be determined quantitatively from the ratio of the 
fluorescence intensity of these two groups.  Moreover, the probe is attached to a high 
molecular weight polymer (dextran) so that it can be successfully trapped within the 
biopolymer (alginate) network that makes up the interior of the hydrogel beads.       
5.1.2 Materials and methods  
5.1.2.1 Materials  
Fluorescein tetramethylrhodamine dextran (FRD, average Mr 70,000) was purchased 
from Molecular Probes (Eugene, OR). Alginic acid (sodium salt), calcium chloride, and 
magnesium hydrate were purchased from the Sigma Chemical Company (St. Louis, MO). 
Sodium phosphate was purchased from Fisher Chemical Company (Pittsburgh, PA). All 
chemicals used were analytical grade. Double distilled water was used to make all 
solutions.  
5.1.2.2 Hydrogel beads preparation 
Aqueous alginate solutions were prepared by dispersing powdered alginic acid (0.8%, 
w/w) into phosphate buffer solution (5 mM, pH 7.0) and then continuously stirring at 
60 °C for an hour.  The temperature was then reduced to 35 °C and the samples were 
continually stirred until the solution became clear indicating that the alginate had fully 
  131 
dissolved. 10 mg/mL FRD in phosphate buffer (5 mM, pH 7.0) was then added to the 
alginate solution (at a volume ratio of 1:200) with or without 0.3% Mg(OH)2. After 
ensuring the sample was homogeneous by stirring, the mixture was injected into a 10% 
w/w calcium chloride solution using a commercial encapsulation unit (Encapsulator B-
390, BUCHI, Switzerland) with a 120 µm vibrating nozzle to prepare the hydrogel beads. 
The encapsulation device was operated under fixed conditions: frequency = 800 Hz; 
electrode potential = 800 V; and operating pressure = 500 mbar. The alginate beads 
formed were kept in the Ca2+ solution for 1 h at ambient temperature to promote cross-
linking and bead hardening.  
5.1.2.3 Simulated gastric conditions  
The impact of exposure of the hydrogel beads to simulated gastric fluid (SGF) on 
their internal pH was determined using a method described previously (Zhang, Zhang, 
Zhang, Decker, & McClements, 2015). Hydrogel beads (with or without encapsulated 
Mg(OH)2) were added at a ratio of 1:4 (w/w) to SGF that had been preheated to 37 °C 
and adjusted to pH 2.5. This mixture was then incubated in an incubated shaker for 2 h at 
37 °C to mimic stomach conditions.  
5.1.2.4 Confocal Laser Scanning Microscopy  
Images were obtained using confocal laser scanning microscopy with a 20´ objective 
lens (Nikon D-Eclipse C1 80i, Nikon, Melville, NY, USA). The images of the ratiometric 
fluorescence dye were obtained using excitation wavelengths of 543 and 488 nm, and 
detection wavelengths/bandwidths of 650 nm/LP and 590 nm/50 nm, respectively. All 
samples were imaged using an exposure time of 0.5 s and a 12.5% excitation power level 
for both channels. The complete images of each sample were typically acquired in less 
than 2 min with at least eight measurements. The microstructural images for confocal 
microscopy were analyzed using image analysis software (NIS-Elements, Nikon, 
Melville, NY, USA).  
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5.1.2.5 Standard curve preparation 
A stock FRD solution (10 mg/mL) was prepared by dissolving the powdered FRD 
dye in phosphate buffer (5 mM, pH 7) solution. 5 µL/ml FRD stock solution at pH 2.5–7 
(adjusted by hydrochloric acid) was imaged using confocal microscopy to determine the 
linear range of the pH response. Solutions containing different concentrations of FRD 
(2.5, 5 and 10 µL/ml) were also used to prepare a standard curve using a SpectraMax 
spectrophotometer (Molecular Devices, Sunnyvale, CA) to assess the impact of dye 
concentration on the fluorescence intensity ratio used to calculate the local pH.  
5.1.2.6 Image processing for pH measurement 
The images were analyzed using Image J Software (1.50I, imagej.nih.gov). The ratio 
of pixel intensities of two images obtained from two wavelengths (488 and 543 nm) were 
calculated and correlated with the pH obtained from the standard curve. The average 
intensity was calculated from at least eight measurements. The pH gradient within the 
beads was determined by dividing their circular images into a series of same-pixel 
thickness concentric rings, and the mean pixel intensity was calculated for each ring from 
the number of pixels and individual pixel intensities in the ring. 
5.1.3 Results and discussion 
5.1.3.1 Development of pH standard curve  
In this study, relatively small hydrogel beads (around 200 µm) were fabricated using 
a specialized extrusion device (Encapsulator) with a vibrating nozzle (Figure 5.1). The 
small dimensions and viscoelastic nature of these beads meant that it was not possible to 
measure their internal pH using traditional methods, such as pH electrodes. It was 
therefore necessary to develop an alternative method to measure the pH within the beads 
so as to confirm the potential of the encapsulated Mg(OH)2 to control their internal pH 
profile. A fluorescent probe method was therefore developed to determine the local pH 
profile inside the beads. A dextran conjugated fluorescent probe, Fluorescein and 
Tetramethylrhodamine (FRD), was used as the pH indicator. This probe was selected 
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because it has a relatively high molecular weight (around 70 kDa), which ensures that it 
remains trapped inside the porous biopolymer network that makes up the bead interior. 
Moreover, this probe is a ratiometric dye that has both pH-dependent (FITC) and pH-
independent (TMR) fluorescence groups. For this type of dye, the pH-independent 
channel can be used as an internal standard for quantitative pH evaluation (Chen & 
Arriaga, 2006; Deriy, et al., 2009). This ratiometric method also eliminates problems 
associated with photo-bleaching, variable bead thickness, and non-uniform dye 
distribution within the bead (Cope, Hibberd, Whetstone, MacRae, & Melia, 2002; Li & 
Schwendeman, 2005).  
 
Figure 5. 1 Schematic diagram showing the fabrication of self-adjusting microclimate pH 
hydrogel beads. The beads are formed by injecting alginate and insoluble buffer into a 
cross-linking calcium ion solution. 
 
In preliminary confocal microscopy studies, it was observed that the fluorescence 
emission intensity was pH-independent when an excitation wavelength of 543 nm was 
used, but pH-dependent when an excitation wavelength of 488 nm was used. The pH of a 
sample could therefore be obtained independent of dye concentration by taking the ratio 
of the emission intensities at these two excitation wavelengths (543 nm/ 488 nm). 
Standard curves of fluorescence intensity ratio versus pH were determined using a series 
of buffer solutions (pH 2.5-7.0) with dye concentrations of 2.5, 5 and 10 µL/ml of stock 
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solution (10 mg/mL). The fluorescence intensity ratio was exponentially related to pH 
from pH 2.5 to 7.0 when determined from the confocal microscopy images (Fig. 5.2a), 
but linearly related when measured using a microplate reader (Fig. 5.2b). Moreover, the 
fluorescence intensity ratio (TMR/FITC) was largely independent of overall dye 
concentration across the entire pH range as determined using the microplate reader. 
These results suggest that the pH inside the beads can be successfully mapped even 
though there may be some local variations in dye concentration within the beads e.g., due 
to diffusion of dye outwards. The major advantage of the confocal microscopy approach 
is that the local pH can be obtained from the images, whereas only the overall pH of a 
sample can be obtained using the microplate reader.   
 
(a) (b) 
Figure 5. 2 Standard curve of pH versus fluorescence intensity ratio (TMR/FITC) taken 
by (a) microplate at concentrations of 2.5, 5 and 10 µL/ml stock solution (10 mg/mL) and 
(b) confocal microscopy at 5 µL/ml stock solution (10 mg/mL). 
5.1.3.2 Mapping the pH inside the beads  
The highly acidic pH of human gastric juices causes an unwanted reduction in the 
activity of many orally delivered bioactive agents, such as many enzymes, probiotics, and 
nutraceuticals.  Consequently, an antacid buffering agent (Mg(OH)2) was encapsulated 
inside the hydrogel beads to create an internal pH that was considerably higher than the 
external pH, thereby protecting any co-encapsulated acid-sensitive bioactives. Under 
neutral pH conditions, Mg(OH)2 forms insoluble solid particles that are retained within 
the hydrogel beads.  However, when the beads are exposed to acid conditions some of the 
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Mg(OH)2 particles will dissolve, thereby releasing OH- ions that will neutralize any H+ 
ions that diffuse into the hydrogel interior, thereby helping to maintain a high internal pH.  
 
 (a) 
 
(b) 
Figure 5. 3 Differential interference contrast (DIC) and fluorescent microscopy images 
of (a) hydrogel beads without Mg(OH)2 encapsulation and (b) with 0.3% Mg(OH)2 
encapsulation.  These images were taken after the beads were prepared. The images of 
the ratio channel were generated using Image J software (imagej.nih.gov) and the color 
strip shown on the top right represents the pseudocolor change with pH (intensity of 
TMR signal was enhanced using Image J to improve contrast).  
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Hydrogel beads were formed by injecting a solution containing gelling agent 
(alginate) and fluorescence dye (FRD) in the absence or presence of insoluble buffer 
particles (magnesium oxide) into another solution containing a cross-linking agent 
(calcium chloride).  The initial beads formed by this method had mean diameters of 
around 200 µm as determined by confocal fluorescence and optical microscopy (Fig. 5.3 
and 5.4). Initially, the average internal pH values of the hydrogel beads determined from 
the CLSM images were around pH 6.5 for buffer-free beads and around pH 7.5 for 
buffer-loaded beads. The presence of Mg(OH)2 slightly increased the internal pH of the 
buffer-loaded hydrogel beads, which can be attributed to the fact that it is a weak base 
and some dissolution may have occurred. The confocal images also indicated that the pH 
values inside the beads were not uniformly distributed after Mg(OH)2 encapsulation (Fig. 
5.3b). There appeared to be microenvironments around the insoluble Mg(OH)2 particles 
that had a higher pH that the surrounding solution. The pH gradient distribution analysis 
indicated that the pH was relatively uniform throughout the buffer-free hydrogel beads, 
being in the range from pH 6.8-7 (Fig. 5.4c). Conversely, the pH was slightly lower at the 
edge of the buffer-loaded hydrogel beads than in their interiors, with the local pH values 
increasing from around pH 7.2 at the edge to pH 7.6 at the center (Fig. 5.5c). Presumably, 
most of the insoluble buffer particles were located in the center rather than at the edge of 
the hydrogel beads. 
   
 
 
(a)                                   (b)                                             (c) 
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Figure 5. 4 An illustration of the image processing approach used to generate the pH 
gradient profile within buffer-free hydrogel beads. (a) The fluorescence intensity ratio 
image with pseudocolor color; (b) concentric rings of similar pixel thickness obtained 
from the images of the beads; and (c) the average pH value within each ring as a function 
of distance from the bead edge.  
5.1.3.3 Monitoring pH changes after exposure to gastric conditions 
Many types of bioactive agents are degraded when exposed to the highly acidic 
conditions found in the human stomach, and therefore it would be valuable to have 
delivery systems that protected them within the gastric fluids.  In this section, we 
therefore applied the confocal fluorescence pH mapping method to monitor changes in 
the internal pH of the hydrogel beads in the absence and presence of encapsulated 
magnesium hydroxide.  After incubation in simulated gastric fluids (SGF), the 
fluorescence intensity inside the buffer-free hydrogel beads rapidly decreased to around 
pH 3 (Figs. 5.6 and 5.7).  Presumably, the small H+ ions rapidly diffused through the 
porous alginate network within the hydrogel beads driven by the concentration gradient 
between the inside and outside of the beads.  Consequently, the internal pH of the buffer-
free beads was fairly similar to that of the external pH of the SGF after 2 h incubation in 
the gastric phase. Conversely, the pH value within the Mg(OH)2-loaded hydrogel beads 
remained fairly similar to that of the original value (»pH 7.5) after 2 hours of incubation 
in the acidic SGF (Figs. 5.6 and 5.7). This result suggests that these antacid hydrogel 
beads could be used to protect acid-sensitive bioactives during passage though the 
stomach. The confocal fluorescence images suggest that the pH was higher in the center 
of the beads than at their edges (Fig. 5.6).  This effect is probably because the insoluble 
Mg(OH)2 particles in the exterior regions of the beads dissolve first as hydrogen ions 
from the SGF diffuse into the beads. To verify this dissolution process, DIC optical 
images of the Mg(OH)2-loaded hydrogel beads were taken throughout the simulated 
stomach phase (Fig. 5.8).  These images clearly indicated that Mg(OH)2 particles slowly 
dissolved during the stomach phase incubation, which can be attributed to their 
neutralization reaction with hydrogen ions arising from the gastric fluids. 
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(a)                                  (b)                                              (c) 
 
Figure 5. 5 An illustration of the image processing approach used to generate the pH 
gradient profile within Mg(OH)2-loaded hydrogel beads. (a) The fluorescence intensity 
ratio image with pseudocolor color; (b) concentric rings of similar pixel thickness 
obtained from the images of the beads; and (c) the average pH value within each ring as a 
function of distance from the bead edge. 
 
 
 
Figure 5. 6 Confocal fluorescence microscopy images of hydrogel beads without 
Mg(OH)2 encapsulation (top) and with 0.3% Mg(OH)2 encapsulation (bottom) after 
passage through the stomach phase. The images of the ratio channel were generated using 
Image J software and the color strip (top right of images) represents the pseudo-color 
change with pH.  The intensity of the TMR signal was enhanced using Image J to 
improve the contrast.  
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Figure 5. 7 The pH value of hydrogel beads without and with Mg(OH)2 encapsulation 
during 2h stomach digestion process.  
5.1.3.4 Dynamic pH change during incubation   
The acid degradation of many bioactives is a rapid process, and so it is important to 
determine how long the hydrogel beads can maintain their high internal pH values after 
exposure to gastric fluids. Therefore, the internal pH of buffer-free and buffer-loaded 
hydrogel beads was periodically determined throughout the stomach phase (Fig. 5.8). In 
the presence of buffer, the average pH inside the beads remained fairly constant (pH 6.6 
to 7.5) throughout the entire 2 hour incubation period within the SGF (Fig. 5.7).  This 
result suggested that the amount of Mg(OH)2 inside the beads was sufficient to act as a 
local antacid throughout the duration of the gastric phase. On the contrary, the pH value 
inside the buffer-free hydrogel beads fell sharply from pH 6.5 to 3.3 within the first 5 
minutes, followed by a more gradual decrease at longer incubation times. As mentioned 
earlier, small H+ ions can rapidly diffuse into highly porous hydrogel beads, thereby 
causing the pH inside the beads to be fairly similar to that outside.   
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Figure 5. 8 Differential interference contrast (DIC) images of hydrogel beads containing 
encapsulated Mg(OH)2 taken during incubation in the simulated stomach phase.  
 
The amount of time required for hydrogen ions to diffuse into the hydrogel beads can 
be estimated from the following expression (Crank, 1975): 
 
     (1) 
 
Here, F is the fraction of hydrogen ions that have diffused into the hydrogel beads at 
time t, M(t) and M(∞) are the hydrogen ion concentrations within the hydrogel beads at 
time t and at equilibrium, n is an integer, a is the radius of the hydrogel beads, and Dgel is 
the diffusion coefficient of the hydrogen ions through the biopolymer network inside the 
beads, which can be estimated using the following expression (Chan & Neufeld, 2009):  
 
       (2) 
 
Here, Dw is the diffusion coefficient of the hydrogen ions through pure water, rH is 
the hydrodynamic radius of the hydrogen ions, rf is the cross-sectional radius of the 
biopolymer chains (alginate) in the hydrogel network, and z is the mesh pore diameter of 
the hydrogel network.  The following structural parameters have been reported for 
alginate hydrogels: pore diameter (z) = 4 to 400 nm; alginate chain radius (rf) = 0.83 nm 
(Chan, et al., 2009).  The radius of hydration (rH) of the hydrogen ion (actually H3O+) has 
been estimated to be 0.1 nm (Marcus, 2012).  The diffusion coefficient of hydrogen ions 
in water can be estimated from the expression: Dw = kBT/6phrH, where kB is Boltzmann’s 
constant, T is absolute temperature, and h is the viscosity of the solvent.  The above 
å
¥
=
÷
÷
ø
ö
ç
ç
è
æ
--=
¥
=F
1
2
22
22 exp
161
)(
)(
n
gel
a
tnD
nM
tM p
p
÷
÷
ø
ö
ç
ç
è
æ
÷
÷
ø
ö
ç
ç
è
æ
+
-
-=
f
fH
wgel r
rr
DD
2
exp
x
p
  141 
equations were used to estimate the time-dependence of the fraction of hydrogen ions 
diffusing into hydrogel beads with different pore sizes after submerging in a more acidic 
environment (Figure 5.9).  For these calculations, it was assumed that the pore diameter 
(z) of the alginate beads was 10 nm.  Even assuming this relatively small pore size, the 
theoretical predictions suggest that the hydrogen ions would rapidly diffuse into the 
hydrogel beads in a few seconds, which supports our experimental results. These 
predictions suggest that any acid-sensitive bioactives encapsulated within the hydrogels 
beads would be rapidly exposed to highly acid conditions in the stomach in the absence 
of a co-encapsulated insoluble buffering agent.   
 
Figure 5. 9 Predicted time dependence of the fraction of hydrogen ions (H3O+) absorbed 
by alginate beads with a diameter of 200 µm and a pore size of 10 nm after submersion in 
an acidic environment.  
5.1.4. Conclusions 
Certain types of bioactive agents are degraded when exposed to highly acidic 
conditions, such as probiotics, enzymes, and some nutraceuticals. The development of 
microparticle-based delivery systems that are able to control the pH in the immediate 
vicinity of these bioactive agents may therefore be useful for improving their stability. In 
this study, edible hydrogel beads were fabricated using a simple injection method that 
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were able to maintain an internal pH that was appreciably higher than the pH of the 
surrounding solution. A fluorescence method to map the pH profile inside the hydrogel 
beads was also developed based on ratiometric imaging with a confocal laser scanning 
microscopy. This method showed that the average internal pH of the buffer-free hydrogel 
beads was around 6.5, while that of the buffer-loaded beads was around 7.5.   In addition, 
the method showed that there were some local variations in pH inside the hydrogel beads. 
After exposure to simulated gastric fluids, the average pH inside the buffer-loaded beads 
remained fairly constant (around pH 6.6 to 7.5), whereas that in the buffer-free beads fell 
sharply within the first few minutes (from pH 6.5 to 3.3).  The confocal microscopy 
method also indicated that the pH was higher in the center of the buffer-loaded beads 
than at their edges.  These results show that the encapsulated Mg(OH)2 particles acted as 
effective buffering agents that inhibited excessive acidification within the beads during 
the gastric phase. Overall, the novel hydrogel beads developed in this study may be 
suitable for encapsulation and delivery of acid-sensitive bioactives, which may be 
advantageous for certain food, supplement, and pharmaceutical applications.  
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5.2 Encapsulation of pancreatic lipase in hydrogel beads with self-regulating 
internal pH microenvironments: Retention of lipase activity after exposure to 
gastric conditions 
5.2.1  Introduction 
Exocrine pancreatic insufficiency (EPI) is a serious condition occurring accompanied 
with a several diseases (e.g., chronic pancreatitis and pancreatic cancer, etc.) 260-261. EPI 
happens due to the pancreas of the patients fails to produce and/or secrete sufficient 
amounts of digestive enzymes to support digestion of intraluminal nutrients such as fats, 
proteins and carbohydrates, which results in the nutritional deficiencies of the patients 262. 
The digestive enzymes normally refer to the trypsin, chymotrypsin, amylase and lipase. 
Lipase is one of the most important digestive enzymes derived from the pancreas and it 
plays a leading role in the digestion of fat, which provide the majority of calories for 
human body 263. Enzyme supplementation is an important therapy for pancreatic 
insufficiency 264. However, the supplementation of lipase by direct oral intake is 
unpractical because this enzyme is extremely susceptible to acidic degeneration during 
stomach incubation process. In healthy people, it was reported that just 1% of the lipase 
activity can survive through intestinal transit 265. Thus the entrapment strategies are 
required for the lipase encapsulation and delivery.  
Encapsulation of enzymes within porous polymer matrices have been widely utilized 
for many years to improve the stability and recovery of enzymes 6, 266. In this techniques, 
the enzymes can be trapped within a porous matrix, which provide the enzyme with 
physical isolation from the surrounding medium. Several entrapment methods can be 
included for enzymes encapsulation such as physical entrapment, physical bonding, 
and/or chemical covalent bonding 267-268. The physical approaches may have potential 
advantages over chemical methods because no chemical modification of the enzyme is 
required to form a covalent linkage with the hydrogel network. These physical 
approaches normally enable the enzymes to interact with the substrate molecules without 
causing pronounced changes in enzyme structure and activity, and thus are regarded as 
the best strategy for enzyme encapsulation. Hydrogel beads fabricated from biopolymers 
are particularly suitable for the enzyme encapsulation, because they often involve mild 
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preparation conditions to physical entrap the enzyme without altering their properties 269. 
Moreover, the bead matrices can be prepared from food-grade ingredients (e.g., 
polysaccharides and/or proteins), which are more acceptable by majority of people 229. 
The hydrogel beads are commonly fabricated using extrusion-gelation method. In this 
approach, a biopolymer solution containing the bioactive agents (e.g., enzyme) is injected 
into another “harden” solution to promote the biopolymer gelation, and the hydrogel 
beads can be formed during this procedure with bioactives trapped inside the biopolymer 
matrix 270. One major drawback associated with the use of conventional hydrogel beads 
for lipase encapsulation and intestine target delivery is that the polymer matrix of these 
beads are highly porous, which allow the acid ions (H+) easily diffuse in and out the 
beads network, thereby may hardly inhibit the encapsulated lipase from acid deactivation 
during stomach digestion process.  Researches have been carried out to modify the 
properties of hydrogel beads to improve the pH-stability of encapsulated enzyme, such as 
by crosslinking the hydrogel matrix using specific enzymes or by coating the beads with 
one or more layers of biopolymers through electrostatic deposition 271-272. The 
mechanism of these approaches are based on delaying the diffusion of pH determining 
ions (H+ or OH-) through the bead matrix 273. However, there are several other limitations 
associated with these modifications, the most important one is that the function of 
encapsulated enzyme can be negatively interfered; because the diffusion of the enzyme 
and substrate can also be retarded at the desired site of action, which limit their mutual 
contaction and further hydrolysis reaction.       
In this study, we fabricated a novel hydrogel beads with an internal pH self-
regulating property. Specially, Mg(OH)2 as the buffer agent was co-encapsulated with 
lipase into the hydrogel beads formed by alginate crosslinking with calcium chloride. 
Mg(OH)2 was used because it was typical insoluble salts at neutral pH condition, which 
make it possible to be trapped inside the beads during storage; while it can be dissolved at 
acid condition and thus can be used as an antacid agent at low pH conditions. Moreover, 
Mg(OH)2 has been regarded as the safe ingredient and widely used as an acid neutralize 
agent in food and pharmaceutical industries 274. Alginate was used for hydrogel beads 
formation because it is a food-grade ingredient already widely utilized for bioactive agent 
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encapsulation. The mild cross-linking conditions of alginate gel are especially suitable for 
the enzyme entrapment and encapsulation. Furthermore, the acid insolubility of alginate 
gels makes them a good candidate for bioactives encapsulation and target delivery in 
harsh acid condition (e.g., the stomach) with improved stability. The digestion 
characteristic of lipid by the lipase loaded in the hydrogel beads with/without Mg(OH)2 
co-encapsulation was compared. An in vitro model developed in our lab was used to 
simulate the digestion conditions in mouth, stomach and small intestine. The 
microclimate pH change of the hydrogel beads after going through different digestion 
steps was also estimated using a quantitative ratiometric method based on confocal laser 
scanning microscopy (CLSM). The results obtained from this study may provide valuable 
information for lipase encapsulation and target delivery. 
5.2.2 Materials and methods  
5.2.2.1 Materials  
Fluorescein tetramethylrhodamine dextran (FRD, average Mr 70,000) was obtained 
from Molecular Probes (Eugene, OR). Alginic acid (sodium salt), calcium chloride, and 
magnesium hydrate were purchased from Sigma Chemical Company (St. Louis, MO). 
Lipase was purchased from Sigma-Aldrich (Sigma Chemical Co., St. Louis, MO) and as 
reported by the manufacturer the activity was 100-400 units/mg. Mucin from porcine 
stomach, porcine bile extract, sodium chloride, monobasic phosphate and dibasic 
phosphate, Nile red and fluorescein thiocyanate isomer I (FITC) were obtained from 
either Sigma-Aldrich (Sigma Chemical Co., St. Louis, MO) or Fisher Scientific 
(Pittsburgh, PA). All chemicals used were analytical grade. Double distilled water was 
used to make all solutions.  
5.2.2.2 Hydrogel beads preparation 
The alginate aqueous solution was prepared by dissolving powdered alginic acid 
(1.6%, w/w) in phosphate buffer and continuously stirring at 60 °C for an hour, then 
reducing the temperature to 35 °C with continuously stirring until totally dissolved. The 
alginate solution was then mixed with lipase solution to obtain a concentration of 0.8% 
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alginate and 2.7% lipase mixture with or without 0.15% Mg(OH)2. For the pH mapping, 
10 mg/mL FRD in phosphate buffer was added to the 0.8% alginate solution (at a volume 
ratio of 1:200) with or without 0.15% Mg(OH)2. After continuously stirring, the mixtures 
were injected into 10% calcium chloride solution using a commercial encapsulation unit 
(Encapsulator B-390, BUCHI, Switzerland) with a 120 mm vibrating nozzle to prepare 
the hydrogel beads. The encapsulation device was operated under fixed conditions: 
frequency 800 Hz; electrode 800 V; and pressure 500 mbar. The formed beads were held 
in the Ca2+ solution for 30 min at ambient temperature to promote cross-linking.  
5.2.2.3 In vitro digestion model  
The lipase-loaded hydrogel beads with or without buffer (0.15% Mg(OH)2) co-
encapsulation were passed through a gastrointestinal tract (GIT) model that simulated the 
mouth, stomach and small intestine, which was slightly modified from the one developed 
in our lab 230. The free lipase without beads encapsulation was also studied as the control 
sample passing through the same digestion model.   
Initial system: 7.5 g of the initial systems were placed into a glass beaker in an incubator 
shaker at a rotation speed of 100 rpm for 15 min at 37 °C for preheating. Two different 
initial lipase-loaded delivery systems were tested: with or without buffer co-
encapsulation. 
Mouth phase: 7.5 g of simulated saliva fluid (SSF) containing 0.03 g/mL mucin was 
preheated to 37 °C and then adjusted to pH 6.8. After being mixed with the initial 
samples, the mixture was incubated in an incubator shaker for 2 min at 37 °C to mimic 
agitation in the mouth. 
Stomach phase: 15 g of simulated gastric fluid preheated to 37 °C, and the pH was 
adjusted to 2.1. After being mixed with 15 g of the “bolus” sample resulting from the 
mouth phase, the initial pH of the mixture was about 2.5 and incubated in the incubator 
shaker for 2 h at 37 °C to mimic stomach conditions. 
  147 
Small intestine phase: 30 g of “chyme” sample from the stomach phase was placed into a 
100 mL glass beaker that was placed into a water bath at 37 °C and then adjusted to pH 
7.00. 1.5 g of simulated intestinal fluid was added to the reaction vessel, followed by 3.5 
g of bile salt solution with constant stirring. The pH of the reaction system was adjusted 
back to 7.00. 2.5 g of 6% (w/w) corn oil-loaded emulsions was then added to the sample 
and an automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and 
maintain it at pH 7.0 by titrating 0.1 N NaOH solution into the reaction vessel for 2 h at 
37 °C. The amount of free fatty acids released was calculated from the titration curves as 
described previously using the following formula: 
……………………………… (1) 
Here VNaOH is the volume of sodium hydroxide required to neutralize the FFAs produced 
(mL), mNaOH is the molarity of the sodium hydroxide solution (0.1 N), WLipid is the total 
weight of lipid initially present in the reaction vessel (0.15 g), and MLipid is the molecular 
weight of the corn oil (800 g/mol).  
5.2.2.2.4 Confocal laser scanning microscopy  
Images were obtained using a confocal scanning laser microscope with a 20 
objective lens (Nikon D-Eclipse C1 80i, Nikon, Melville, NY, USA). The images of 
ratiometric dye were emitted at 543 and 488 nm, and detected at 650/LP and 590/50 
respectively. All samples were imaged with exposure time of 0.5 s and a 12.5% 
excitation power level for both channel. The images for each sample was achieved 
typically in less than 2min with at least eight measurements. After intestine digestion, the 
oil phase in the digestion phase was dyed with Nile red solution (1 mg/mL ethanol). The 
lipase was dyed with FITC solution (1 mg/mL dimethyl sulfoxide) prior to measurements 
by incubating the lipase-loaded beads in 0.1 mL of FITC dye solution. The excitation and 
emission spectrum for Nile red were 543 nm and 605 nm, respectively and for FITC were 
488 nm and 515 nm, respectively. The microstructure images for confocal microscopy 
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were taken and analyzed using image analysis software (NIS- Elements, Nikon, Melville, 
NY, USA). 
5.2.2.2.5 Standard curve preparation 
The stock FRD solution (10 mg/mL) was prepared by dissolving the powdered FRD 
dye in phosphate buffer (5mM, pH 7) solution. 5 µL/ml FRD stock solution at pH 4–7 
(adjusted by hydrochloric acid) was imaged using confocal microscope to determine the 
linear range of pH response. 
5.2.2.2.6 Image processing for pH measurement 
The images were analyzed using the Image J software (1.50I). The ratio of pixel 
intensities of two images obtained from two wavelengths (488 nm, 543 nm) were 
calculated and correlated with pH from the obtained standard curve. The images were 
processed by repeated scan with frame averaging from at least eight measurements.  
5.2.2.2.7 Determination of droplet size  
The particle size distribution of the hydrogel beads with/without Mg(OH)2 co-
encapsulation initially and after stomach digestion was determined using a laser 
diffraction device (Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, 
UK), which utilizes measurements of the angular scattering pattern of emulsions. 
Samples were diluted in aqueous solutions to avoid multiple scattering effects, and then 
stirred (1200 rpm) to ensure homogeneity. Phosphate buffer (5 mM, pH 7.0) was used to 
dilute the initial samples, while pH 2.5 adjusted distilled water was used to dilute 
stomach samples. The average particle sizes are reported as the volume-weighted mean 
diameter (d43).  
5.2.2.2.8 Statistical analysis 
 All experiments were performed on at least three freshly prepared samples. The 
results are reported as averages and standard deviations. These analyses were carried out 
using Excel (Microsoft, Redmond, VA, USA) and a statistical software package (SPSS). 
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5.2.3 Results and discussion 
5.2.3.1 Development of the standard curve  
In this study, mapping the pH values inside the beads is critical for the verification of 
antacid effect of our hydrogel beads during the digestion process. Therefore, a 
quantitative ratiometric method based on CLSM methods was developed to quantitatively 
measure the microclimate pH in the hydrogel bead matrix. Fluorescein and 
Tetramethylrhodamine (FRD), as the pH indicator dye, was used to estimate the pH 
change inside the beads during the whole digestion process. This fluorescent dye was 
selected because it has both pH-dependent (FITC) and pH-independent (TMR) 
fluorescence groups within its molecule structure, which enable the quantitatively 
measure the pH value based on the fluorescence intensity ratio with the elimination of the 
dye concentration effect 275-276. Furthermore, these two fluorescence groups are 
conjugated to the dextran with relatively large molecule weight (around 70,000 Da), 
which ensures the entrapment of dye inside the beads during the measurement process. 
The ratiometric method has also been used for the pH measurements inside the pellets or 
microspheres by other studies, it was reported that this ratiometric method can eliminates 
the problems associated with variable microsphere or pellet matrix thickness, and non-
uniform indicator distribution within the microsphere or pellet because of loading 
efficiency variations 277-279.  
It was indicated based on the preliminary studies that the emission intensity obtained 
from the FITC channel was correspondingly increased for the dye incubated in higher pH 
buffer, while the emission intensity of TMR channel remains at a constant value 
irrespective of change of stock buffer with different pH values (data not shown). The 
corresponding pH can therefore be obtained independent of dye concentration by taking 
the ratio of the emission intensities at these two channels (FITC/TMR). In this study, the 
standard curve of pH vs. intensity ratio was determined using standard pH buffer 
solutions of pH 4-7 (Fig. 5.10). Based on our previous studies, the TMR/FITC value was 
almost independent of the dye concentrations across the pH range of 2.5-7. Therefore, it 
can be estimated that the pH value inside the beads could still be quantitatively measured 
even though the leakage of the dye occurs during the fabrication and incubation.  
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Figure 5. 10 Standard curve of pH vs. intensity ratio taken by 5 µL/ml stock solution 
(10mg/mL). 
5.2.3.2 Mapping the pH inside the beads during digestion  
An antacid buffer agent (Mg(OH)2) was encapsulated within the hydrogel beads to 
adjust the internal pH inside the beads during the simulated digestion process. It was 
estimated that Mg(OH)2 can be retained within the hydrogel beads with its intrinsic solid 
state at neutral condition, while partly dissolved and ionized the hydroxide ion (OH-) 
when incubated at low pH conditions. Hydrogel beads fabricated at the same conditions 
without Mg(OH)2 encapsulation were also studied as the control samples, and the pH 
value inside the beads with or without Mg(OH)2 encapsulation during different steps of 
digestion process (i.e., mouth stomach and intestine) was measured based on the 
developed standard curve described in previous section.    
It was indicated that the pH value inside the hydrogel beads remained fairly constant 
for the initial samples and the samples after incubation in mouth phase irrespective of 
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Mg(OH)2 encapsulation (Fig. 5.11, Fig. 5.12). This result can be attribute to the reason 
that pH value in the initial phase and mouth phase was relatively similar with each other 
(pH around 7 for initial phase and 6.8 for mouth phase). The averaged internal pH of the 
hydrogel beads before and after mouth digestion was evaluated to be around pH 6.74 to 
6.29 for buffer-free beads and pH 7.25 to 7.33 for buffer-loaded beads (Table 5.1). The 
encapsulated Mg(OH)2 slightly increased the microclimate pH of the hydrogel beads, 
which can be attributed to the weak base characteristic of encapsulated Mg(OH)2. The 
confocal fluorescent images also showed that the pseudo-color was constantly distributed 
within the buffer-free hydrogel beads, which indicated that the pH value was relatively 
uniform within these beads matrix (Fig. 5.11). For the Mg(OH)2 encapsulated beads, the 
pseudo-color inside the beads was not evenly distributed. The insoluble Mg(OH)2 
particles showed higher pH value compared with surrounding solution based on the color 
strip (Fig. 5.12). These results again verify the weak base characteristic of encapsulated 
Mg(OH)2. After incubation in simulated gastric fluids, the fluorescence intensity sharply 
decreased for the hydrogel beads without Mg(OH)2 encapsulation. The pH was estimated 
to be acid value (lower than 4) based on the standard curve calculation. This result can be 
attributed that the hydrogen ions can diffuse through the pores of the hydrogel beads to 
balance the concentration between inside and outside the beads, thus equilibrium state 
was finally achieved after 2h stomach digestion process with a low pH value. On the 
contrary, it was showed that the pH value inside the buffer-loaded beads still remain 
relatively constant compared with initial value (around pH 7.39) after stomach digestion. 
It can be expected that Mg(OH)2 particles slowly ionized and neutralized the hydrogen 
ions arising from the gastric fluids, which maintain the pH value inside the beads 
constant above 7.  
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Figure 5. 11 Fluorescent images of hydrogel beads without buffer encapsulation during 
the digestion process (intensity of TMR signal was enhanced using Image J to improve 
contrast). The images of the TMR channel and FITC channel were emitted at 543 and 
488 nm, detected at 650/LP and 590/50 nm respectively.  
 
Table 5. 1 The measured pH value inside beads with/ without buffer co-encapsulation 
during digestion process 
 
 Initial Mouth Stomach 
Without buffer (pH) 6.74 ± 0.08 6.29 ± 0.104 pH < 4.0 
With buffer (pH) 7.25 ± 0.106 7.33 ± 0.182 7.39 ± 0.15 
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Figure 5. 12 Fluorescent images of hydrogel beads with buffer encapsulation during the 
digestion process (intensity of TMR signal was enhanced using Image J to improve 
contrast). The images of the TMR channel and FITC channel were emitted at 543 and 
488 nm, detected at 650/LP and 590/50 nm respectively.  
 5.2.3.3 Influence of different beads encapsulation on lipid digestion  
In this section, the influence of different beads encapsulation on lipid digestion was 
studied using an automatic titration (“pH-stat”) method. Specifically, the lipase-loaded 
beads with or without Mg(OH)2 co-encapsulation after the mouth and stomach digestion 
were incubated with oil in the simulated intestine phase. The amount of free fatty acids 
released over time was then calculated from the volume of NaOH titrated into the 
samples to maintain a constant pH value (7.0).   
For the buffer free beads and free lipase samples, there is almost no free fatty acids 
released during the whole digestion process, which indicated that lipase has been already 
deactivated during the stomach digestion process even though encapsulated in the 
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hydrogel matrix (Fig. 5.13). The poor lipases activity at low pH has been attributed to the 
titration of the active site histidine or to the weakening of the coordination of stabilizing 
calcium ions 280. It has been noted that the acid ions (H+) can easily diffuse in the beads 
matrix and get access to the active site of lipase during stomach incubation. The lipid 
digestion profile of lipase-load beads with Mg(OH)2 co-encapsulation is significantly 
different from buffer free one: a rapid increase in free fatty acids (FFAs) release can be 
detected within the first 45 min, and then followed by a more gradual increase until a 
relatively constant final value was attained. These results indicated the preservation of 
lipase activity when the Mg(OH)2 was co-encapsulated into the beads.  
 
Figure 5. 13 Amount of free fatty acids released from the systems (free lipase and 
hydrogel beads with or without buffer co-encapsulation) using a pH-stat in vitro digestion 
model.  
 
To visually testify the digestion process in the lipase-loaded beads, lipase was dyed 
to green and oil was dyed to red using FITC and Nile red respectively. The confocal 
microscopy images indicated that most of lipase molecules were trapped inside the 
hydrogel beads, i.e., the green (lipase) fluorescence dyes were mostly located together in 
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the spheroid shape beads matrix (Fig. 5.14). It suggested that large amount of lipase can 
be successfully delivered to intestine phase using hydrogel beads entrapment. The green 
fluorescence intensity can also be detected outside the beads in the surrounding intestine 
phase, which suggested that the lipase can partly release from the beads after intestine 
digestion. The alginate beads have been reported to swell when placed in higher pH 
solutions such as in intestine phase, because the alginate molecules become highly 
charged (carboxylate group) and repel with each other causing the hydrogel network to 
expand, thus the encapsulated lipase can partly release from the beads during intestine 
digestion process 23. Furthermore, compared to the system without buffer, there was a 
decrease in the red fluorescence intensity of the surrounding aqueous phase in system 
with buffer, which is indicative of a reduction in the amount of lipids present the 
surrounding aqueous phase. It can be estimated based on the digestion profiles that the 
lipid droplets had been digested by lipase molecules with reserved activity released from 
buffer-loaded hydrogel beads. These results also indicated that co-encapsulation of 
Mg(OH)2 within the lipase-loaded hydrogel beads can protect the lipase from 
deactivation during digestion process. 
 
Figure 5. 14 Confocal microscope of lipase-loaded beads with and without buffer 
encapsulation after exposure to the small intestine phase for 2 hours. Lipase was dyed 
with FITC to show green fluorescence, while the lipid phase was dyed by Nile Red to 
show red fluorescence. 
With buffer Without buffer 
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5.2.3.4 The particle size characteristic of beads during digestion  
Alginate beads are regarded as a good polymer based acid indicator due to its pH 
dependent behavior. Calcium alginate matrix tend to shrink at acid condition because of 
the loss of negative charge on the alginate molecules when the carboxyl groups become 
protonated (–COOH, pKa=3.5). Conversely, they will swell when incubated in higher pH 
solutions because of charge retrieve which has been discussed in the previous section. It 
is thus interesting to study the size characteristic of hydrogel beads with/without buffer 
co-encapsulation during the digestion process. 
Based on the static light scattering measurements, it was indicated that the general 
shape of the particle size distribution was relatively similar from initial-to-stomach for 
the buffer-loaded bead, exhibiting a major population of large particles with diameters 
around 250µm (Fig. 5.15). The mean particle diameter of these beads was slightly 
decreased during this process (initial-to-stomach), i.e., from 264.2 to 244.5µm (Fig. 5.16). 
For the beads without buffer encapsulation, an obvious size reduction can be detected 
from the particle size distribution after stomach digestion, and the mean particle diameter 
of alginate beads sharply decreased from 273.5 to 208.5µm. These results indicated that 
the alginate beads can undergo swell to shrink transformation when the incubation 
pH reduced from neutral to acid (initial-to-stomach). Moreover, the buffer-loaded 
hydrogel beads could maintain the pH relatively constant during this digestion process, 
which restrained the shrink of hydrogel beads in acid stomach phase. 
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Figure 5. 15 Particle size distributions of different samples initially and after the stomach 
digestion process. 
 
 
Figure 5. 16 Mean particle diameter (d43) of different samples initially and after the 
stomach digestion process.  
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5.2.4 Conclusions 
It is an important challenge to stabilize lipase inside any carriers during the digestion 
process. In this study, alginate based hydrogel beads were fabricated based on injection-
gelation method to encapsulate the lipase, the buffer agent (Mg(OH)2) was also co-
encapsulated in these beads to adjust the microclimate pH inside beads during the 
simulated digestion process. The fluorescence pH measurements based on laser scanning 
confocal microscope indicated that the pH value inside the buffer free beads was sharped 
decreased to acid condition after stomach digestion. For the buffer-loaded beads, the pH 
value was measured to be fairly constant from initial-to-stomach. The lipase-loaded beads 
with buffer co-encapsulation clearly had a pronounced impact on the rate and extent of 
lipid digestion. Conversely, for the lipase-loaded alginate beads without buffer 
encapsulation, no lipid digestion occurred by the end of the 2 h digestion period. The 
particle size of buffer free beads was greatly reduced during the digestion process (initial-
to-stomach), while the size remains relatively similar for the buffer-loaded beads. These 
results indicated that Mg(OH)2 can work as an effective buffer agent against acidification 
in stomach phase, the lipase-loaded hydrogel beads with Mg(OH)2 co-encapsulation can 
reserve the activity of lipase during the digestion. 
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5.3 Lactase (β-galactosidase) encapsulation in hydrogel beads with controlled 
internal pH microenvironments: Impact of bead characteristics on enzyme 
activity 
5.3.1 Introduction 
Lactose intolerance is a common disease in humans that is associated with the 
deficiency of a specific enzyme (β-galactosidase) produced within the brush border of the 
small intestine 281-282. Individuals with lactose intolerance have a limited ability to digest 
and absorb lactose in the small intestine.  As a result, this disaccharide enters the colon in 
an undigested form where it can promote health problems, such as gut distension, 
stomach pain, flatulence, diarrhea, and nausea 283. Individuals who suffer from lactose 
intolerance often avoid consuming milk and other dairy products so as to avoid exhibiting 
these undesirable symptoms. Several other approaches have also been developed to aid 
individuals with lactose intolerance, including creating lactose-free foods and the co-
ingestion of lactase supplements with lactose-containing foods 284. Enzyme supplement 
treatments are particularly promising because they do not cause undesirable changes in 
food quality or nutritional profile.  Typically, a tablet or capsule containing lactase is 
taken at the same time as a lactose-containing food, which promotes lactose hydrolysis 
within the gastrointestinal tract (GIT).  β-galactosidase (β-gal) is the most common form 
of lactase used in enzyme supplements, but it cannot simply be delivered in its free form 
because it is highly susceptible to denaturation and deactivation under GIT conditions 285.  
In particular, lactase is usually deactivated when exposed to the highly acidic gastric 
fluids present within the human stomach 286. 
The encapsulation of enzymes within porous matrices can improve their stability by 
creating a protective microenvironment or by acting as a physical barrier to the external 
environment 287-288. At the same time, the porous matrices can be designed to allow small 
molecules (such as co-factors, substrates, and products) to easily diffuse into them and 
reach the catalytic site of the encapsulated enzyme, which enables the enzyme to 
maintain its activity even after encapsulation 6, 289.  Enzymes can be encapsulated within 
  160 
porous matrices using physical entrapment, physical interactions, or chemical bonding 
267-268. The encapsulation of enzymes in hydrogels is particularly attractive for application 
in the food industry because these semi-solid materials can be fabricated from food-grade 
ingredients using simple processing operations 270. Enzymes are physically entrapped in 
the hydrogel network during the sol-gel transition, which is a relatively mild process that 
tends to preserve the structural integrity and activity of the enzymes. After fabrication, 
the enzymes can be retained within the hydrogel matrix by ensuring that its pore size is 
appreciably smaller than the enzyme dimensions, or by ensuring that there is a 
sufficiently strong attraction between the enzymes and the hydrogel matrix.   
For many applications it is desirable to utilize hydrogel beads, rather than bulk 
hydrogels to encapsulate and deliver bioactive substances 6.  Hydrogel beads consist of 
small particles (typically from 100 nm to 1000 µm) that can easily be dispersed in 
aqueous solutions.  These beads can be fabricated from food-grade biopolymers 
(typically polysaccharides and/or proteins) using simple processing operations, such as 
the injection-gelation method 229, 269, 290-291.  Typically, the formation of hydrogel beads 
requires two-steps that may occur consecutively or simultaneously: particle-formation 
and particle-gelation.  For the injection-gelation method, particle-formation is performed 
by injecting an aqueous solution containing a biopolymer (gelling agent) and a bioactive 
agent (enzyme) into a gas or immiscible liquid, and then particle-gelation is performed by 
exposing the particles formed to solution or environmental conditions that promote 
biopolymer gelation.  This process leads to the formation of hydrogel beads with 
bioactives trapped inside a biopolymer matrix 76.  A serious limitation of this approach 
for the encapsulation of acid-sensitive enzymes (such as lactase) is that small hydrogen 
ions (H+) can easily diffuse through the biopolymer network inside the hydrogel beads, 
thereby inducing enzyme deactivation.  For this reason, a number of research groups have 
tried to improve the acid-resistant characteristics of hydrogel beads, e.g., by reducing the 
pore size of the biopolymer network or by coating the beads with biopolymer layers 271-
272. However, these approaches are often unsuccessful because the hydrogen ions are so 
small that they can still easily penetrate through the biopolymer networks that make up 
the hydrogel core or shell. 
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In the present study, an alternative approach was used to create hydrogel beads that 
would protect enzymes from acid-induced deactivation when exposed to gastric 
conditions.  The enzyme (lactase) was co-encapsulated with magnesium hydroxide (a 
basic buffer) inside the hydrogel beads. Mg(OH)2 was selected as a buffering agent 
because it is a widely used food-grade antacid, which is insoluble in water at neutral and 
basic pH values, but soluble at acidic pH values 274.  When these buffer-loaded hydrogel 
beads are dispersed in an acidic solution, the pH inside them remains close to neutral for 
an extended period.  This phenomenon occurs because as hydrogen ions (H+) from the 
surrounding aqueous phase diffuse into the hydrogel beads they cause some of the 
Mg(OH)2 to dissociate, which generates hydroxyl ions (OH-) that neutralize any pH 
changes.  Moreover, it has been widely proven that the presence of Mg2+ can also 
increase the activity of lactase (Juers, et al., 2009), which should be another advantage of 
co-encapsulation with lactase. The hydrogel beads were fabricated by an injection-
gelation method using an anionic polysaccharide (κ-carrageenan) as the gelling agent and 
a cationic mineral ion (potassium) as a cross-linking agent.  This polysaccharide was 
selected because it was previously shown that relatively high encapsulation efficiency 
(around 63%) can be achieved by the carrageenan beads. In addition, β-gal encapsulated 
within potassium-carrageenan beads had a higher activity than the free enzyme due to the 
stabilization effects of K+ ions on enzyme structure 266. The ability of the buffer-loaded 
hydrogel beads to protect lactase from acid-induced deactivation was demonstrated by 
exposing them to simulated gastric conditions. A quantitative ratiometric fluorescence 
method based on confocal laser scanning microscopy (CLSM) was also used to map the 
pH inside the beads before and after exposure to gastric conditions. This study provides 
information that can be used to facilitate the fabrication of hydrogel beads designed to 
encapsulate and deliver acid-labile enzymes and other bioactive agents.  
5.3.2 Materials and methods  
5.3.2.1 Materials  
Fluorescein tetramethylrhodamine dextran (FRD) with an average molecule weight 
of around 70 kDa was purchased from Molecular Probes (Eugene, OR). Lactase (β-
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galactosidase) with a specific activity of around 2600 U/g was obtained from Sigma 
Chemical Co (St. Louis, MO, USA). Carrageenan was kindly donated by FMC 
Biopolymer (Viscarin SD 389, Philadelphia, PA). The reagents o-nitrophenol (o-NP) and 
o-nitrophenyl-b-d-galactosidase (o-NPG) were obtained from the Sigma Chemical Co. 
(St. Louis, MO, USA). All chemicals used were analytical grade. Double distilled water 
was used to prepare all solutions.  
5.3.2.2 Hydrogel beads preparation 
An aqueous κ-carrageenan (2% w/v) solution was prepared by dissolving the 
powdered ingredient in distilled water by stirring at 50 °C for an hour, and then reducing 
the temperature to room temperature with continuous stirring until fully dissolved. The κ-
carrageenan solution was then mixed with β-gal solution to obtain a concentration of 1% 
κ-carrageenan and 130 U β-gal mixture with or without different amount of Mg(OH)2 co-
encapsulation. After continuously stirring, the mixtures were injected into 10% potassium 
chloride solution using a syringe or a commercial encapsulation unit (Encapsulator B-390, 
BUCHI, Switzerland) with a 150 µm vibrating nozzle to prepare the hydrogel beads. The 
encapsulation device was operated under the following conditions: frequency 800 Hz; 
electrode 750 V; and pressure 450 mbar. The formed beads were held in the K+ solution 
for 30 min at ambient temperature to promote bead hardening.  
5.3.2.3 Simulated gastric conditions  
A simulated stomach model was used to investigate the influence of exposure to 
acidic gastric fluids on the internal pH and lactase activity of the hydrogel beads as 
described previously 230. Hydrogel beads (with or without Mg(OH)2) were added to 
preheated simulated gastric fluids (pH 2.5, 37 °C) at a ratio of 1:4 (w/w). This mixture 
was then incubated in an incubated shaker for 2 h at 37 °C to mimic stomach conditions.  
5.3.2.4 Local pH determination by confocal laser scanning microscopy  
The fluorescence images were obtained using confocal laser scanning microscopy 
with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon, Melville, NY, USA). The 
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images of the fluorescence probe (FRD) were obtained using emission wavelengths of 
543 and 488 nm, and detection wavelengths/bandwidths of 650 nm/LP and 590 nm/50 
nm, respectively. All samples were imaged using an exposure time of 0.5 s and a 12.5% 
excitation power level. The complete images of each sample were typically acquired in 
less than 2 min with at least eight measurements. The microstructural images for confocal 
microscopy were acquired using image specialized software (NIS-Elements, Nikon, 
Melville, NY, USA).  
A stock FRD solution (10 mg/mL) was prepared by dissolving powdered FRD dye in 
phosphate buffer (5mM, pH 7) solution. 5 µL/ml of FRD stock solution was dissolved in 
a series of phosphate buffer solutions with different pH values and imaged using confocal 
microscopy to determine the linear range of pH response. 
The confocal microscopy images were analyzed using Image J software (1.50I, 
imagej.nih.gov). The ratio of pixel intensities of images taken using two wavelength 
channels (488 nm, 543 nm) was calculated and correlated to the pH using the standard 
curve. Each pH value was estimated from at least eight measurements.  
5.3.2.5 Measurement of lactase activity 
The relative activity of β-gal encapsulated in hydrogel beads that was retained after 
different incubation times in simulated gastric fluids was assayed using a colorimetric test 
with o-NPG as a substrate. Filtered beads were added to 2 mL of o-NPG in phosphate 
buffer (0.3 mg/ml) to reach a final alginate to o-NPG ratio of 1:40 (v/v).  The formation 
rate of free o-NP was recorded by measuring the absorbance (l = 420 nm) of solutions 
contained in a 1-cm path length cuvette using a UV-visible spectrophotometer. The 
relative activity of encapsulated lactase was calculated based on the conversion rate of 
the substrate (o-NPG) into the reaction products (o-NP) initially and after stomach phase 
incubation. At least three freshly prepared samples were used for the activity 
measurements.  
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5.3.2.6 Measurement of bead dimensions  
The particle size distribution of the small beads was measured using laser diffraction 
(Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, UK), which is 
based on analysis of the angular scattering pattern of particulate suspensions. Samples 
were diluted in aqueous buffer solutions to avoid multiple scattering effects, and then 
stirred (1200 rpm) to ensure homogeneity. The diameter of the large beads was measured 
using a digital micrometer (0–300 mm, EC10, High Precision Digital Caliper, Tresna 
Instruments, Guilin, China). The bead diameter of at least 5 individual beads was 
measured, and the mean and standard deviation were calculated from at least three 
measurements.  
5.3.2.7 Statistical analysis 
 All experiments were performed on at least three freshly prepared samples. The 
results are reported as means and standard deviations. These analyses were carried out 
using Excel (Microsoft, Redmond, VA, USA) and a statistical software package (SPSS). 
5.3.3. Results and discussion 
5.3.2.1 pH Mapping inside the beads  
Knowledge of the local pH inside the hydrogel beads is required to better understand 
the ability of buffer-loaded beads to protect lactase from acid-induced deactivation in 
simulated gastric fluids. A pH-sensitive fluorescence probe (FRD) was therefore used to 
estimate the internal pH of the beads using a ratiometric fluorescence method. FRD has 
both pH-dependent (FITC) and pH-independent (TMR) fluorescence groups within its 
molecular structure 275-276. Consequently, the local pH can be determined by calculating 
the ratio of fluorescence intensities arising from the FITC and TMR groups. In this study, 
the FRD was conjugated to a large molecular weight dextran (70 kDa) to ensure that the 
fluorescence dye remained trapped inside the hydrogel beads.  
The confocal fluorescence microscopy measurements indicated that the emission 
intensity from the FITC channel (488 nm) decreased when the fluorescent dye was 
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incubated in lower pH buffers, while the emission intensity from the TMR channel (543 
nm) remained relatively constant (Fig. 5.16). A standard curve of fluorescence intensity 
ratio versus pH (from pH 4 to 7) was then obtained by taking the ratio of the emission 
intensities for the FITC/TMR channels (data not shown). The pH value inside the 
hydrogel beads could then be determined from the confocal fluorescence microscopy 
images using this calibration curve.  
 
Figure 5. 17 Fluorescent images of fluorescence probe dispersed in phosphate buffer 
solutions with different pH values. The images in the top row (TMR channel) and bottom 
row (FITC channel) were represent the fluorescence intensity using emulsion 
wavelengths of 543 and 488 nm, and detection wavelengths of 650 and 590 nm, 
respectively.  
 
Confocal microscopy images of the hydrogel beads were taken before and after 
exposure to simulated gastric fluids (Figs. 5.17 and 5.18). For the buffer-free beads, the 
fluorescence intensity of the FITC channel (pH-dependent) changed from relatively 
strong before exposure to very weak after exposure, which is indicative of a substantial 
reduction in the internal pH of the beads based on the calibration curve (Fig. 5.17). The 
interior of the buffer-free beads was calculated to be around pH 6.9 before exposure, and 
below the limit of detection (pH < 4) after exposure. These results suggest that the 
hydrogen ions (H+) from the acidic gastric fluids rapidly diffused into the hydrogel beads 
and decreased their internal pH. Conversely, for the buffer-loaded beads, the fluorescence 
intensity of the FITC channel only decreased slightly after incubation in simulated gastric 
fluids (Fig. 5.18).  Indeed, the interior of the buffer-loaded beads changed from around 
pH 7.2 before exposure to around pH 6.6 after exposure.  As mentioned earlier, this effect 
can be attributed to the fact that the encapsulated Mg(OH)2 is insoluble under neutral 
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conditions, but dissolves under acidic conditions.  Consequently, when hydrogen ions 
from the gastric fluids diffuse into the hydrogel beads, some of the Mg(OH)2 dissolves, 
which generates OH- ions that neutralize the H+ ions, thereby maintaining a neutral pH 
inside the beads. Presumably, there was sufficient magnesium hydroxide initially present 
within the hydrogel beads to counteract all the hydrogen ions arising from the gastric 
fluids. 
 
 
Figure 5. 18 Fluorescent microscopy images of hydrogel beads without Mg(OH)2 
encapsulation before and after stomach digestion. The images of the ratio channel were 
generated using Image J software (imagej.nih.gov) and the color strip shown on the top 
right represents the pseudocolor change with pH (intensity of TMR signal was enhanced 
using Image J to improve contrast). 
5.3.2.2 Influence of encapsulation on enzyme activity: Spectrophotometric assay   
The local pH that lactase experiences within the stomach phase influences its 
molecular conformation and enzyme activity. For this reason, the activity of lactase 
encapsulated in hydrogel beads containing different amounts of co-encapsulated 
Mg(OH)2 was measured after incubation in simulated gastric fluids. The impact of bead 
dimensions on enzyme activity were determined by fabricating large and small hydrogel 
beads using either a simple syringe or a dedicated encapsulation unit, respectively.  The 
hydrogel beads were then incubated in simulated gastric fluids for different times, and the 
enzyme activity was measured using a spectrophotometric method. 
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Figure 5. 19 Fluorescent microscopy images of hydrogel beads containing 0.6% 
Mg(OH)2 before and after stomach digestion. The images of the ratio channel were 
generated using Image J software (imagej.nih.gov) and the color strip shown on the top 
right represents the pseudocolor change with pH (intensity of TMR signal was enhanced 
using Image J to improve contrast). 
 
For both sizes of buffer-free beads, lactase activity was completely lost after 5 min 
incubation in simulated gastric fluids (Figs. 5.20 and 5.21).  Presumably, this type of 
hydrogel bead was unable to prevent acid-induced loss of lactase activity because small 
H+ ions easily diffuse through the pores in the biopolymer matrix and rapidly reduced the 
internal pH 292. Conversely, for the buffer-loaded beads, the activity of the encapsulated 
enzyme depended on both the level of Mg(OH)2 present and the bead dimensions (Figs. 
5.20 and 5.21). Lactase activity decreased steeply after 5 minutes incubation for large 
buffer-loaded beads containing only 0.06% or 0.1% Mg(OH)2, with a complete loss of 
enzyme activity after 25 min incubation (Fig. 5.20). These results suggest that there was 
insufficient buffer present inside the beads to completely neutralize all the hydrogen ions 
(H+) that diffused into them. At 0.15% and 0.3% Mg(OH)2, the enzyme activity within 
the large buffer-loaded beads remained > 60% after 120 min incubation (Fig. 5.22), 
which indicated that these systems were effective at preventing the acid-denaturation of 
lactase. This effect can be attributed to their ability to maintain a relatively high pH inside 
the hydrogel beads. For the small buffer-loaded beads, a higher amount (0.6 or 0.8%) of 
TMRTMR FITC Ratio
Initial
Stomach
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Mg(OH)2 was needed to maintain a reasonable level of enzyme activity at the end of the 
gastric phase (26 or 42% respectively) (Figs. 5.21 and 5.22). The observed impact of 
hydrogel bead dimensions on the activity of the enzyme can be attributed to the shorter 
distance that the H+ ions have to diffuse into smaller beads (see later).  
 
Figure 5. 20 The relative activity of β-galactosidase encapsulated in large hydrogel beads 
after incubation in simulated gastric fluids for different times. The enzyme was 
encapsulated in hydrogel beads containing different amounts of Mg(OH)2 (0 to 0.30%). 
Samples designated with different capital letters (a, b) were significantly different 
(Duncan, p < 0.05) when compared between different delivery systems for the final point 
(120 min).  
5.3.2.3 Influence of encapsulation on enzyme activity: Visual appearance   
Additional insights into the impact of encapsulation on the stability of lactase was 
obtained by measuring changes in the appearance of hydrogel bead suspensions 
incubated at pH 2.5 (gastric) and pH 7.0 (intestinal) in the presence of a lactase substrate 
(o-NPG). Photographic images of the samples were taken periodically to indicate color 
changes during incubation: an increase in the intensity of the yellow color of the samples 
is an indication of a higher conversion of o-NPG to galactose o-NP by lactase. 
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 For the buffer-free beads, the yellow color was evenly distributed within the o-NPG 
solution during incubation at pH 7 (Fig. 5.23a), which suggests a high enzyme activity 
under these conditions. Conversely, when buffer-free beads were incubated in the o-NPG 
solution at pH 2.5, no color change was observed indicating that the enzyme was 
completely deactivated under these acidic conditions (Fig. 5.23b). For the buffer-loaded 
beads incubated at pH 2.5, the yellowish color first appeared in the hydrogel beads 
located at the bottom of the tube, then the external o-NPG solution became yellowish at 
longer incubation times (Fig. 5.23c). Presumably, the substrate (o-NPG) initially diffused 
into the hydrogel beads where it was hydrolyzed by the encapsulated lactase. At longer 
times, some of the reaction products diffused out of the hydrogel beads and into the 
surrounding aqueous phase, thereby turning the whole solution yellow. A schematic 
diagram of the proposed reactions taking place in these systems is shown in Figure 5.24.  
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Figure 5. 21 The relative activity of β-galactosidase encapsulated in small hydrogel 
beads after incubation in simulated gastric fluids for different times. The enzyme was 
encapsulated in hydrogel beads combined with different amounts of Mg(OH)2 (0 to 
0.80%). Samples designated with different capital letters (a, b, c) were significantly 
different (Duncan, p < 0.05) when compared between different delivery systems for the 
final point (120 min).   
 
Figure 5. 22 The relative activity of β-galactosidase encapsulated in hydrogel beads after 
120 minutes incubation in simulated gastric fluids. The enzyme was encapsulated in 
hydrogel beads containing different amounts of Mg(OH)2. 
5.3.2.4 Impact of bead dimensions on H+ ion diffusion 
The experimental studies indicated that the hydrogel bead dimensions had a major 
impact on the stability of the encapsulated lactase to acidic environments, which was 
attributed to the impact of particle size on the kinetics of H+ ion diffusion into the beads.  
In this section, the impact of bead dimensions on hydrogen ion diffusion were therefore 
investigated using a mathematical model.   
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(a) 
 
(b) 
 
(c) 
 
Figure 5. 23 Visual appearance of the color change of lactase-loaded large beads 
incubated in (a) the o-NPG solution at pH 7 without buffer co-encapsulation, (b) the o-
NPG solution at pH 2.5 without buffer co-encapsulation, and (c) the o-NPG solution at 
pH 2.5 with 0.3% Mg(OH)2 co-encapsulation. 
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Figure 5. 24 Schematic representation of physicochemical processes occurring in the 
lactase-loaded beads incubated in o-NPG solution at pH 2.5 with Mg(OH)2 co-
encapsulation. 
 
The particle size distributions of suspensions of both small and large hydrogel beads 
contained a single peak (Fig. 5.25a).  Digital photographs of the samples showed that 
they contained fairly uniform size particles that were evenly distributed throughout the 
system (Fig. 5.25b). The mean particle diameters of the small and large beads were 
around 255 and 2610 µm, respectively. 
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(a) 
 
(b) 
Figure 5. 25  (a) Particle size distributions and (b) visual appearances of carrageenan 
beads fabricated by syringe (large beads) and Encapsulator (small beads).  
 
The diffusion of hydrogen ions into hydrogel beads with different dimensions can be 
predicted using the following equation 293: 
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    (1) 
 
Here, F refers to the fraction of H+ ions that have diffused into the hydrogel beads at time 
t, M(t) and M(∞) are the concentrations of H+ ions inside the hydrogel beads at time t and 
at equilibrium, n is an integer, a is the hydrogel bead radius, and Dgel is the diffusion 
coefficient of the H+ ions through the hydrogel bead matrix, which can be estimated 
based on the following expression 239:  
 
     (2) 
Here, Dw is the diffusion coefficient of the H+ ions through pure water, rH is the 
hydrodynamic radius of the H+ ions, rf is the cross-sectional radius of the biopolymer 
chains (κ-carrageenan) in the hydrogel network, and z is the mesh pore diameter of the 
hydrogel network. The radius (rf) of the carrageenan chain has been reported to be around 
0.50 nm 294. Typical pore sizes of biopolymer hydrogels are reported to be in the range 5 
to 500 nm 270, and a value of 15 nm was assumed for the purpose of this study. The 
hydration (rH) radius of the H+ ions (actually H3O+ ions) has been estimated to be around 
0.1 nm 295. The diffusion coefficient of H+ ions in water can be obtained from: Dw = 
kBT/6phrH, where kB is Boltzmann’s constant, T is absolute temperature, and h is the 
viscosity of the solvent.  These equations can be used to estimate the time-dependence of 
the fraction of H+ ions diffusing into hydrogel beads with different sizes after incubation 
in the stomach phase (Fig. 5.26).  
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Figure 5. 26 Predicted time dependence of the fraction of hydrogen ions (H3O+) absorbed 
by carrageenan beads with a diameter of 255 µm (small size beads) and 2609 µm (larger 
size beads) with a pore size of 15 nm after submersion in an acidic environment.  
 
The calculations highlight the importance of hydrogel bead dimensions on the 
diffusion rate of H+ ions into the beads. The predictions show that H+ ions can diffuse 
into the small beads much quicker (in a few seconds) than into the large ones, which 
would account for the fact that a higher amount of Mg(OH)2 has to be loaded into the 
smaller beads to maintain a neutral internal pH. These calculations partly account for the 
reason that the smaller beads are less effective at protecting the lactase from acidic 
conditions than the larger beads   
In practice, smaller hydrogel beads are often preferred for applications in the food 
industry because they give products with more desirable optical, rheological, stability, 
and mouthfeel characteristics.  This study has shown that smaller beads can still be used 
to protect lactase from acid-induced degradation, but that a higher level of Mg(OH)2 must 
be incorporated into the beads.  In addition, it may be possible to further enhance enzyme 
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activity by using different types and amounts of biopolymers or cross-linking agents to 
control the hydrogel pore size and physical interactions. 
5.3.4. Conclusion 
In this study, lactase was encapsulated within potassium carrageenan-based hydrogel 
beads using the injection-gelation method.  The acid-stability of the enzyme could be 
improved by co-encapsulating it with a basic buffering agent: Mg(OH)2.  This buffer is 
insoluble under neutral conditions, but dissolves when hydrogen ions diffuse into the 
hydrogel beads, thereby ensuring a neutral internal pH (as long as some buffer remains).  
A quantitative ratiometric fluorescence method proved to be highly effective at 
determining the local pH inside the beads before and after exposure to simulated gastric 
conditions.  The interior of the buffer-free beads rapidly decreased from pH 6.9 to < 4 
when exposed to the stomach phase, which led to rapid deactivation of the encapsulated 
lactase. Conversely, the interior of the buffer-loaded beads remained relatively close to 
neutral (pH 6.6) even after 2 hours exposure to simulated gastric fluids, which helped to 
retain lactase activity.  A higher amount of Mg(OH)2 was required to protect lactase 
encapsulated in small beads than in large beads, which was attributed to faster diffusion 
of H+ ions into the smaller bead interiors.  This study suggests that buffer-loaded 
hydrogel beads may be suitable food-grade delivery systems for acid-sensitive enzymes, 
such as lactase. However, in vivo animal and human studies are stilled needed to confirm 
that buffer-loaded beads can maintain lactase activity under real life conditions.  
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5.4 Protection of insulin from gastric conditions by encapsulation in antacid-loaded 
biopolymer microgels 
5.4.1 Introduction 
It has been estimated that there were around 382 million people in the world with 
diabetes in 2013, and that this number will increase to around 592 million by 2035 296.  
Consequently, diabetes is a global health concern, which reduces the quality of life of 
numerous people, and is a major economic burden on society due to increased health 
costs and lost economic activity 297-298.  Individuals with Type 1 diabetes, as well as those 
with advanced Type 2 diabetes, have a chronic health condition in which their pancreases 
cannot produce sufficient insulin to properly regulate their blood sugar levels 299-300.  
Insulin is a peptide-based hormone that normally regulates the uptake of glucose into 
cells where it can be used as an energy source, and so individuals with diabetes need to 
receive regular doses of insulin to remain healthy 301.  At present, regular subcutaneous 
injections are the most common means of administering insulin, which is associated with 
local discomfort and the possibility of infection 299, 302-303.  Delivery of insulin through the 
oral route would be much more preferable, as it would be more convenient and less 
painful than injections 304-305.  
 However, there are a number of challenges that currently hold back the 
development of successful oral insulin delivery systems.  First, insulin is highly 
susceptible to degradation in the stomach due to the high proteolytic activity and acidity 
of the gastric fluids 306-307.  Second, the fraction of ingested insulin, which is a 
hydrophilic peptide, that is actually absorbed by the epithelium cells is relatively low 308.  
In the current study, we focus on the first of these challenges – improving the gastric 
stability of insulin.  One of the most promising strategies for increasing the stability of 
insulin within the stomach is to encapsulate it inside colloidal particles, such as 
nanoparticles or microparticles 16, 305, 309-310.  These colloidal delivery systems may be 
assembled from synthetic polymers, natural polymers, lipids, surfactants, or 
phospholipids suitable for oral ingestion, using various types of particle preparation 
methods.  In this study, we examined the possibility of encapsulating insulin within 
biopolymer microgels assembled from calcium alginate.  These microgels can be 
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fabricated using a mild preparation method, simple injection at ambient temperature, 
which is important to minimize any loss of insulin activity during the loading procedure 
311.  
 A number of researchers have examined the efficacy of calcium alginate 
microgels for encapsulating, protecting, and delivering insulin.  Insulin has been 
encapsulated within calcium alginate microgels fabricated using an 
emulsification/gelation method, but this system was unable to protect the insulin from 
degradation under simulated gastrointestinal conditions 304, presumably because these 
simple microgels have relatively large pores and are therefore unable to protect insulin 
from the acids and pepsin in the gastric juices.  Structural design principles have 
therefore been employed to improve the encapsulation and protection properties of 
alginate microgels.  For instance, the anionic alginate microgels have been coated with 
cationic biopolymers such as poly-L-lysine 312 or chitosan 313-314 to form a protective 
coating around them.  Alternatively, alginate has been used in combination with other 
biopolymers to form a mixed hydrogel matrix inside the microgels, such as cellulose 
derivatives, pectin, and chitosan 315-317. These studies showed that the insulin could be 
successfully entrapped and retained within the microgels, but that it was still susceptible 
to degradation under simulated gastrointestinal conditions.  Again, the reason for this is 
because the pores in biopolymer microgel cores or coatings are still relatively large 
compared to the size of small ions (H+) or digestive enzymes (pepsin) in the gastric fluids.  
Consequently, these molecular species can easily diffuse into the interior of the microgels 
and promote insulin degradation.    
 In the current study, a different approach was adopted to create alginate microgels 
that could protect insulin from acid and pepsin-induced deactivation when exposed to 
gastric conditions.  In this approach, insulin was co-encapsulated with magnesium 
hydroxide inside the microgels. Mg(OH)2 is a widely used food-grade antacid, which is 
soluble in water at acidic pH, but insoluble at neutral and basic pH 274. Consequently, the 
pH inside antacid-loaded microgels stays close to neutral for an extended time when 
dispersed in simulated gastric fluids, because some of the antacid dissolves and releases 
hydroxyl ions (OH-) when hydrogen ions (H+) diffuse into them 318-319.  It has been 
reported that pepsin loses most of its enzyme activity at neutral pH 320.  Consequently, 
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any gastric pepsin that diffuses into the neutral interior of antacid-loaded microgels may 
lose its activity, and therefore be unable to hydrolyze the encapsulated insulin.  We 
therefore postulated that these antacid-loaded biopolymer microgels could protect insulin 
from both acid- and protease-degradation in gastric fluids.    For this reason, we carried 
out a series of experiments to determine the effectiveness of the antacid-loaded microgels 
for the encapsulation, retention, protection, and release of insulin under simulated 
gastrointestinal conditions.   
5.4.2 Materials and methods 
5.4.2.1 Materials  
The pH-sensitive fluorescence probe, fluorescein tetramethylrhodamine dextran 
(FRD, average Mr 70,000), was purchased from Molecular Probes (Eugene, OR). L6 
cells were from American Type Culture Collection (Manassas, VA). α-minimum Eagle’s 
medium (α-MEM) was from Invitrogen (Carlsbad, CA). RIPA buffer, phosphatase 
inhibitor and protease inhibitor cocktail were from Thermo Scientific, Rockford, IL). 
Protein (or insulin) concentrations were determined with a protein DC assay kit (Bio-Rad 
Co., Hercules, CA). Immobilin P membrane was from Millipore (Bedford, MA). Primary 
rabbit antibodies including protein kinase B (AKT), phospho-AKT Thr308, phosphor-
Akt Ser473, β-actin and horseradish peroxidase conjugated goat anti-rabbit IgG were 
obtained from Cell Signaling Technology (Danvers, MA). Enhanced chemi-luminescence 
detection kit (Bio-Rad Co., Hercules, CA). The following chemicals were purchased 
from the Sigma Chemical Company (St. Louis, MO): fetal bovine serum; Penicillin; 
Streptomycin; alginic acid (sodium salt); pepsin from porcine gastric mucosa; fluorescein 
isothiocynate (FITC) isomer I; calcium chloride dehydrate; and magnesium hydrate. 
Sodium phosphate and calcium chloride were purchased from Fisher Chemical Company 
(Pittsburgh, PA). All chemicals used were analytical grade. Double distilled water was 
used to make all solutions.  
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5.4.2.2 Microgels preparation 
The microgels were prepared using an injection-gelation method as described 
previously 318-319, with some slight modifications.  Aqueous alginate solutions were 
prepared by dispersing powdered sodium alginate (1%, w/w) into phosphate buffer 
solution (5 mM, pH 7.0), and then stirring at 60 °C for 60 min. The temperature was then 
reduced to 35 °C with continuous stirring until the alginate was fully dissolved.  The 
alginate solution was then mixed with powdered 1 mg/mL insulin and either 0% (antacid-
free) or 0.15% (antacid-loaded) Mg(OH)2, and then stirred until the system was 
homogeneous.  Microgels were then prepared by injecting these mixtures through a 120 
µm vibrating nozzle into a 5% w/w calcium chloride solution using a dedicated 
encapsulation device (Encapsulator B-390, BUCHI, Switzerland). The operating 
conditions used for the encapsulation device were as follows: frequency = 800 Hz; 
electrode potential = 650 V; and operating pressure = 300 mbar. The biopolymer 
microgels formed were held in the Ca2+ solution for 20 min at ambient temperature to 
promote hardening before being removed. They were then filtered and washed with 
buffer solution to remove any residual hardening solution.    
5.4.2.3 Simulated gastrointestinal conditions  
The impact of incubation of the microgels in simulated gastric fluid (SGF) on their 
internal pH and on insulin activity was determined using a method described previously 
319, with some slight modifications. Specifically, microgels (with or without Mg(OH)2) 
were added at a ratio of 1:4 (w/w) to SGF (containing 0.0032 g/mL pepsin) that had been 
preheated to 37 °C and adjusted to pH 2.5.  The resulting mixture was then incubated 
within a shaking device for 2 h at 37 °C to mimic stomach conditions.  
After exposure to stomach phase, the microgels were then exposed to simulated 
small intestinal conditions by mixing them with phosphate buffer solution (pH 7.0, 37 °C) 
at a fixed mass ratio of 1:4, and then the mixture was adjusted to pH 7.0. For the release 
experiments, the microgels were incubated in this simulated small intestinal phase for 2 h 
at 37 °C.  
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5.4.2.4 Confocal laser scanning microscopy  
The microstructural analysis of the biopolymer microgels was carried out using a 
confocal scanning laser fluorescence microscope with a 20 × objective lens (Nikon D-
Eclipse C1 80i, Nikon, Melville, NY, U.S.). The insulin was dyed using FITC solution 
and then stored at 5 °C overnight. The excitation and emission wavelength used for 
detection of the FITC-labeled insulin were 488 nm and 515 nm, respectively.  
The pH inside the biopolymer microgels was measured using a fluorescence intensity 
method described previously 321.  A known amount of the pH-sensitive dye (10 mg/mL 
FRD) was dissolved in phosphate buffer (5 mM, pH 7.0), and then mixed with alginate 
solution (1:200 v/v) with or without 0.15% Mg(OH)2. Microgels were then fabricated 
using the encapsulation device described in Section 2.2. Images of the microgels were 
acquired using the confocal laser scanning fluorescence microscope with a 20´objective 
lens. Images of the pH-sensitive dye were obtained using excitation wavelengths of 543 
and 488 nm, and detection wavelengths/bandwidths of 650 nm/LP and 590 nm/50 nm, 
respectively 322-323. All samples were imaged using an exposure time of 0.5 s and a 12.5% 
excitation power level for both channels.  Full images of each sample were typically 
acquired in less than 2 min and then stored on the computer using the microscope’s 
software (NIS-Elements, Nikon, Melville, NY, USA). The images were then analyzed 
using Image J software (1.50I, imagej.nih.gov). The ratio of pixel intensities of the two 
images obtained at two different wavelengths (488 and 543 nm) were calculated and 
correlated with the pH obtained using a standard curve, as described previously 321.  The 
average intensity ratio was calculated from at least eight measurements. 
5.4.2.5 Particle size characterization 
Particle size distributions were carried out using a static light scattering instrument 
(Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, UK). Phosphate 
buffer (5 mM, pH 7.0) was used for the dilution of the initial samples and acidified 
distilled water (pH 2.5) was used to dilute the gastric samples to avoid multiple scattering 
effects.  
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5.4.2.6 Insulin activity assay with L6 myotubes and immunoblotting 
The activity of insulin was assayed by determining its ability to stimulate Akt 
phosphorylation in L6 myotubes. L6 cells were maintained in α-MEM with 10% fetal 
bovine serum, 100 µg/ml streptomycin, and 100 U/ml penicillin at 37 °C in a humidified 
5% CO2 atmosphere. Cells were differentiated into myotubes for 6 days as has been 
reported previously 324.  Prior to analysis the microgels were dissociated by mixing them 
with a calcium chelating agent (EDTA).  Filtered microgels were dissolved in 2 mL of 10% 
EDTA solution and then immediately diluted with α-minimum Eagle’s medium by 100 
times before treating myotubes for 10 minutes. Cells were lysed with RIPA buffer 
supplemented with phosphatase inhibitor and protease inhibitor cocktail. Protein 
concentrations were measured using a protein DC assay kit. Cell lysates containing 50 µg 
of protein were separated with 10 % SDS-polyacrylamide gel and transferred to 
Immobilin P membrane and incubated with primary antibodies overnight at 4 C and 
then secondary antibodies for 1 hour. Detections were performed with an enhanced 
chemi-luminescence detection kit.  The images acquired were quantified using the Image 
J software described earlier.    
5.4.2.7 Statistical analysis 
All experiments were performed on at least three freshly prepared samples, and the 
results reported as averages and standard deviations calculated using Excel (Microsoft, 
Redmond, VA, USA). 
5.4.3 Results and discussion 
5.4.3.1 Preparation and characterization of insulin-loaded microgels  
The ability of the biopolymer microgels to encapsulate insulin and then retain it 
within the stomach phase was determined using confocal fluorescence microscopy (Fig. 
5.27).  Prior to exposure to simulated gastric conditions, the insulin (stained green) was 
distributed evenly throughout the interior of the microgels indicating that it had been 
successfully encapsulated.  After exposure, the interior of the microgels was still stained 
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green, indicating that the insulin was retained within the microgels.  However, there was 
a significant decrease in the fluorescence intensity of the insulin after exposure to the 
stomach phase.  This effect can mainly be attributed to the fact that the intensity of the 
fluorescence probe used to stain the insulin (FITC) decreases under acidic conditions 321. 
It should be noted that the fluorescence measurements only indicate the location of the 
insulin within the system, rather than its biological activity, and so this was measured 
using another method (described later).   
 
   
(a)                                                                 (b) 
Figure 5. 27 Confocal microscopy images of antacid-loaded microgels (a) before and (b) 
after exposure to simulated gastric conditions. 
 
The confocal microscopy images indicated that the microgels had a roughly spherical 
shape, and remained intact after exposure to the simulated gastric conditions, which is in 
agreement with earlier studies 318-319. The light scattering measurements indicated that the 
microgels had a monomodal particle size distribution both before and after exposure (Fig. 
5.28).  In addition, they indicated that there was a slight shrinkage of the microgels after 
they were incubated in the gastric fluids, with the mean particle diameter decreasing from 
around 280 µm before exposure to 265 µm after exposure.  Microgel shrinkage under 
highly acidic conditions can be attributed to a decrease in the electrostatic repulsion 
between the alginate chains when the carboxyl groups become more protonated: −COO- 
+ H+ « −COOH, pKa = 3.5 319.  This phenomenon is advantageous for the retention of 
the insulin within the microgels in the stomach, since a cross-linked biopolymer network 
with smaller pores will trap the insulin molecules more effectively. 
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Figure 5. 28 The particle size distribution of antacid-loaded microgels before and after 
exposure to simulated gastric conditions. 
 
5.4.3.2 Mapping the pH inside the microgels  
As mentioned earlier, one of the main hurdles to the oral administration of insulin is 
its tendency to degrade in the stomach due to the high acidity and protease activity of the 
gastric fluids 307, 325. Protection against these effects is therefore an important strategy for 
the development of effective oral delivery systems for insulin 326-327.  We hypothesized 
that antacid-loaded microgels would protect insulin from both acid- and protease-
degradation by maintaining a neutral pH inside them.  Insulin is known to degrade under 
acidic conditions 325, and therefore keeping the local environment neutral should protect 
it from this type of degradation.  Moreover, the optimum activity of pepsin has been 
reported to be around pH 2 to 3 328, and it is known to be deactivated around pH 7 320.  
Consequently, maintaining a neutral environment inside the microgels may also protect 
the insulin from protease-induced degradation by reducing the local pepsin activity.  
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In this study, an insoluble antacid (Mg(OH)2) was co-encapsulated with the insulin to 
control the internal pH of the microgels under gastric conditions. The local pH inside the 
microgels was measured using a pH-sensitive fluorescence probe (FRD) based on a 
fluorescence intensity ratio method described earlier 321.  The FRD probe has both pH-
dependent (FITC) and pH-independent (TMR) fluorescence groups, and so the pH can be 
determined by measuring the FITC-to-TMR fluorescence intensity ratio.  In addition, the 
FRD probe selected for this study had a polymer chain (dextran) attached to inhibit its 
release from the biopolymers microgels.  
 
(a) 
 
(b) 
 
After
stomach
FITC TMR
Initial
Antacid-loaded microgels
FITC TMR
Antacid-free microgels
Initial
After
stomach
FITC TMR
  186 
Figure 5. 29 Fluorescent microscopy images of microgels (a) with or (b) without 0.15% 
Mg(OH)2 before and after exposure to simulated gastric conditions.  The intensity of the 
TMR signal was enhanced using Image J to improve contrast.  
 
Confocal fluorescence microscopy images of the FRD probe within the microgels 
was acquired before and after exposure to simulated gastric fluids (Fig. 5.29).  For the 
antacid-loaded microgels, the fluorescence intensity of the FITC channel (pH-dependent) 
was relatively strong both before and after incubation in the stomach phase.  Conversely, 
for the antacid-free microgels, the fluorescence intensity of the FITC channel changed 
from relatively strong before incubation to very weak after incubation.  The average 
internal pH value was determined to be around pH 7.4 for the antacid-loaded microgels 
after exposure to the simulated gastric fluids, but below the limit of detection (pH < 4) for 
the antacid-free microgels.  These results indicate that the co-encapsulated magnesium 
hydroxide was able to maintain a neutral pH inside the microgels, which is in agreement 
with our previous studies with lipase- and lactase-loaded alginate microgels 318-319.  This 
effect has been attributed to the ability of the Mg(OH)2 particles to partially dissolve 
when hydrogen ions diffuse into the microgels, thereby releasing OH- ions that neutralize 
the H+ ions and maintain a neutral pH.  
5.4.3.3 Influence of encapsulation on insulin activity 
 In this series of experiments, a biological model was used to test the activity of 
insulin after it had been exposed to simulated gastric conditions.  In its active form, 
insulin is known to stimulate Akt phosphorylation in L6 myotubes 324, and so this assay 
was used to determine the activity of free and encapsulated insulin.  Insulin was 
encapsulated in both antacid-free and antacid-loaded microgels to ascertain the impact of 
the antacid on its stability under gastric conditions.   
The Akt phosphorylation at both Thr308 and Ser473 was significantly higher for 
insulin encapsulated in the antacid-loaded microgels, than for free insulin or for insulin 
encapsulated in antacid-free microgels (Figs. 5.30 and 5.31). This result suggests that the 
microgels containing the antacid protected the insulin under gastric conditions, which can 
be attributed to its ability to maintain a neutral pH inside the microgels, thereby inhibiting 
both acid- and pepsin-induced degradation.  
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Figure 5. 30 Effects of diluted digestion solution with insulin (beads free, encapsulated 
in beads and encapsulated in microgels with antacid) on Akt phosphorylation in L6 
myotubes. (The diluted digestion solution was obtained by diluting orginal digestion 
solution by 100 times with DMEM medium. Protein expression levels were determined 
after treatment with or without diluted digestion solution (100 nM) for 15 min). 
 
A number of previous researchers have focused on the impact of encapsulation of 
insulin on its activity under gastric conditions.  Studies have shown that insulin can be 
encapsulated in biopolymer nanoparticles fabricated from alginate and dextran sulfate, 
and that its biological activity was retained after encapsulation 329.  However, the activity 
of the insulin in this study was only tested by injecting insulin-loaded nanoparticles 
subcutaneously into diabetic rats.  Hence, it is unclear whether the insulin would still 
remain active if insulin-loaded nanoparticles were orally administered to the rats.  Insulin 
has also been successfully loaded into poly(lactic-co-glycolic acid) nanoparticles, which 
were shown to protect it from gastric degradation, and to maintain its activity after oral 
administration to diabetic rats 330.  Alginate-chitosan microgels have also been shown to 
be effective at encapsulating insulin, protecting it from degradation under gastrointestinal 
conditions, and maintaining its activity after oral administration to diabetic rats 331.  Thus, 
various types of polymer-based microgels seem to have promise as oral delivery systems 
for insulin 332.  Each system has its own advantages and disadvantages in terms of the 
commercial viability of the ingredients and fabrication processes used to prepare them, 
and their functional attributes. 
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Figure 5. 31 The ratio of (a) pAkt/T308 and (b) pAkt/Akt S473, representing the 
phosphorylation of Akt, which is due to insulin stimulation in muscle cells. The higher 
ratio of beads + antacid group suggests that insulin was better protected under gastric 
conditions than the other groups.   
 
5.4.3.4 Release of insulin in a simulated small intestine phase   
Insulin that survives intact after passage through the stomach has to be absorbed by 
the epithelium cells after reaching the small intestine so that it can enter the systemic 
b
b
a
0.0 
0.5 
1.0 
1.5 
2.0 
Free insulin Microgels Microgels 
+Antacid
Fo
ld
in
cr
ea
se
(a) pAkt T308/Akt
b b
a
0.0 
0.5 
1.0 
1.5 
2.0 
2.5 
Free insulin Microgels Microgels 
+Antacid
Fo
ld
in
cr
ea
se
(b) pAkt S473/Akt
  189 
circulation.  It has been reported that free insulin can be absorbed by intestinal 
enterocytes through various internalization mechanisms 333-334.  It is therefore important 
to understand the release properties of the insulin from the microgels in the small 
intestine.   
In this section, we determined the release profile of insulin from the antacid-loaded 
microgels during incubation in simulated small intestinal fluids for two hours (Fig. 5.32). 
Around 21% of the insulin was released fairly rapidly during the first 30 minutes and 
then another 10% was released more gradually over the next 90 minutes.  Presumably, 
the remainder of the insulin would also be released gradually at longer incubation times, 
which may be useful for sustained release applications.  The release of insulin from the 
biopolymer microgels in the small intestine phase can be attributed to changes in the 
electrical properties of the alginate and insulin molecules, as well as alternations in the 
structure of the alginate microgels. The insulin and alginate molecules are both 
negatively charged in the small intestine phase (pH 7) and so they will electrostatically 
repel each other, which promotes insulin release 335.  Moreover, alginate microgels swell 
when they are moved from acidic to neutral conditions because of the increase in 
electrostatic repulsion between the anionic alginate chains 291.  This leads to an increase 
in hydrogel pore size, which can increase the release of any encapsulated substances 336.  
Overall, these results suggest that insulin could be successfully released from the 
microgels in the small intestine phase, which would facilitate their subsequent absorption.  
Nevertheless, it is also possible that the insulin would still be degraded in the small 
intestinal fluids prior to adsorption due to the presence of digestive enzymes, such as 
proteases.  In addition, it will be important to determine the fraction of insulin that is 
actually absorbed and enters the systemic circulation where it can have its beneficial 
effects. In future studies, it will therefore be important to test the efficacy of these 
antacid-loaded microgels using animal feeding studies, e.g., with diabetic rats.    
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Figure 5. 32 The release profile of insulin from antacid-loaded biopolymer microgels 
during incubation in a simulated small intestine phase. 
 
5.4.4 Conclusion 
 In this study, insulin was encapsulated within calcium alginate microgels using an 
injection-gelation method.  The stability of insulin after exposure to simulated gastric 
conditions was improved by co-encapsulating it with a basic antacid: Mg(OH)2. This 
antacid is insoluble under neutral conditions, but dissolves when hydrogen ions diffuse 
into the microgels, thereby ensuring that a neutral internal pH is maintained (as long as 
some antacid remains). Gastric pepsin is rapidly inactivated under neutral pH conditions, 
and so encapsulation of insulin in antacid-loaded microgels protects it from both acid- 
and protease-degradation. This study suggests that antacid-loaded microgels may be a 
suitable food-grade delivery system for acid and/or pepsin-sensitive bioactive proteins 
and peptides. However, in vivo animal and human studies are needed to confirm that 
these microgels can maintain their insulin activity under real life conditions.  In addition, 
0
10
20
30
40
0 20 40 60 80 100 120
Pr
ot
ei
n
re
le
as
e(
%
)
Incubation Time (min)
  191 
it will be important to establish that the microgels can be fabricated economically on a 
sufficiently large scale for commercial applications, and that they can be successfully 
incorporated into formulations intended for oral administration.   
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CHAPTER 6 
 
CONTROL THE DIGESTION AND RELEASE OF BIOACTIVE PROTEIN 
USING HYDROGEL BEADS 
6.1 Protein encapsulation in alginate hydrogel beads: Effect of pH on microgel 
stability, protein retention and protein release 
6.1.1 Introduction 
Colloidal delivery systems are finding increasing application for the encapsulation, 
protection, and release of bioactive agents in the pharmaceutical, supplement, and food 
industries 337-339.  Each type of bioactive agent has its own unique molecular and 
physicochemical properties, which means that delivery systems typically have to be 
specifically designed for each application.  Proteins and peptides are commonly used as 
bioactive agents because they exhibit a range of biological activities, including nutritional, 
antimicrobial, antioxidant, flavor, anti-hypertension, anti-diabetic, and anticancer 128, 130, 
227, 340.  Nevertheless, the incorporation of these bioactive proteins into food products is 
often challenging because of their sensitivity to chemical or biochemical degradation, 
their susceptibility to aggregation, and their potential for causing off-flavors (such as 
bitterness or astringency).  For this reason, there has been considerable interest in 
encapsulating proteins within polymer particles to protect and release them in different 
environments 341-344.  Studies have shown that proteins encapsulated within polymer 
matrices may be protected from unfolding and aggregation 345.  Moreover, these protein-
loaded polymer particles can be designed to carry bioactive proteins to specific locations 
within the gastrointestinal tract (GIT) and release them at a controlled rate or in response 
to a particular trigger 227.  Consequently, the functional attributes and biological activity 
of proteins can be enhanced by encapsulating them within microgels 291, 341. 
Many different approaches have been developed to fabricate hydrogel beads 
suitable for protein encapsulation, including extrusion, emulsion, molding, and phase 
separation methods 228, 346-348.  For certain applications, it is important that the fabrication 
method used does not promote unfolding or aggregation of the encapsulated proteins, as 
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this may lead to a loss of their functional attributes or biological activity. Hydrogel beads 
fabricated from biopolymers (proteins and/or polysaccharides) are particularly suitable 
for the encapsulation of bioactive proteins because they often involve mild preparation 
conditions that do not alter protein properties, and can be prepared using food-grade 
ingredients 227-229.  The extrusion-gelation method is one of the most commonly used and 
effective methods of producing hydrogel beads 291.  In this method, a biopolymer solution 
containing the bioactive protein is injected into another ‘‘hardening’’ solution that 
promotes biopolymer gelation. This procedure results in the formation of hydrogel beads 
with bioactive proteins trapped inside a biopolymer matrix.  
When designing a suitable hydrogel bead for this type of application it is important 
that it has good encapsulation, retention, and release properties 229, 270, 341. There are a 
number of potential strategies to control the retention and release properties of hydrogel 
beads 270.  First, the pore size of the hydrogel matrix can be controlled by manipulating 
the amount of biopolymer and cross-linking agent used: larger pores typically lead to 
faster release.  Second, the overall dimensions of the hydrogel beads can be controlled 
using different fabrication methods or preparation conditions: smaller beads typically 
lead to faster release.  Third, specific interactions between the bioactive agents and 
biopolymer molecules in the hydrogel matrix can be utilized, e.g., hydrophobic, hydrogen 
bonding, or electrostatic interactions.  Fourth, the hydrogel beads can be designed to 
dissociate upon exposure to specific environmental conditions, thereby releasing their 
payload.  Fifth, the hydrogel beads can be coated with layers of biopolymers or other 
materials to alter their permeability. The mechanism that is important for a particular 
delivery system depends on its composition and structure. 
In the current study, we investigated the utilization of alginate as a building block 
for creating protein-loaded hydrogel beads that could release encapsulated proteins in 
response to pH changes. Alginate is a naturally occurring anionic polymer isolated from 
brown algae that has the ability to form strong hydrogels 349. Protein-loaded alginate 
beads can be fabricated by extruding a solution of sodium alginate containing the 
bioactive protein into a divalent crosslinking solution, such as one containing Ca2+ ions 
291. Biopolymer gelation primarily occurs due to exchange of Na+ ions from carboxylic 
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acids on the sodium alginate molecules with Ca2+ ions from the crosslinking solution, 
which leads to the formation of cross-links with a characteristic “egg-box” structure 18-19, 
21.  The internal environment of alginate hydrogels has been shown to have little impact 
on the functional properties of many globular proteins 291.  In addition, proteins can be 
retained within alginate beads that have sufficiently small pore sizes and/or specific 
attractive interactions between the proteins and alginate molecules 76 However, the 
proteins can be released when the system conditions are changed to increase the pore size 
and/or reduce the attractive interactions.  
In the present study, whey protein was incorporated into hydrogel beads fabricated 
from calcium alginate using an automated extrusion device with a small vibrating nozzle.  
We hypothesized that the retention and release of the protein molecules would depend on 
their electrical characteristics because this would influence their interactions with the 
alginate molecules in the hydrogel matrix.  The solution pH was therefore altered relative 
to the isoelectric point (pI) of the whey proteins so as to obtain highly positive (pH 3), 
approximately neutral (pH 5) and highly negative (pH 7) proteins.  The influence of pH 
on the encapsulation, retention and release of the proteins was then measured.  The 
information obtained from this study may be useful for the rational design of more 
effective delivery systems for bioactive proteins in the food and other industries. 
6.1.2. Materials and methods 
6.1.2.1 Materials 
Whey protein isolate (WPI) was kindly provided by Davisco Foods International Inc. 
(Le Sueur MN). The company reported that the WPI contained 97.9 wt.% protein and 0.2 
wt.% fat. Alginic acid (sodium salt), calcium chloride dihydrate (CaCl2·H2O) and 
fluorescein isothiocynate (FITC) isomer I was purchased from the Sigma Chemical 
Company (St. Louis, MO). Double distilled water was used to make all solutions. 
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6.1.2.2 Methods 
6.1.2.2.1. ζ-potential measurements 
ζ-potential versus pH profiles of WPI and alginate solutions was measured using a 
commercial micro-electrophoresis instrument (Zetasizer Nano ZA series, Malvern 
Instruments Ltd. Worcestershire, UK). Samples were diluted using 10 mM phosphate 
buffer (at the same pH as the sample) prior to analysis to keep the instrument attenuation 
value between 5 and 10.  
6.1.2.2.2. Turbidity measurements 
Turbidity versus pH profiles of WPI or WPI-alginate solutions was determined 
using a UV–visible spectrophotometer at 600 nm (Ultrospec 3000 pro, Biochrom Ltd., 
Cambridge, UK). The samples were contained within 1 cm path length optical cells, and 
phosphate buffer (PBS) was used as a control. Turbidity measurements were carried out 
on at least two freshly prepared samples. 
6.1.2.2.3 Encapsulation of WPI in alginate beads 
An aqueous alginate (2% w/v) solution was prepared by dissolving the powdered 
ingredient in distilled water, stirring at 60 ºC for an hour, and then reducing the 
temperature to 35 ºC. The WPI (2% w/v) and alginate (2% w/v) solutions were then 
mixed together (1:1 v/v) for 1 h with continuous stirring to form a uniform solution. And 
then the mixture solution was adjusted to different pH (3. 5 and 7) for the different 
hydrogel beads formation. WPI-loaded hydrogel beads were prepared using a commercial 
encapsulation unit (Encapsulator B-390, BUCHI, Switzerland) to inject the different 
WPI/alginate solutions into 10% corresponding pH calcium chloride solution with 
continuous stirring. The hydrogel beads were allowed to crosslink with Ca2+ for 1 h at 
ambient temperature. The hardened beads were then collected by filtration and 
subsequently washed with distilled water and buffer solution to remove any excess Ca2+ 
from their surfaces.  
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6.1.2.2.4 Particle size measurements 
The mean particle diameter and particle size distribution of biopolymer mixtures 
(WPI and alginate) and hydrogel beads formed at different pH values (3, 5 and 7) were 
determined using static light scattering (Mastersizer 2000, Malvern Instruments, 
Worcestershire, United Kingdom). This instrument infers the size of the particles from 
measurements of their angular scattering pattern. Samples were diluted in 10 mM PBS 
buffer (pH 3, 5 and 7) by adding small aliquots into a measurement chamber.  
6.1.2.2.5 Encapsulation efficiency and protein release 
The ability of hydrogel beads formed at different pH values (pH 3, 5, and 7) to retain 
the protein was determined by immersing them within the corresponding phosphate 
buffer solutions (pH 3, 5 and 7) at room temperature.  The concentration of protein in the 
surrounding aqueous phase was then measured at various time intervals by recording the 
absorbance at 280 nm using the UV-visible spectrophotometer.  The encapsulation 
efficiency (%) was determined by dividing the amount of protein remaining in the beads 
by the initial protein in the beads.  The amount of protein in the beads was taken to be he 
difference between the initial protein and that released into the phosphate buffer.  In some 
cases, the amount of protein released was determined for protein-loaded hydrogel beads 
formed at pH 3, and then incubated in solutions at higher pH values for 10 min. 
6.1.2.2.6 Microstructure analysis 
The microstructure of hydrogel beads formed at different pH values (pH 3, 5 and 7) 
was recorded, as well as the impact of pH on protein release from alginate-based beads. 
The microstructure of the protein-loaded alginate beads was examined using confocal 
scanning laser microscopy with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon, 
Melville, NY, U.S.). The proteins were dyed prior to hydrogel bead formed by adding 0.1 
mL of FITC dye solution (1 mg FITC /mL dimethyl sulfoxide) to 2 mL of sample and 
then storing at 5 °C overnight. The excitation and emission wavelength used for FITC 
were 488 nm and 515 nm, respectively. Specially, a relatively high gain value was 
adjusted in the hydrogel beads (formed at different pH values) detection to facilitate the 
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observation of encapsulated protein. The microstructure images for confocal microscopy 
were analyzed using image analysis software (NIS-Elements, Nikon, Melville, NY).  
6.1.2.3 Statistical analysis  
All experiments were carried out in triplicate using freshly prepared samples. Means 
and standard deviations were calculated from a minimum of three measurements using 
Excel (Microsoft, Redmond, VA, USA). 
6.1.3 Results and discussion 
6.1.3.1 Electrical characteristics of biopolymer molecules 
An encapsulated protein can electrically interact with the charged biopolymer 
molecules used to fabricate the hydrogel beads and thereby influence its encapsulation, 
retention, and release properties.  For this reason, the pH dependence of the ζ-potential of 
WPI and alginate solutions was determined using an electrophoresis method.  The ζ-
potential of the WPI solution went from negative at pH 7.0 (≈ -26 mV) to positive at pH 
2.0 (≈ +23 mV), with a point of zero charge around pH 4.7 (Fig. 6.1), which can be 
attributed to changes in the protonation of acid (-COOH) and basic (-NH2) groups on the 
protein molecules with pH.  The ζ-potential of the alginate solution remained negative 
across the whole pH range studied (from pH 2 to 7), changing from strongly negative (≈ -
68 mV) at pH 7 to slightly negative (≈ -10 mV) at pH 2.  The magnitude of the negative 
charge on the alginate molecules was lower under acidic conditions than neutral 
conditions due to partial protonation of the carboxylic acid groups on the mannuronic and 
guluronic acid groups: -COO- Þ -COOH (pK ≈ 3.5) 349.  The pH dependence of the ζ-
potential of mixed WPI-alginate solutions was also measured by electrophoresis to obtain 
information about the interactions between the two biopolymers (Fig. 6.1).  At relatively 
high pH values (pH > 5.5), the ζ-potential of the mixed system was between that of the 
two individual biopolymers, which suggests that both biopolymers contributed to the 
overall ζ-potential.  At lower pH values, the ζ-potential of the mixed system tended 
towards that of the alginate molecules, which suggests that an electrostatic complex was 
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formed between the two biopolymers whose charge characteristics were dominated by 
the presence of the anionic alginate molecules.    
 
Figure 6. 1 Dependence of the ζ-potential on pH for 0.1 wt% WPI solution, 0.1 wt% 
sodium alginate solution, and 0.1% WPI + 0.1 wt% sodium alginate solution (10 mM 
phosphate buffer). 
 
Based on the electrical characteristics of the two individual biopolymers (Fig.6.1), it 
would be expected that alginate and whey protein should be attracted to each other at 
low-to-intermediate pH (pH < 4.7) where they have opposite charges, but repel each 
other at high pH (pH > 4.7) where they have similar charges (negative charge).  However, 
the ζ-potential and turbidity measurements on the mixed systems suggest that the two 
biopolymers become associated at higher pH values (pH 5.5) even though they have 
similar charges (Figs. 6.1 and 6.2), which can be attributed to the binding of anionic 
groups on the alginate molecules to cationic patches on the surfaces of the protein 
molecules 191. Based on these measurements, we anticipate that whey proteins would be 
retained by the beads at relatively low pH values due to electrostatic attraction, but be 
released at high pH values due to electrostatic repulsion.   
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Figure 6. 2 Turbidity (at 600 nm) as a function of pH for aqueous solutions containing 
either 0.1% WPI and 0.1% sodium alginate or 0.1% WPI only. 
6.1.3.2 Turbidity characterization of mixed biopolymer systems 
The formation of electrostatic complexes in biopolymer solutions can simply be 
monitored using turbidity measurements 194. In this section, the turbidity versus pH 
profiles of the alginate solution, WPI solution, and WPI-alginate mixture were measured 
as a function of pH using a spectrophotometric method.  The alginate solution had a very 
low turbidity at all pH values (data not shown), indicating that the alginate molecules did 
not aggregate.  As expected, there was a large increase in the turbidity of the WPI 
solution around the protein’s isoelectric point (pI ≈ 4.5) due to protein aggregation 
associated with the low electrostatic repulsion between the whey protein molecules (Fig. 
6.2). For the alginate-WPI mixtures, the solution turbidity was relatively low at high pH 
(5 < pH < 7) due to the high solubility of the individual protein and alginate molecules, 
and the fact that there would be a strong electrostatic repulsion between the two types of 
biopolymer in this pH range. When the pH was reduced further, there was a gradual 
increase in turbidity from pH 5 to 3, followed by a steep increase from pH 3 to a 
maximum value at pH 2.  This result suggests that electrostatic complexes large enough 
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to scatter light strongly were formed at pH values below about 4.  As mentioned earlier, 
small electrostatic complexes may also be formed under conditions (pH 4.0 to 5.5) where 
both the WPI and alginate molecules have net negative charges due to electrostatic 
attraction between anionic groups on the polysaccharide and cationic patches on the 
protein surfaces 166, 191, 350.  As reported in these studies, the presence of an anionic 
polysaccharide can suppress the aggregation of globular proteins that normally occurs 
around their isoelectric point.  This effect can be attributed to the fact that the protein and 
polysaccharide molecules form an electrostatic complex, and there is a relatively strong 
electrostatic and steric repulsion between the complexes.  In summary, these results have 
highlighted the fact that the alginate and whey protein molecules should bind strongly to 
each other at relatively low pH values due to electrostatic attraction. 
6.1.3.3 Particle size characterization of polymer mixtures at different pH  
Three different pH values were selected for further study based on the expected 
differences in the electrostatic interactions between the whey protein and alginate 
molecules: electrostatic repulsion at pH 7; soluble complex formation at pH 5; and, 
insoluble complex formation at pH 3. The particle size distributions of biopolymer 
mixtures containing alginate and WPI at a ratio of 1:1 (w/w) were measured at different 
pH values (Fig. 6.3).  At pH 7, the biopolymer mixtures appeared optically transparent, 
which suggested that they did not contain particles large enough to scatter light 
appreciably, consequently reliable light scattering measurements could not be made.  At 
pH 5, the particle size distribution of the biopolymer mixtures was bimodal, suggesting 
there was a wide range of different-sized colloidal particles present. These particles were 
presumably held together by a weak electrostatic attraction between the whey protein and 
alginate molecules.  Visually, these samples had a turbid appearance, which again 
indicated the formation of relatively large complexes in these samples.  At pH 3, there 
was a monomodal distribution of relatively large particles present (d » 500 µm), which 
formed due to the strong electrostatic attraction between the cationic whey protein and 
anionic alginate molecules.  The colloidal dispersions formed in the mixed systems at pH 
3 had a higher lightness (white color) than those formed at pH 5, which suggests that the 
former particles scattered light more strongly.  This may have occurred because the 
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biopolymer molecules were packed more tightly together in the complexes at the lower 
pH value 191, which led to a higher refractive index contrast.  
6.1.3.4 Hydrogel beads formed at different pH  
Relatively large alginate beads (d > 1 mm) are typically formed using the most 
commonly used extrusion method, which involves simply injecting an alginate solution 
into a calcium bath using a syringe or pipette 252, 351-352.  This bead size is too large for 
many commercial applications since it adversely impacts the physicochemical or sensory 
properties of the products they are incorporated into.  In this study, we therefore 
fabricated relatively small alginate beads (d < 500 µm) using a specially designed 
extrusion device (Encapsulator) that uses a vibrating 120-µm nozzle and a syringe pump.  
These smaller beads may have several advantages over larger ones in terms of their 
impact on product appearance, rheology, mouthfeel and stability. On the other hand, 
smaller beads may have lower retention and higher release rates than large ones because 
of the reduced diffusion path of the encapsulated agents through the hydrogel matrix 76. It 
is therefore important to design alginate beads so that they satisfy the different 
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physicochemical requirements for each application. 
 
Figure 6. 3 Particle size distribution and appearance of biopolymer mixtures containing 
alginate and WPI (1:1 w/w) at pH 3 and 5.  The solutions were transparent at pH 7, and 
therefore reliable particle size measurements could not be made. 
 
The influence of fabrication pH on the properties of alginate beads was investigated 
by injecting WPI-alginate mixtures into Ca2+ solutions at pH 3, 5, and 7.  As mentioned 
earlier, these three pH values were selected because they led to different electrostatic 
interactions between the protein and alginate molecules.  The light scattering 
measurements indicated that the particle size distribution and mean diameter of the 
hydrogel beads was influenced by the fabrication pH: d43 = 288, 471, and 516 µm at pH 7, 
5 and 3, respectively (Fig. 6.4).  There are a number of factors that may contribute to the 
influence of pH on bead dimensions.  First, the negative charge on the alginate molecules 
decreases with decreasing pH (Fig. 6.1), which may reduce the number of anionic groups 
on the alginate molecules that are available for cross-linking with calcium ions.  Second, 
the charge on the protein molecules varied from negative to positive with decreasing pH 
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(Fig. 6.1), which will have altered any interactions between the protein and alginate 
molecules.  Again, these interactions may also have interfered with the ability of the 
calcium ions to cross-link the alginate molecules.  As a result of these effects, the kinetics 
of alginate gelation, as well as the nature of the gel network formed, may have been 
changed, which altered the dimensions of the beads formed. 
 
Figure 6. 4 Particle size distribution and appearance images of hydrogel beads formed at 
different pH (pH 3, 5 and 7). 
 
The appearance of the suspensions of hydrogel beads changed from translucent to a 
whitish color when the fabrication pH was reduced from 7 to 3 (Fig. 6.4). In addition, 
there appeared to be some visible clumping of the particles at lower pH values.  This 
result suggests that there may have been some aggregation of the protein-loaded alginate 
beads, which may have been due to a reduction in the electrostatic repulsion between the 
beads at lower pH values.  
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The protein encapsulation efficiency of the alginate beads depended on the pH used 
to fabricate them: pH 7 (11.6%) < pH 5 (19.1%) < pH 3 (58.6%) (Fig. 6.5). In addition, 
the confocal fluorescence microscopy images of the hydrogel beads indicated that the 
protein concentration (fluorescence intensity) within them was higher at the lowest 
fabrication pH (Fig. 6.5). This trend is related to the strength of the electrostatic 
interactions between the protein and alginate molecules. At pH 5 and 7, there will be a 
strong electrostatic repulsion between the anionic protein and anionic alginate molecules 
(Fig. 6.1), and therefore the protein molecules may not have been effectively trapped 
within the alginate beads during their formation.  As mentioned earlier, at pH 5 alginate 
and protein molecules may bind together due to the attraction of anionic groups on the 
alginate molecules to cationic patches on the protein surfaces (even though both have a 
net negative charge).  However, the attractive alginate-protein interactions may have been 
much weaker than the alginate-calcium interactions, and so the protein was released 
when the alginate solution was titrated into the calcium solution.  At pH 3, there will have 
been a strong electrostatic attraction between the cationic protein and anionic alginate 
molecules (Fig. 6.1), and therefore the two biopolymers may be held together more 
strongly during the cross-linking process.  Consequently, the protein molecules are 
retained within the alginate beads during their fabrication at low pH values.  It should 
also be noted that the pores within the alginate beads must have been sufficiently large to 
allow the protein molecules to diffuse through them 291. It is interesting to note that the 
particle size of beads observed from these confocal images was slightly inconsistent with 
the results of light scattering measurements (Fig.6.4). It may be because the beads 
fabricated in this study were not uniform sphere, and then the size characterization 
observed by the confocal microscope could be influenced by the viewing angle. 
Moreover, all the beads formed at different pH conditions showed the broad particle size 
distributions. The confocal images of these beads were taken by random, which cannot 
guarantee the obtaining of images of beads with the representative characterization (e.g., 
a mean diameter).  
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Figure 6. 5 Confocal images and protein encapsulation efficiency of hydrogel beads 
formed at different pH (pH 3, 5 and 7). The WPI (green) was stained with FITC. 
6.1.3.5 Protein release during storage 
In this section, the rate of protein release from the alginate beads formed at different 
fabrication pH values was compared.  At pH 5 and 7, there was a relatively rapid release 
of protein during the first 30 min of storage, followed by a more gradual release at longer 
storage times (Fig. 6.6). On the other hand, at pH 3, the release of protein occurred 
relatively slowly throughout the 6-hour storage period. The final amount of protein 
released at the end of the incubation period depended strongly on pH: pH 3 (24%) < pH 5 
(78.9%) < pH 7 (95.3%).  As discussed in the previous section, this effect can be 
attributed to differences in the electrostatic interactions of the alginate and protein 
molecules at different pH values.  At pH 3, the protein and alginate have opposite charges 
and are strongly attracted to each other, and so the protein is better retained within the 
hydrogel beads.  Conversely, at pH 5 and 7 the protein and alginate have similar charges 
and therefore tend to electrostatically repel each other, so the protein tends to leach out of 
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the hydrogel beads. A similar effect has also been observed with electrically charged 
drugs trapped within alginate beads.  For example, it has been reported that a cationic 
drug (chlorpheniramine maleate) showed a much slower release rate from alginate gels 
than an anionic drug (sodium salicylate) 353-354.  
 
Figure 6. 6 Leakage of WPI from hydrogel beads formed at different pH as a function of 
incubation time. The beads were immersed into the according PBS buffer (pH 3, 5 and 7) 
at room temperature.  
 
The pH dependence of the protein release rate may also depend on changes in the 
structure of the alginate beads under different solution conditions. It was reported that 
calcium alginate beads tend to shrink at low pH due to the loss of negative charge on the 
alginate molecules when the carboxyl groups become protonated (–COOH, pKa ≈ 3.5) 76. 
Conversely, they tend to swell when placed in higher pH solutions due to the fact that the 
alginate molecules become highly charged and repel each other 270.  Thus, the faster 
release of the protein molecules at pH 5 and 7 may have been partly due to the fact that 
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the hydrogel network had larger pores at these higher pH values. Nevertheless, further 
work is required to measure the pore size of the alginate beads to confirm the importance 
of this mechanism, e.g., using electron microscopy or size exclusion methods 291.  
6.1.3.6 pH-triggered protein release from hydrogel beads 
The change in the electrical properties of the alginate and protein molecules with pH 
means that protein-loaded alginate beads may be designed to release the proteins in 
response to a pH trigger 270.  In this section, protein-loaded alginate beads were initially 
fabricated at pH 3 since they had a high loading capacity and good retention properties 
(Sections 3.4 and 4.5).  The protein release from these hydrogel beads was then measured 
after they were stored at different pH values for 10 min. The storage pH of the beads had 
a pronounced impact on the amount of protein released, with the amount released 
increasing with increasing pH (Fig. 6.7b).  For example, around 11% protein was 
released from the hydrogel beads after incubation at pH 3.5, whereas around 90% protein 
was released when they were incubated at pH 7.  These results were confirmed by 
confocal fluorescence microscopy images of the hydrogel beads, which showed that the 
fluorescence intensity (protein) of the hydrogel beads decreased with increasing pH (Fig. 
6.7a), which suggests that some of the whey protein molecules had diffused out of the 
hydrogel beads at higher pH values.  These results suggest that protein-loaded alginate 
beads could be fabricated at relatively low pH values (pH 3) to effectively retain the 
protein, and then the protein could be released by increasing the pH of the hydrogel beads 
environment. This type of pH-triggered hydrogel bead may be a useful tool for protection 
of proteins in the acidic environment of the stomach, and then releasing them in the 
neutral environment of the small intestine. If required, the initial hydrogel beads could be 
coated with extra layers of biopolymers (e.g., chitosan or polylysine) using an 
electrostatic deposition approach to modulate their functional properties, such as stability, 
integrity, and permeability 291. 
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(a) 
 
(b) 
Figure 6. 7 Protein release characterization from the hydrogel beads by changing pH 
from the initial condition (pH 3): (a) confocal images of hydrogel beads at initial and 
final pH. (b) WPI release fraction (%) after changing pH condition.   
6.1.4 Conclusions 
The effect of pH on the encapsulation, retention and release of whey proteins from 
alginate-based hydrogel beads was studied. Different pH values (pH 3, 5 and 7) were 
chosen to fabricate the hydrogel beads based on differences in the nature of the 
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electrostatic interactions (attraction or repulsion) between the alginate and protein 
molecules. Protein-loaded hydrogel beads were successfully prepared using an 
encapsulation unit with a small vibrating nozzle to inject the whey protein/alginate 
mixture into a Ca2+ solution. The protein encapsulation efficiency and retention of the 
beads increased with decreasing fabrication pH (pH 7 < pH 5 < pH 3), which was 
attributed to the fact that there was a strong electrostatic attraction between the cationic 
protein and anionic alginate molecules at pH 3. Consequently, the protein molecules were 
held in the alginate beads more strongly. The hydrogel beads prepared in this study could 
be designed to release the protein molecules in response to a pH trigger.  The amount of 
protein released increased as the pH of the surrounding solution was increased from pH 3 
to pH 7, which was again attributed mainly to a weakening of the electrostatic attraction 
between the encapsulated protein molecules and the alginate hydrogel with increasing pH.  
These results have important implications for designing hydrogel beads to encapsulate, 
retain, and release of proteins in food products and within the gastrointestinal tract. 
 
 
 
 
 
 
 
 
 
 
  210 
6.2 Fabrication of microgels to encapsulate the protein and control its digestion 
properties in GIT 
6.2.1 Introduction 
Proteins play a number of important roles as nutritional components within the 
human diet. They are a source of essential amino acids and bioactive peptides, provide 
energy, are potential allergens, and regulate hormonal responses, such as hunger, satiety 
and satiation 128, 133, 355-358.  The rate, extent, and location of protein hydrolysis within the 
human gastrointestinal tract (GIT) impacts many of these attributes.  Protein hydrolysis is 
typically carried out by digestive enzymes within the stomach and small intestine 133, 359.  
In humans, protein digestion begins in the stomach due to the presence of gastric pepsins 
that are activated under acidic conditions 360. These enzymes breakdown peptide bonds 
within the protein molecule, which results in the formation of a mixture of polypeptides, 
oligopeptides, and amino acids.  After leaving the stomach, any remaining proteins or 
peptides are further hydrolyzed by pancreatic enzymes (such as trypsin, chymotryosin, 
elastase and carboxypeptidases A and B) activated in the duodenum 361. Eventually, the 
amino acids and small peptides resulting from protein digestion are absorbed by the 
epithelium cells and enter the systemic circulation.  Protein digestion products impact 
various human functions regulated by hormones, including gastrointestinal motility, 
gastric emptying time, secretion of acid and pepsinogen, and total protein and energy 
intake 362-363. It may therefore be possible to modulate these hormonal responses by 
controlling the rate and extent of protein digestion within the GIT.  
Structural design of food matrices has been proposed as a method of controlling the 
digestion and release of macronutrients within the GIT, and therefore as a means to 
modulate their physiological effects 363-364. In the current study, we examined the impact 
of encapsulating proteins inside biopolymer microgels on their gastrointestinal fate using 
an in vitro digestion model.  Our previous studies showed that encapsulation of lipids 
inside biopolymer microgels retarded the rate and extent of lipid digestion under 
simulated GIT conditions, which was attributed to the ability of the biopolymer network 
to restrict interactions between the digestive enzymes and their substrates 76, 365.  
Biopolymer microgels are normally fabricated from food-grade proteins and/or 
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polysaccharides 270, 366. The substance to be encapsulated is typically mixed with a 
biopolymer solution, which is then gelled by adding an appropriate cross-linking agent 
(such as an ion, acid, base or enzyme) or by changing environmental conditions (such as 
temperature or pressure) 229, 270. Numerous approaches can potentially be used to fabricate 
protein-loaded microgels, including injection, templating, and phase separation methods 
367-368. The injection-gelation method is one of the most commonly used approaches for 
encapsulating bioactive substances in biopolymer microgels because of its relative 
simplicity and low cost. In this approach, an aqueous solution containing the bioactive 
agent and a gelling biopolymer is injected into a ‘‘hardening’’ solution to promote 
particle formation and biopolymer cross-linking. This procedure results in the formation 
of biopolymer microgels with the bioactive agent trapped inside. The GIT fate of the 
bioactive agent can be modulated by changing the composition, dimensions, or pore size 
of the microgels 270.  
In this study, we examined the possibility of control the digestion of proteins under 
simulated GIT conditions by encapsulating them inside biopolymer microgels fabricated 
from calcium alginate.   Our previous studies have shown that native proteins can easily 
escape from biopolymer microgels under conditions where there is not a strong attraction 
between the biopolymer network and protein molecules, i.e., at pH values above the 
isoelectric point of the protein 269.  This phenomenon was mainly attributed to the fact 
that the pore size of the microgels is appreciably greater than the dimensions of the native 
protein molecules.  Consequently, the protein molecules can easily diffuse out of the 
microgels when there is no electrostatic attraction between them and the biopolymer 
network. For this reason, we examined the impact of using a thermal treatment to 
promote protein denaturation and aggregation inside the microgels on protein 
encapsulation and retention. The resulting protein-loaded microgels were passed through 
a simulated GIT that included mouth, stomach, and small intestinal phases. An in vitro 
pH-stat method was used to determine the degree of protein hydrolysis in the simulated 
stomach and small intestine phases. We hypothesized that the encapsulation of denatured 
protein inside the microgels would retard its digestion and release under simulated GIT 
conditions. The present work for the first time combined the alginate and WPI cross-
linking through the calcium ions within one delivery system and then evaluated the 
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digestion fate of protein in this novel system. The information obtained in this study may 
be useful for the development of functional foods to regulate gastrointestinal responses, 
such as hunger, satiety, and satiation. 
6.2.2 Materials and Methods 
6.2.2.1 Materials  
Whey protein isolate (WPI) was kindly provided by Davisco Foods International 
Inc. (Le Sueur MN). The following chemicals were purchased from the Sigma Chemical 
Company (St. Louis, MO): alginic acid (sodium salt); pepsin from porcine gastric mucosa; 
fluorescein isothiocynate (FITC) isomer I; calcium chloride dehydrate; porcine trypsin 
and bovine α-chymotrypsin. All chemicals used were analytical grade. Double distilled 
water was used to prepare all solutions.  All concentrations are expressed as weight 
percentages (% w/w), unless otherwise stated. 
6.2.2.2 Heated protein preparation 
Protein solutions (10% WPI) were prepared by dissolving powdered whey protein 
isolate into phosphate buffer solution at pH 7 with continual stirring. In some cases, the 
dissolved protein solutions were heated at 80 °C for 15 min in a water-bath, then rapidly 
transferred to an ice-water bath for 10 min, and then stored at room temperature for 24 h.  
6.2.2.3 Protein-loaded microgel preparation 
For the heated WPI-loaded microgels, an aqueous alginate solution was first 
prepared by dissolving powdered sodium alginate (1.6%) in phosphate buffer with 
continual stirring until complete dissolution. The heated WPI and alginate solutions were 
then mixed together (1:1, v/v) for 1 h with continual stirring to form a uniform solution. 
The resulting mixture was then injected into a 10% calcium chloride solution using a 
commercial encapsulation unit with a 120 mm vibrating nozzle (Encapsulator B-390, 
BUCHI, Switzerland). The microgels formed by this process were then kept in the 
calcium chloride solution for 1 h at ambient temperature to promote cross-linking of the 
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alginate molecules. For digestion experiments, the calcium alginate beads were collected 
by filtration and then washed with phosphate buffer and distilled water to remove any 
excess ions from their surfaces. After determining the total weight of the dry beads, they 
were stored in a refrigerator for further measurements. 
Two control samples were also fabricated to determine the impact of protein state on 
protein encapsulation and retention: native WPI-loaded microgels and heated native WPI-
loaded microgels. The native WPI-loaded microgels were fabricated by encapsulation of 
unheated whey protein inside the microgels using the same procedure as described above. 
The heated native WPI-loaded microgels were prepared by firstly fabricating the native 
WPI-loaded microgels, and then heating them at 80 °C for 15 min in a water-bath.  The 
resulting microgels were then cooled using an ice-water bath for 10 min, and then stored 
at room temperature for 24 h. 
6.2.2.4 Gastrointestinal tract model  
For the simulated GIT studies, four samples were prepared using the procedures 
described in the previous sections: native WPI; heated WPI; heated WPI-loaded beads; 
and, heated WPI with beads. The heated WPI with microgels samples were prepared by 
mixing a heated WPI solution with un-loaded microgels. All the samples were then 
diluted with buffer solution (5 mM phosphate buffer, pH 7) to obtain the same initial 
protein amount (0.375g). The diluted samples were then passed through a static GIT 
model that simulated the mouth, stomach, and small intestine phases.  
Initial system. 7.5 g of the initial samples were preheated in an incubator shaker at a 
rotation speed of 100 rpm at 37 °C for 15 min (Innova Incubator Shaker, Model 4080, 
New Brunswick Scientc, Edison, NJ).  
Mouth phase. 7.5 g of simulated saliva fluid (SSF) was preheated to 37 °C and then 
mixed with the initial samples with continual stirring. After being adjusted to pH 6.8, the 
mixture was incubated in an incubator shaker (37 °C) for 2 min to mimic agitation in the 
mouth.  
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Stomach phase. The potential gastric fate of the samples was monitored using a 
simulated stomach model based on previously reported standardized in vitro methods 253, 
369-370, with some small modifications. Specifically, 15 g of sample solution resulting 
from the mouth phase was placed into a water bath at 37 °C and then adjusted to pH 3.0. 
15 g of simulated gastric fluid (containing 0.0032 g/mL pepsin (≥ 250U/mg), preheated 
to 37 °C, at pH 3.0) was then added to the reaction vessel with constant stirring. An 
automatic titration unit (Metrohm, USA Inc.) was used to monitor the pH and maintain it 
at pH 3.0 by titrating 0.05 N HCl solution into the reaction vessel for 2 hours at 37 °C. 
The volume of acid added to the stomach phase was recorded over time and used to 
calculate the degree of hydrolysis (DH) of the proteins using the following equation 371 (1, 
2): 
DH = [(VA × NA)/MP] × (1/P) × FPH × 100%    (1) 
 
Here: VA is the volume of acid (HCl) solution (mL) titrated into the reaction vessel, NA is 
the normality of the acid (0.05 N), MP is the mass of the protein (0.375 g), P is the total 
number of peptide bonds (8.75 mol/g for WPI) and FPH is a correction factor (1.8) that 
takes into account that the peptides are only partially ionized at pH 3.0. 
Small intestinal phase. Samples from the stomach phase were adjusted to pH 7.00 
and then 1.5 mL of simulated intestinal fluid and 3.5 mL of bile salts (bile extract, 
porcine) solution was added to the reaction vessel with constant stirring. The resulting 
mixture was then adjusted back to pH 7.00 if required. 2 mL of 1.25 mg/mL trypsin 
(1000-2000U/mg) and 2 mL of 5 mg/mL α-chymotrypsin (≥ 40U/mg) were added to the 
reaction vessel. The quantity of enzymes used in this step based on previously published 
values 371-372. The pH was maintained at 7.0 by titrating 0.1 N NaOH solution into the 
reaction vessel for 2 hours at 37 °C. The volume of alkali solution added to the small 
intestine phase was recorded over time and used to calculate the degree of protein 
hydrolysis using the following equation : 
DH = [(VB × NB)/MP] × (1/P) × FPH × 100%    (2) 
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Where: VB is the volume of base (NaOH) solution (mL) titrated into the reaction vessel, 
NB is the normality of the base solution (0.1 N), (1/α = 3.03 at pH 7 at 37°C), MP is the 
mass of the protein [0.375g×(1-DHstomach%)], P is the total number of peptide bonds (8.75 
mol/g for WPI), and FPH is a correction factor (3.03) that takes into account that the 
peptides are only partially ionized at pH 7.0 371. 
6.2.2.5 Particle charge 
The electrical characteristics (ζ-potential) of the samples were measured using an 
electrophoresis instrument (Zetasizer Nano ZA series, Malvern Instruments Ltd. 
Worcestershire, UK). Samples were diluted with appropriate pH-adjusted solutions prior 
to measurements to avoid multiple scattering effects. Phosphate buffer (5 mM, pH 7.0) 
was used to dilute the initial, mouth, and small intestine samples while acidified water 
(pH 3) was used for the dilution of stomach samples.  
6.2.2.6 Particle size characterization 
Particle size distributions of the samples were determined using static light 
scattering (Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, UK). 
Again, phosphate buffer (5 mM, pH 7.0) was used for the dilution of the initial, mouth 
and small intestine samples and acidified water (pH 3) was used to dilute the stomach 
samples to avoid multiple scattering effects. The average particle sizes are reported as the 
surface-weighted mean diameter (d43).  
6.2.2.7 Microstructure analysis 
The microstructure of samples was analyzed using confocal scanning fluorescence 
laser microscopy with a 20 × objective lens (Nikon D-Eclipse C1 80i, Nikon, Melville, 
NY, U.S.). The proteins were dyed by adding 0.1 mL of FITC dye solution (1 mg 
FITC/mL dimethyl sulfoxide) to 2 mL of sample and then storing at 5 °C overnight. The 
excitation and emission wavelength used for FITC were 488 nm and 515 nm, respectively. 
The resulting confocal microstructure images were analyzed using image analysis 
software (NIS-Elements, Nikon, Melville, NY).  
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6.2.2.8 Statistical analysis 
All experiments were performed on at least three freshly prepared samples. The 
results are reported as averages and standard deviations. These analyses were carried out 
using Excel (Microsoft, Redmond, VA, USA). 
6.2.3 Results and discussion 
6.2.3.1 Protein-loaded bead preparation and characterization 
Three types of whey protein-loaded microgels were fabricated so as to determine 
the impact of protein state (native versus denatured) and time of denaturation (before or 
after protein loading) on microgel formation and protein retention.  The three systems 
studied were: (i) native protein microgels (N-MGs); (ii) post-loading denatured protein 
microgels (post-D-MGs); and, (iii) pre-loading denatured protein microgels (pre-D-MGs). 
For system (ii), native whey proteins were first encapsulated inside microgels, and then 
the microgels were heated to denature the proteins.  For system (iii), a solution of whey 
proteins was first heated to denature the proteins, and then the denatured proteins were 
encapsulated inside the microgels.   
The visual appearance and confocal fluorescence images of these samples are 
shown in Figure 6.8. The microscopy images of the N-MGs showed that the proteins 
(stained green) were uniformly distributed throughout the continuous phase surrounding 
the microgels, rather than being located within the microgels (Fig. 6.8a). This result can 
be attributed to the low encapsulation efficiency of the native whey proteins in the 
microgels. Our previous studies have also shown that native proteins leaked out of 
alginate microgels when they are incubated in neutral buffer solutions 266, 269. The reason 
for this phenomenon can be attributed to the relatively large pore size of the biopolymer 
network inside the microgels (tens to hundreds of nanometers) compared to the 
dimensions of the protein molecules (a few nanometers). In addition, the protein 
molecules and biopolymer network (alginate) are both negatively charged at neutral pH 
and so they tend to electrostatically repel each other. Fairly similar results were observed 
for the systems in which the proteins were denatured after they had been loaded into the 
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microgels, i.e., post-D-MGs (Fig. 6.8b). Again, most of the proteins (stained green) were 
present in the continuous phase surrounding the microgels, rather than trapped inside 
them. There may have been a number of reasons for this phenomenon.  First, the native 
proteins may have rapidly diffused out of the microgels prior to heating. Second, the 
protein molecules inside the microgels may have been resistant to thermal denaturation or 
aggregation, and so they were still small enough to rapidly diffuse out of the microgels. 
In contrast, almost all of the proteins appeared to remain trapped inside the microgels 
when the proteins were denatured before they were incorporated into the microgels, i.e., 
pre-D-MGs (Fig. 6.8c). In addition, visual observations of these microgels indicated that 
they had a whitish color rather than the more translucent appearance of the other two 
samples.  This effect was probably because the presence of the proteins inside the 
microgels increased their refractive index, which led to stronger light scattering 373. These 
results suggest that the most effective means of ensuring a high retention of the proteins 
under neutral pH conditions is to pre-heat the proteins prior to forming the microgels. 
Previous studies have reported that heating aqueous whey protein solutions above 
their thermal denaturation temperature at neutral pH leads to the formation of long 
filaments 374. Moreover, studies have shown that these anionic protein filaments are 
cross-linked in the presence of Ca2+ ions at ambient temperature 375-377.  Consequently, 
the proteins may have remained within the microgels for the pre-D-MGs because they 
were present as large filaments that could not easily diffuse through the biopolymer 
network, and because they were cross-linked by the calcium ions during the alginate 
gelation process (Fig. 6.9). For this reason, the pre-D-MGs were selected to study the 
effect of bead encapsulation on the gastrointestinal fate of the whey proteins in the 
remainder of the study.  
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(a) 
              
(b) 
                               
(c)  
Figure 6. 8 Visual appearance and confocal images of (a) native protein microgels (N-
MGs), (b) post-loading denatured protein microgels (post-D-MGs), and (c) pre-loading 
denatured protein microgels (pre-D-MGs) in the calcium chloride solution.   
6.2.3.2 Impact of gastrointestinal passage on electrical characteristics 
In this section, four different samples were studied to determine the impact of 
denaturation and encapsulation on the gastrointestinal fate of the proteins: native protein 
solutions (N-S); denatured protein solutions (D-S); pre-loading denatured protein 
microgels (pre-D-MGs); and, denatured protein solutions mixed with microgels (D-
S+MGs).  The electrical characteristics (z-potential) of these samples were measured as 
they passed through the various stages of the simulated GIT. The initial ζ-potential values 
of all the samples were highly negative: -19.9, -22.8, -26.7 and -21.9 mV for N-S, D-S, 
pre-D-MGs and D-S+MGs, respectively (Figure 6.9). The net negative charge of the 
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native and denatured protein solutions can be attributed to the fact that the pH was above 
the isoelectric point of the whey proteins.  The negative charge on the protein-loaded 
microgels (pre-D-MGs) can be attributed to the presence of anionic carboxylic (-COO- ) 
groups on the mannuronic and guluronic acid monosaccharides that make up the alginate 
chains. As expected, the sample containing a mixture of denatured proteins and microgels 
(D-S+MGs) also had a negative charged because both the anionic proteins and the 
anionic microgels contributed to the overall electrophoretic signal 365.  
 
Figure 6. 9 The schematic of the fabrication and incubation properties of native protein 
microgels (N-MGs) and pre-loading denatured protein microgels (pre-D-MGs). 
 
After passing through the simulated mouth phase, there was a slight decrease in the 
magnitude of the negative z-potential for all samples (Figure 6.9). This reduction may 
have occurred due to the presence of mineral ions in the simulated saliva, which decrease 
the magnitude of the ζ-potential due to ion binding and electrostatic screening effects 365. 
A large reduction in the magnitude of the ζ-potential occurred on all the samples after 
incubation in the simulated stomach phase. Previous studies have attributed this effect to 
protonation of ionizable groups and electrostatic screening due to the low pH and high 
ionic strength of the simulated gastric fluids 230.  Under highly acidic pH conditions, the 
proteins should become positively charged, but this charge may have been partially 
neutralized by the presence of the anionic mucin molecules from the mouth.  The 
microgels should also lose much of their negative charge under highly acidic conditions 
due to protonation of the carboxyl groups on the alginate chains. After exposure to the 
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simulated small intestine phase, all the samples again showed relatively high negative 
charges.  Under these conditions both the digested proteins and the alginate molecules 
should have regained their negative charge since the pH was well above the pKa values of 
the anionic carboxyl groups. Moreover, there will have been other types of anionic 
species present in the small intestine phase after digestion, such as bile salts, mucin, and 
digestive enzymes.  
6.2.3.3 Impact of gastrointestinal passage on particle size and microstructure  
In this section, the microstructure of the different systems was determined after 
exposure to each GIT stage.  In addition, the particle size of the samples containing 
microgels was measured using static light scattering.  The protein solutions could not be 
analyzed using light scattering because the particles were too small to detect using this 
instrument.    
Protein solutions. The confocal microscopy images indicated that the 
microstructures of both protein solutions (native and denatured) were fairly similar 
throughout the GIT process (Figure 6.11). Initially, the proteins were uniformly 
dispersed throughout the samples. Previous studies have reported that heat denatured 
proteins tend to form homogenous fine stranded network structures at neutral pH 378. 
After exposure to the mouth phase, the proteins were still fairly evenly dispersed 
throughout the system, but there did appear to be some evidence of clumping in the 
microscopy images.  This may have been due to association of the protein molecules with 
mucin from the simulated saliva. A significant decrease in fluorescence intensity was 
observed when both protein solutions moved from the mouth to the stomach phase.  This 
decrease can mainly be attributed to the fact that the intensity of the fluorescence probe 
used to stain the proteins (FITC) is reduced under highly acidic conditions due to 
quenching 275, 292. After passing through the small intestine, some relatively large protein-
rich particles were observed in the digesta by confocal microscopy, which were probably 
aggregated whey proteins, peptides, or digestive enzymes.  
Microgel samples. The general shape of the particle size distributions of the 
microgel samples remained monomodal after passing through the different stages of the 
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GIT model (Figure 6.10).  This suggested that the microgels were resistant to digestion 
and disintegration within the GIT, which was confirmed by the confocal microscopy 
images (Figure 6.11). These results were also in agreement with the finding in previous 
study (3). Nevertheless, appreciable changes in the average dimensions of the microgels 
were observed when they were exposed to different GIT phases.  As has been reported in 
previous studies, the mean diameter of the alginate microgels was slightly smaller in the 
highly acidic gastric fluids than in the other phases 379. This result can be attributed to the 
fact that the carboxyl groups on the alginate chains are highly charged at neutral pH, and 
so there is a relatively strong electrostatic repulsion between the chains that promotes 
swelling of the microgels. On the other hand, the carboxyl groups are partially protonated 
and so lose their negative charge in acid solutions (i.e., stomach phase), which weakens 
the electrostatic repulsion between the chains and promotes shrinking of the microgels.  
 
Figure 6. 10 Electrical properties of the different samples measured after exposure to 
different GIT stages. Samples designated with different capital letters (A, B, C and D) 
were significantly different (Duncan, p < 0.05) when compared between different GIT 
regions. Samples designated with different lower letters (a, b, c) were significantly 
different (Duncan, p < 0.05) when compared between different delivery systems. (N-S: 
native protein solutions; D-S: denatured protein solutions; pre-D-MGs: pre-loading 
denatured protein microgels; and, D-S+MGs: denatured protein solutions mixed with 
microgels).  
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The confocal microscopy images of the system that contained denatured proteins 
mixed with microgels (D-S+MGs) indicated that the proteins in the aqueous phase 
behaved in a fairly similar manner to those in the denatured protein solutions (D-S).  
Thus, the GIT fate of the denatured proteins did not appear to be significantly altered by 
the presence of the alginate microgels (Figure 6.11). The confocal microscopy images of 
the system that contained denatured proteins encapsulated within microgels (pre-D-MGs) 
indicated that the proteins remained trapped inside the microgels throughout the GIT.  
          
(a) (b) 
 
Figure 6. 11 Particle size distributions of different samples after exposure to successive 
GIT stage: (a) heated WPI in beads (pre-D-MGs) and (b) heated WPI with beads (D-
S+MGs). 
6.2.3.4 Impact of encapsulation on protein digestion  
In this series of experiments, an automatic titration (pH stat) method was used to 
evaluate the rate and extent of protein digestion in different delivery systems. The 
principle of this method is that protein hydrolysis causes a change in pH that depends on 
the number of peptide bonds cleaved, which can be determined by measuring the volume 
of acid or base solution required to keep the pH constant 371. 
Under simulated stomach conditions, there was a rapid digestion of whey protein in 
all of the samples during the first 5 minutes, followed by a more gradual digestion 
throughout the rest of the incubation period (Figure 6.12). Nevertheless, there were some 
differences in the digestion rates between the different samples.  For the proteins in 
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solution, the native protein (N-S) was digested more slowly than the denatured protein 
(D-S).  Previous studies have also reported that native whey proteins are more resistant to 
gastric digestion than denatured ones 380-381, which was attributed to the fact that the 
peptide bonds in the native globular proteins are more difficult for the proteases to access.  
Heat treatment induces conformational changes in the protein molecules, which increases 
the exposure of peptic cleavage sites and thus increases their susceptibility to pepsin 
hydrolysis. The denatured proteins were digested at a similar rate in the protein solutions 
(D-S) and in the mixed systems (D-S+MGs), which suggested that the microgels did not 
alter their hydrolysis. On the other hand, encapsulation of the denatured proteins inside 
the microgels led to an appreciable decrease in their digestion under simulated gastric 
conditions (Figure 6.12).  Presumably, the microgels were able to restrict the ability of 
the proteases from the aqueous phase to come into contact with the encapsulated protein 
molecules, thereby reducing their digestion.  
Under small intestine conditions, the native protein solution (N-S) showed the 
fastest rate of protein hydrolysis, while all the samples containing denatured protein were 
digested at a similar slower rate (Figure 6.13). Previous studies have reported that the 
digestion of native proteins in the small intestine is facilitated after they pass through the 
stomach, which is probably due to partial denaturation of the proteins in the highly acidic 
gastric fluids 371.  The fact that encapsulation of the denatured proteins within the 
microgels did not appear to inhibit their digestion under small intestine conditions, 
despite the fact that the proteins appeared to be trapped within the microgels (Figure 
6.11), suggests that the digestive enzymes may have been able to penetrate into the 
microgels under these conditions.  These results suggest that the microgels may be able to 
inhibit protein digestion in the stomach phase, but not in the small intestine phase.   
  224 
 
Figure 6. 12 Microstructures of different samples after exposing to different regions of 
the simulated GIT (Scale bar is 100 µm). (N-S: native protein solutions; D-S: denatured 
protein solutions; pre-D-MGs: pre-loading denatured protein microgels; and, D-S+MGs: 
denatured protein solutions mixed with microgels)  
 
Overall, the relatively low extents of protein hydrolysis observed in our study (< 
20%), are similar to those reported in other in vitro studies 371.  In reality, in vitro GIT 
models cannot reproduce the complex conditions that occur in vivo 370. Therefore, animal 
and human studies are still needed to verify the impact of encapsulation on protein 
digestion in practice.  
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Figure 6. 13 The hydrolytic performance of WPI in different samples under simulated 
stomach digestion measured using a pH-stat in vitro digestion model. (N-S: native protein 
solutions; D-S: denatured protein solutions; pre-D-MGs: pre-loading denatured protein 
microgels; and, D-S+MGs: denatured protein solutions mixed with microgels)  
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Figure 6. 14 The hydrolytic performance of WPI in different sample after simulated 
small intestine digestion measured using a pH-stat in vitro digestion model. (N-S: native 
protein solutions; D-S: denatured protein solutions; pre-D-MGs: pre-loading denatured 
protein microgels; and, D-S+MGs: denatured protein solutions mixed with microgels)  
 
6.2.4 Conclusion 
In the present study, it was shown that protein-loaded microgels could be fabricated 
by injecting a mixture heat-denatured whey protein and alginate molecules into a calcium 
solution.  If the protein molecules were not denatured prior to incorporation into the 
microgels, they had a tendency to leach out, presumably because they were small enough 
to diffuse through the pores in the biopolymer network that makes up the interior of the 
microgels.  A simulated GIT method suggested that encapsulation of the denatured 
proteins within the microgels inhibited their hydrolysis under stomach conditions, but not 
under small intestine conditions.  These results suggest that protein encapsulation in 
biopolymer microgels may be useful for modulating protein digestion and peptide release 
within the gastrointestinal tract.  However, animal and human studies are needed to 
confirm these findings in real GITs.  Moreover, studies are needed to determine whether 
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modulating the rate and extent of protein digestion can impact hormonal responses such 
as hunger, satiety, and satiation.  
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CHAPTER 7 
 
CONTROL THE RELEASE AND DIGESTION OF LIPIDS USING HYDROGEL 
BEADS 
7.1 Introduction 
 Triacylglycerols are nutritionally important constituents of the human diet 
because they are a major supply of energy, a source of essential fatty acids, and carriers 
of lipophilic micronutrients and nutraceuticals 382.  The digestion of triacylglycerols 
within the human body is usually highly efficient 126, 383, which can be attributed to the 
fact that humans evolved in an environment where calories were often scarce.  From a 
physicochemical point of view, lipid digestion is a highly complicated process involving 
various types of colloidal and interfacial processes throughout the gastrointestinal tract 
(GIT) 126, 384-385.  The triacylglycerols in ingested foods often exist as lipid droplets or 
they are converted into lipid droplets during mastication in the mouth or churning in the 
stomach 1, 385.  In humans, the process of triacylglycerol digestion begins in the stomach 
due to the presence of gastric lipase, but is mainly carried out in the small intestine due to 
the presence of pancreatic lipase 126, 238.  These lipases typically adsorb to the surfaces of 
the lipid droplets and convert the triacylglycerols (TGs) into diacylglycerols (DGs), 
monoacylglycerols (MGs), and free fatty acids (FFAs).  The presence of lipid digestion 
products in the small intestine stimulates the release of hormones that regulate 
gastrointestinal motility, gastric emptying times, feelings of hunger/satiety/satiation, and 
total energy intake 386-388. Consequently, controlling the rate and extent of triacylglycerol 
digestion within the GIT may lead to the creation of functional foods that can modulate 
food intake, and therefore aid in the fight against problems with overweight and obesity 
389. 
 Structural design approaches can be used to create emulsion-based foods that can 
control lipid digestion within the GIT 62, 385, 390.  These approaches are used to change the 
size, composition, interfacial properties, aggregation state, or local environment of the 
lipid droplets in foods, thereby altering the way they are processed within the GIT 1. 
Previous studies have shown that filled hydrogel beads are one of the most effective 
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means of retarding lipid digestion under simulated GIT conditions 76.  This type of 
delivery system consists of lipid droplets trapped within hydrogel beads.  Filled hydrogel 
beads are typically fabricated using a two-step process: (i) a droplet-loaded biopolymer-
rich particle is formed; (ii) the biopolymer molecules are cross-linked using a suitable 
physical or covalent method.  A number of particle formation methods are available, 
including injection, coacervation, segregation, antisolvent precipitation, emulsion 
templating, and molding methods 270. The injection-gelation method is one of the 
simplest and most widely used for encapsulating lipid droplets.  An aqueous solution 
containing a mixture of lipid droplets and biopolymer is injected into a ‘‘hardening’’ 
solution that promotes cross-linking and gelation of the biopolymer molecules. This 
procedure results in the formation of a hydrogel bead with lipid droplets trapped inside. 
Changing the composition, dimensions, or pore size of the hydrogel beads can be used to 
modulate the GIT fate of the lipid droplets 76.  
Magnetic resonance imaging (MRI) is a potentially powerful tool for the 
investigation of filled hydrogel beads in the GI tract as it is non-invasive and 
differentially sensitive to meal components without using ionising radiation. MRI can 
image fat and water components of model meals separately based on T1 relaxation and 
chemical-shift properties. MRI have been previously used to directly visualize the lipids 
in alginate beads within the meal in the human GI tract, as well as in simulated GI 
conditions. Magnetic resonance spectroscopy (MRS) is a long established MR-based 
method and generally considered the clinical gold-standard technique to quantify the fat 
fraction in a sample or organ. The method is based on integrating the frequency spectrum 
peaks of water and the fat, which is obtained from a small, spatially localized volume of 
interest (voxel) within the region of interest. 
 In this study, we examined the possibility of modulating the rate and extent of 
lipid digestion under simulated GIT conditions by mixing together rapidly digesting and 
slowly digesting delivery systems.  The rapidly digesting delivery systems were 
nanoemulsions containing free lipid droplets, whereas the slowly digesting delivery 
systems were lipid droplets encapsulated within hydrogel beads.  It was hypothesized that 
mixing different ratios of free and encapsulated lipid droplets would lead to delivery 
systems with different lipid digestion profiles. Moreover, we examined the possibility of 
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utilizing MRI and MRS to determine the lipids release properties from hydrogel beads in 
simulated gastric conditions. The information obtained in this study may therefore lead to 
the development of functional foods that can control triacylglycerol blood levels, 
hunger/satiety/satiation responses, and calorie intake by controlling the rate and extent of 
lipid digestion. Furthermore, the results obtained from current study may also provide us 
the valuable evaluation of novel use of MR-based technology in emulsion based colloidal 
delivery system within GIT.  
7.2 Materials and methods 
7.2.1 Materials  
 Corn oil was purchased from a local supermarket and used without further 
purification. Carrageenan (κ-) was donated by FMC Biopolymer (Viscarin SD 389, 
Philadelphia, PA). Tween 80 and alginic acid (sodium salt, from brown algae, medium 
viscosity) were purchased from the Sigma Chemical Company (St. Louis, MO). All other 
chemicals were analytical grade.  Double distilled water was obtained from a water-
purification unit. 
7.2.2. Preparation of nanoemulsions 
The aqueous phase consisted of 4% (w/w) Tween 80 dispersed in buffer solution (5 
mM phosphate buffer, pH 7.0), stirred for 2 hour at ambient temperature, and then stored 
overnight at 4 °C. The oil phase consisted of corn oil at ambient temperature.  
Coarse emulsions were prepared by blending 40% (w/w) oil phase and 60% (w/w) 
aqueous phase using a high-shear mixer (Bamix, Biospec Products, Bartlesville, OK) for 
2 min at ambient temperature.  Nanoemulsions were prepared by passing the coarse 
emulsions through a dual-channel microfluidizer equipped with a Y- and Z-type 
interaction chamber (Microfluidics PureNano, Newton, MA, USA) three-times at 12 kpsi. 
The Y-type chamber was placed before the Z-type chamber, which facilitate the 
formation of small emulsion droplets with high lipid concentration. The resulting 
nanoemulsions were then diluted with buffer solution (5 mM phosphate, pH 7.0) to 
obtain samples with a range of lipid droplet levels. 
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7.2.3. Preparation of filled biopolymer microgels 
Aqueous alginate and κ-carrageenan solutions were prepared by dissolving powdered 
polysaccharide ingredients in distilled water at evaluated temperature (60 °C), then 
reducing the temperature to 35 °C with continuous stirring until totally dissolved. 
Nanoemulsions were then mixed with polysaccharide solutions to create a final system 
containing 35% lipid droplets (w/w) and 0.5% polysaccharide (w/w). Filled alginate 
microgels were formed by using a simple hand-held syringe (BD Safety-Lok 10 mL 
Syringe with a 0.6 mm-diameter tip, Franklin Lakes, NJ) to drip nanoemulsion-alginate 
mixtures (2s per drop) into 20 mL 5% (w/w) calcium chloride (Ca2+) solutions with 
continuous stirring. Similarly, filled carrageenan microgels were prepared by dripping 
nanoemulsion-κ-carrageenan mixtures into 5% (w/w) potassium chloride (K+) solutions.  
The filled microgels formed were incubated in the cation (Ca2+ or K+) solutions for 20 
min at ambient temperature to promote crosslinking. They were then filtered by filtration 
paper (Fisher Science, P5) and washed with distilled water and phosphate buffer solution 
to remove any excess ions from their surfaces. The particle size of microgels were 
determined using a digital caliper (Fowler high Precision, Newton, MA, USA)  
7.2.4. Simulated gastric conditions 
The effect of simulated gastric conditions on the properties of the filled microgels 
was determined using a method described previously 318, with some slight modifications.  
Filled alginate or carrageenan microgels were added at a ratio of 1:1 (w/w) to simulated 
gastric fluids (SGF) that had been preheated to 37 °C and then adjusted to pH 2.5. The 
resulting mixture maintained at 37 °C with continual stirring for 2 h to mimic gastric 
peristalsis and digestion
7.2.5. Turbidity measurements  
The turbidity of the fluids surrounding the microgels was determined as an indication 
of the release of the lipid droplets. The beads were removed by filtration and the 
turbidities of residual solution were measured using a UV-visible spectrophotometer at 
600 nm (Ultrospec 3000 pro, Biochrom Ltd., Cambridge, UK). Test samples were 
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contained within 1-cm path length optical cells and phosphate buffer was used as a 
control. Turbidity measurements were carried out on at least two freshly prepared 
samples. Changes in the appearance of the samples were also recorded throughout gastric 
digestion using a digital camera. A fraction of microgels were taken from the digestion 
phase to facilitate their detection. 
7.2.6. MRI and MRS analysis 
The release of the lipid droplets from the filled microgels during the simulated 
stomach digestion period were studied using a MRI instrument (3T, Siemens Skyra). 
Samples collected from the stomach phase were loaded into an glass tube with a screw-
top. Any air bubbles were completely removed from the samples before sealing to 
eliminate deviationMR imaging and spectroscopy were performed by placing the 
samples into the 3T MR instrument with a 15-ch knee RF coil. The tubes were positioned 
axially as a bundle of 7 tubes so that the tube axis was aligned with the magnet axis for 
the quantitation study in which the lipid content was measured. The tube bundle was also 
positioned vertically for the imaging of individual microgel. The tubes were scanned with 
a 3-dimensional T1-weighted sequence, i.e., T1 VIBE or water-selected T1 VIBE 
sequence, in an axial orientation with TR/TE = 10/4.92 ms, voxel size = 0.8×0.8×4 mm3, 
and flip angle = 10 degree. The MR spectra were obtained using a stimulated echo 
acquisition mode (STEAM) sequence of a single voxel of 10×10×15 (F/H) mm3, 
TR/TE=1200/20 ms, and water suppression 391-392. 
7.2.7. Statistical analysis 
 All experiments were performed on at least two freshly prepared samples. The 
results are reported as averages and standard deviations. These analyses were carried out 
by T-tests using Excel (Microsoft, Redmond, VA, USA). 
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7.3. Results and Discussion 
7.3.1. Influence of gastric conditions on characteristics of filled microgels 
Filled microgels were prepared by injecting mixtures of lipid droplets and anionic 
biopolymers (carrageenan or alginate) into cationic mineral solutions (K+ or Ca2+). These 
constituents were selected as the formed microgels showed significantly different 
structure and properties. The carrageenan microgels produced had an irregular shape with 
rough surfaces, whereas the alginate microgels had spheroid shapes with smooth surfaces 
(Fig. 1). The diameter of the carrageenan microgels (» 3 mm) was slightly larger than 
that of the alginate ones (» 2.5 mm).  These structural differences have previously been 
attributed to the different gelation mechanisms of the two polysaccharides.  Carrageenan 
gelation is induced by crosslinking anionic sulfate groups in different polysaccharide 
chains with cationic potassium ions, whereas alginate gelation is the result of crosslinking 
of anionic carboxylic groups with cationic calcium ions 233.  Gelation of alginate would 
be expected to be stronger and faster than carrageenan because divalent calcium ions are 
more efficient crosslinking agents than monovalent potassium ions 393.   
Initially, all of the lipid droplets were trapped inside the microgels, which could be 
deduced from the fact that the microgels looked white while the surrounding solution was 
optically clear (Figs. 1 and 2). Thus, both types of microgel could effectively trap the 
lipid droplets inside.  Presumably, the dimensions of the lipid droplets were greater than 
those of the pore size of the biopolymer network inside the microgels, thereby inhibiting 
their movement 76.  
After exposure to gastric conditions, visual observations showed there was a 
progressive reduction in the size and integrity of the carrageenan microgels, as well as an 
increase in the cloudiness of the surrounding aqueous phase (Figure 7.1).  Indeed, almost 
all of the carrageenan microgels had fully dissociated after 120 min exposure to the 
simulated stomach phase.  Conversely, the alginate microgels remained intact throughout 
the entire incubation period in the gastric fluids and there was only a slight increase in the 
cloudiness of the surrounding fluids. The turbidity of the solution surrounding the 
microgels increased steeply during incubation in the gastric fluids for the carrageenan 
system but only slightly for the alginate system (Figure 7.2). Taken together, these 
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results indicated that the carrageenan microgels were more unstable in simulated gastric 
conditions than the alginate microgels.  
 
 
Figure 7. 1 The optical images of two types of microgels after different simulated 
stomach digestion period (a fraction of microgels were taken out from the simulated 
digestion phase to facilitate the observation). 
 
The disintegration of carrageenan microgels under stomach conditions can be 
attributed to the strong acidity, high ionic strength, and mechanical agitation of the 
gastric fluids.  Presumably, the crosslinks holding the carrageenan molecules together in 
the microgels are weaker than those holding the alginate molecules together.  As a result, 
they are more likely to be disrupted at high ionic strengths because this weakens the 
electrostatic attraction between the polysaccharide molecules and the counter-ions.  In 
particular, the sodium ions in the gastric fluids could displace the potassium ions that 
form the crosslinks between the carrageenan molecules, but not the calcium ions that 
form the crosslinks between the alginate molecules.  Interestingly, the pKa values of the 
sulfate groups in carrageenan (around pH 2) are considerably lower than those of the 
carboxyl groups in alginate (around pH 3.5).  This suggests that deionization of the 
anionic groups on the polysaccharide molecules was not a major factor contributing to 
differences in their behavior in the acidic gastric fluids. 
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Figure 7. 2 The turbidity of residual solution in two types of microgels during different 
simulated stomach digestion period (0-120 min). 
 
It has been reported that up to 30-40% of lipid digestion occurs within the human 
stomach 394. Our previous study showed that free lipid droplets are digested much more 
rapidly than lipid droplets encapsulated within biopolymer microgels, which was 
attributed to the restricted diffusion of lipase molecules through the biopolymer matrix 76. 
The early release of the lipid droplets from the carrageenan microgels might therefore be 
expected to lead to faster lipid digestion under gastrointestinal conditions, which has been 
reported in previous studies 395-396.  
7.3.2. Development of standard curve for lipid quantification 
A major goal of our research was to demonstrate the potential for magnetic 
resonance imaging and spectroscopy to non-invasively monitor the release of 
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encapsulated lipids from biopolymer microgels.  Initially, it was therefore necessary to 
establish correlations between lipid droplets levels in the GIT fluids and measurable MRI 
parameters.  We examined two different approaches for discriminating between the lipid 
and water in the samples, one based on measurements of relaxation times and the other 
based on chemical shift spectroscopy.  
 
 
Figure 7. 3 A transaxial view of the 3-dimensional T1-weighted water-selected images 
from tubes filled with emulsions with different lipid concentration. The lipid 
concentration of each tube is marked in percentage on or next to each tube. The tube axis 
was aligned with the magnet axis and thus the trapped air was seen as signal void on the 
top portion of some tubes.  
 
A series of samples with different lipid levels (0-40%) was prepared by diluting the 
most concentrated nano emulsions produced by micro fluidization with buffer solutions.  
Water-selected T1 weighted images and spectroscopy analysis of the samples were then 
carried out using the MRI instrument. The axis of the cylindrical phantom was aligned 
parallel to the static magnetic field and positioned in the center of the knee RF coil to 
improve magnetic homogeneity and obtain better water excitation images with high 
resolution.  
Relaxation Measurements:  Initially, we consider the use of relaxation measurements 
to determine the lipid content of the samples.  A water-selected sequence was used to 
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discriminate the water phase from the lipid phase in the nanoemulsions 397. Using this 
pulse sequence, the water is excited and produces a signal that appears as bright regions 
in the images. Conversely, the lipid remains in equilibrium, thereby producing no signal, 
which results in dark regions in the images.  
Nanoemulsion samples with different lipid contents could clearly be distinguished 
using the T1 water-selected images (Figure 7.3).  As expected, the images became 
brighter as the lipid level decreased, i.e., as the water level increased.  For quantitative 
analyses, the signal intensity at identical positions within each sample was measured by 
selecting a target region of interest (ROI). The mean signal intensity over the ROI was 
used to represent the signal of each nanoemulsion sample.  The signal intensity decreased 
linearly with increasing lipid concentration (Figure 7.4a), with a high negative 
correlation (R2 = 0.9882). These results suggest that the MRI relaxation approach is 
suitable for determining the lipid content of samples. 
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(b) 
 
Figure 7. 4 Relationship of the lipid concentration with (a) T1-weighted image intensity 
and (b) MR spectral peak amplitude. The dotted line in each graph indicates the linear 
regression with the equation denoted in each graph. 
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Figure 7. 5 MR spectra of emulsion samples with different lipid concentrations (0-40%). 
The peak integral value of the lipid peak is marked with a red rectangle.  
 
Spectroscopy Measurements: A chemical spectroscopy method was also used to 
discriminate between the lipid and water phases in the samples (Figure 7.5).  The peaks 
in the MRI frequency spectrum corresponding to the lipids and water were integrated 
from the ROI for each nanoemulsion sample.  Previously, the main CH2 (1.6 ppm) peak 
has been reported to be particularly useful for determining lipid contents in biological 
samples at clinical field strengths 398-399. The area under the curve of the real part of the 
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frequency domain signal was used as the integrated signal amplitude to correlate to the 
lipid concentration.  Our results indicated that the integral values increased linearly with 
lipid concentration in the nanoemulsion samples with a high positive correlation (R2 = 
0.9755) (Figure 7.4b, Figure 7.5). These results indicate that MR spectroscopy may also 
be used to determine the lipid content of samples.   
7.3.3. Determination of the release properties of lipid droplets from microgels 
In this section, filled carrageenan and alginate microgels were prepared for analysis 
using the two MR-based methods.  T1-weighted VIBE sequence images and T1-weighted 
water-selected images of the microgel dispersions were then acquired after they were 
incubated in simulated gastric fluids for different period (0 to 120 min). The phantom 
configuration that was set vertically or aligned to the knee of coil to facilitate the 
observation or quantitation. 
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Figure 7. 6 Digestion periods of two types of microgels: (a) The phantom configuration 
that was set vertically inside the knee of coil, (b) T1-weighted MRI and (c) water-selected 
T1-weighted MRI. In each image, ‘Car’ and ‘Alg’ denote the carrageenan and alginate 
microgels, respectively. The digestion period of each tube is denoted next to each tube in 
minute.  
 
For obtaining the T1-weighted images, the tube bundle was positioned vertically 
inside the coil and a relatively small voxel size (0.8×0.8×4 mm3) was used to visualize 
individual microgels. These images showed that the filled alginate microgels retained 
their spherical shape and integrity throughout the incubation period (Figure 7.6b).  While 
the filled carrageenan microgels exhibited quite different behavior.  They progressively 
disintegrated when they were dispersed in the gastric fluids, almost completely 
disappearing after 60 minutes of incubation (Figure 7.6b). These results agree with our 
previous studies, which showed that the digestion of lipid droplets was much slower 
when they were encapsulated in alginate microgels rather than carrageenan ones 400.  
Again, these effects can be attributed to the fact that the crosslinks between the alginate 
molecules in the microgels are much stronger than those between the carrageenan 
molecules.  As a result, the alginate microgels are more resistant to gastric conditions 
than the carrageenan molecules.     
The phantom configuration was also set aligned to the knee of coil to improve 
magnetic homogeneity. We could observe that the lipid-loaded alginate microgels floated 
to the top of the simulated gastric fluids (Figure 7.7b).  These results suggest that the 
encapsulation of the lipid droplets inside the alginate microgels could delay their gastric 
emptying, since they would tend to float on top of the gastric fluids and not easily pass 
through the pylorus sphincter 401. This characteristic may be advantageous for certain 
applications of microgels in functional foods. For carrageenan microgels, most of them 
were dissolved in the simulated stomach phase after 60 minutes of incubation. However, 
they still floated to the top of the gastric fluids at shorter incubation times (Figure 7.7b). 
We then determined the changes in the water-selected T1-weighted images of the 
microgel samples over different simulated digestion time (Figure 7.6c and 7.7c). The 
results obtained were very similar to those obtained from the T1-weighted images. The 
alginate microgels remained intact throughout the digestion period, whereas the 
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carrageenan microgels progressively disintegrated.  In addition, the microgels could again 
be seen to float to the top of the gastric fluids using this approach.  
 
 
(a) 
    
(b)                                                            (c) 
 
 
Figure 7. 7 Digestion periods of two types of microgels: (a) The phantom configuration 
that was set in the knee of coil, (b) T1-weighted MRI and (c) water-selected T1-weighted 
MRI. In each image, ‘Car’ and ‘Alg’ denote the carrageenan and alginate microgels, 
retrospectively. The digestion period of each tube is denoted next to each tube in minute. 
The tube axis was aligned with the magnet axis to improve magnetic homogeneity.   
 
Quantification of Lipid Release: Finally, we compared the effectiveness of the 
relaxation and spectroscopy approaches for monitoring lipid droplet release from the 
microgels during incubation in the simulated gastric fluids (Figure 7.8, Figure 7.9 and 7. 
10).  The lipid release profiles were obtained using the standard curves of intensity versus 
lipid content (relaxation) or integral value versus lipid content (spectroscopy) described 
in the previous section.  These measurements were carried out on the fluid phase 
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surrounding the microgels in the tubes settled aligned to the magnetic axis. Only the 
carrageenan microgels were analyzed in these experiments because there were so few 
lipid droplets released from the alginate microgels. 
 
Figure 7. 8 The release profile of lipid from carrageenan microgels during 2h’ simulated 
stomach digestion period. The lipid release fraction were calculated based on the 
intensity and integral value of carrageenan microgels samples obtained from T1 weighted 
MRI and the MR spectra.  
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Figure 7. 9 Image intensities of two types of microgels obtained from the water-selected 
T1-weighted MRI. ‘Car’ and ‘Alg’ denote the carrageenan and alginate microgels, 
respectively. The digestion period of each tube is denoted next to each tube in minute.  
 
Our results suggest that the release of the lipid droplets from the carrageenan 
microgels occurred relatively slowly within the first 30 min, and then became faster after 
about 60 min’s incubation (Figure 7.8).  This effect can be attributed to the disintegration 
of the carrageenan microgels at around the same time, as seen in the MR images (Figure 
7.6 and 7.7).  The lipid release profiles obtained from intensity and integral values 
showed very similar trends, indicating both of these methods can be used to detect 
microgel integrity and lipid release in situ. Interestingly, the UV-visible spectroscopy 
measurements indicated that the turbidity of the carrageenan microgels increased 
immediately after they were incubated in gastric fluids (Figure 7.2).  This may have been 
because only a very low concentration of lipid droplets is required to increase the 
turbidity of a solution, whereas a relatively high concentration is required to be detectable 
by MRI. The turbidity measurements are therefore not very useful for quantifying lipid 
droplet release at realistic food compositions. Moreover, turbidity measurements would 
be problematic in complex food systems that contained other types of particles that can 
scatter light. 
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Figure 7. 10 MR spectra of two types of microgels after different simulated stomach 
digestion period. The integral value of the lipid peak is marked with a red rectangle.  In 
each image, ‘Car’ and ‘Alg’ denote the carrageenan and alginate microgels, respectively. 
 
7.4. Conclusion 
This study demonstrates the feasibility of MRI-based approaches to non-invasively 
monitor microgel integrity and to quantify lipid droplet release under gastrointestinal 
conditions.  The MRI techniques used clearly showed that alginate microgels are much 
more resistant to gastric conditions than carrageenan microgels.  Carrageenan microgels 
broken down and released their lipid droplets, whereas alginate microgels stayed intact 
and retained their lipid droplets.  This phenomenon may have important implications for 
the design of functional foods that control the release of bioactive agents within the 
human GIT.  Carrageenan microgels could be used to slowly release bioactive agents in 
the stomach, whereas alginate microgels could be used to deliver them further down the 
gastrointestinal tract.  One of the advantages of the MRI method is that 3-dimensional 
images of the samples can be obtained so it is possible to detect the location of the 
microgels over time.  In this study, it was found that the lipid-loaded microgels tended to 
float on top of the gastric fluids, which would be expected to alter the gastrointestinal fate. 
Previous studies have shown that MRI measurements can be carried out in humans to 
monitor the gastrointestinal of ingested microgels after a meal.  The two signal 
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acquisition approaches developed in the current study may increase the power of MRI for 
obtaining detailed information about the behavior of lipids inside humans.  These tools 
may facilitate the more rational design of functional foods that behave in a controlled 
fashion inside our bodies. 
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